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Abstract  
The profile of severe allergy and particularly food allergy has developed significantly 
since the early 1990s. The establishment of the Anaphylaxis Campaign in 1994 in the 
UK led to a serendipitous relationship between advocacy and research. Investigating 
the impact of food allergy through early member surveys informed Campaign 
initiatives and government and food industry policies, both to improve food 
information and the control of allergen risks, and access to specialist health care and 
the management of allergic emergencies. Their success in turn depended on 
individuals and organisations understanding their own roles in reducing allergy risks 
and being ready to work together to contribute to further research and advocacy. 
Collaborative and trusted partnerships within and beyond the UK continue to shape 
food and healthcare regulation and best practice, and contribute to standards for 
patient and consumer support, clinical and academic research. Formal and informal 
education and training, strategies to make scientific and clinical research accessible 
and applicable in food production and healthcare, and active use of social and other 
media shape knowledge and understanding for individuals at risk, those caring for 
them and those responsible for supplying their food.  
There are elusive knowledge gaps and research questions which require further 
attention. Primary prevention of food allergy seems to be possible through protocols 
for early dietary intervention, but the longer-term allergy profile for these children is 
not yet known. Initiatives are underway to reverse food allergy through 
immunotherapy, both through supervised consumption of everyday foods and through 
pharmaceutically prepared updosing for consumption or via the skin. The impact of 
severe allergy on quality of life indicates a need for tailored psychological support for 
some children, young people and adults. 
The role of local and national food control bodies to advise and supervise food 
businesses in controlling and communicating the presence of food allergens is key to 
ensuring consumer protection for those at risk. Investigations following severe and 
fatal reactions which may have involved food allergy require a collaborative approach, 
the timely collection of samples (wherever possible), careful selection and use of 
appropriate legislation, analytical support and reporting.  
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Work continues to define allergen thresholds, and to understand their inter-
relationship with symptom severity. Studies currently underway attempt to take into 
account some of the co-factors associated with severity. Progress towards the 
adoption and acceptance of allergen thresholds in food production and labelling, 
voluntarily or through regulation depends on improved stakeholder understanding and 
a high degree of trust, particularly for those making risk decisions about their own 
food, or food for those in their care.  
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1 Introduction 
 
M Hazel Gowland - Expert patient representative, researcher, lecturer and trainer 
specialising in food allergies  
Background 
Hazel Gowland has been allergic to nuts and peanuts since 1960 and has survived some 
severe reactions since. Her first degree was in French (with Management Studies) and 
after working in France and Germany, she qualified as a youth worker and secondary 
school teacher of modern languages and business studies. Since 1994 she has worked 
for and with the UK Anaphylaxis Campaign, a registered charity www.anaphylaxis.org.uk 
and independently to protect those at risk from severe food allergies through 
assessment, management and communication of allergy risks throughout the food 
supply chain and by campaigning for better access to diagnosis, allergen avoidance 
advice and symptoms management. Since 1988, she has investigated and recorded 
allergy-related deaths and ‘near misses’ and works at policy level to improve 
understanding of risk practice and behaviour, both among allergic people and food 
business operators. In 2000, she established Allergy Action – a sole trader organisation 
through which she undertakes research with a wide range of academic, regulatory and 
commercial bodies. She also develops materials and delivers lectures and training 
courses for many different audiences including university undergraduate and 
postgraduate students, food businesses, health care professionals, schools, nurseries, 
care personnel and families living with allergy.  
A personal note 
Living through a 1960s childhood, having severe early eczema, being exposed to 
peanut in the home environment and then having a severe reaction when first given it 
at the age of 14 months, being called Hazel and allergic to nuts, and following an 
unknown, but later all too familiar path through an atopic childhood, with associated 
asthma and some particularly severe reactions were all key circumstances which led to 
Gowland’s work in allergy. 
She was also shaped by a very matter of fact attitude to what was known to be a 
potentially life-threatening allergy from her parents and wider family. Although there 
were no food allergic people in their acquaintance, and only a few with asthma, their 
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explanations were clear and matter of fact. Gowland was never in any doubt that she 
might die from her allergy, but was also confident that she should be able to lead a 
normal life, learn languages (perhaps to ensure communication about her food 
allergies), take a variety of different jobs, live abroad, go to university, and find useful 
and fulfilling occupation.  
This portfolio of published work includes: 
 29 journal papers, P1-29 
 12 abstracts for oral presentations or posters A1-12 
 4 book chapters B1-4 
 24 examples of other work in the public domain W1-24 
(The published work is referenced in purple throughout.)  
This work will be examined to illustrate the following themes: 
 Investigating the impact of food allergies 
 Developing partnerships with key stakeholders 
 Shaping regulation and voluntary best practice  
 Setting standards to reduce risks 
Examples of the published work will also be used: 
 To indicate the impact and career context of Hazel Gowland’s work in food 
allergy 
 To illustrate novel research methods and strategies and their impact on food 
allergy risks 
 To illustrate the different roles undertaken and skills acquired by Hazel Gowland  
 To demonstrate the relationships established to protect those with food allergies 
and intolerances 
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2 The research outputs 
 
Key to research outputs: 
P = Journal Paper, A = Abstract, B = Book Chapter, W = Other Work 
* Peer reviewed 
Literature is cited in Harvard style.  
 
 
Figure 1:  M H Gowland Output by year 1997 - 2018 
Papers in journals P1 – P29 
The number of citations has been noted (where recorded) for all journal papers. 
A co-author has certified Hazel Gowland’s contribution for journal papers wherever 
possible, (See Appendix 1) and an estimate has been made of her percentage 
contribution to the project and the publication. 
P1 - 2001 
Gowland, M. H. (2001). Food allergen avoidance - the patient’s viewpoint. Allergy, 56 
(Supp. 67), pp. 117–120. * 
This paper was written at the request of the European Academy of Allergy and Clinical 
Immunology (EAACI) following an invitation to speak at their symposium in Venice in 
2001. The purpose was to present the patient’s perspective of living with food allergy 
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and associated atopic conditions to an audience of European allergy clinicians. (Sole 
author) 
This paper has been cited 51 times on Google Scholar and 27 times on Wiley Online and 
CrossRef. (Accessed 31st March 2018) 
P2 – 2002 
Gowland, M.H. (2002). Food allergen avoidance: Risk assessment for life. Proceedings of 
the Nutrition Society, 61 (1), pp. 39–43. * 
This paper was written at the invitation of the (UK and Ireland) Nutrition Society 
following a presentation at their meeting in Coleraine in 2001. The audience were 
primarily academic and clinical practitioners in nutrition and dietetics. (Sole author) 
This paper has been cited 34 times on Google Scholar and 19 times on the Cambridge 
University press website, Cambridge Core. (Accessed 31st March 2018) 
P3 – 2005 
Derby, C.J., Gowland, M.H., Hourihane, J.O’B. (2005). Sesame allergy in Britain: A 
questionnaire survey of members of the Anaphylaxis Campaign. Pediatric Allergy and 
Immunology, 16 (2), pp. 171–175. * 
This paper summarised the results of a member survey about the impact of sesame 
allergy amongst adult and children members of the Anaphylaxis Campaign.  
Gowland devised, designed, distributed and collected the survey questionnaires. Derby 
collated and analysed the survey data. Derby and Gowland both contacted subjects to 
elicit further data and followed up queries. Hourihane provided clinical insight and 
oversaw the data analysis and reporting. All three contributed to writing and editing the 
final paper. 
(Certified by C J Derby) (Gowland’s contribution c 40%) 
It has been cited 30 times on Wiley Online Library. (Accessed 31st March 2018) 
P4 – 2007 
Pumphrey, R. S. H. and Gowland, M. H. (2007). Further fatal allergic reactions to food 
in the United Kingdom, 1999-2006. Journal of Allergy and Clinical Immunology, 119 (4), 
pp. 1018–1019. * 
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This letter to the editor by Dr Richard Pumphrey and Hazel Gowland was proposed by 
the leading international Journal of Allergy and Clinical Immunology following 
publication of Pumphrey’s earlier longitudinal review of fatal food reactions to which 
Gowland had contributed informally. Pumphrey’s clinical database of severe and fatal 
reactions and Gowland’s informal records of fatal reactions to foods collected from 
families and inquests were cross-matched, reviewed, summarised and updated. Both 
authors contributed equally to writing and editing the publication.  
(Gowland’s Contribution c 50%) 
This letter has been very widely cited with 443 citations on Google Scholar. (Accessed 
31st March 2018) 
P5 – 2009 
Gowland, M.H. (2009). Food allergies. Perspectives in Public Health, 129 (2), pp. 62–
63.* 
This was a review article for the journal of the Royal Society of Public Health. (Sole 
author) 
P6 - 2010 
Madsen, C.B., Crevel, R., Chan, C.H., Dubois, A.E.J., DunnGalvin, A., Flokstra-de Blok, 
B.M.J., Gowland, M.H., Hattersley, S., Hourihane, J.O’B., Nørhede, P., Pfaff, S., Rowe, G., 
Schnadt, S., Vlieg-Boerstra, B.J. (2010). Food allergy: Stakeholder perspectives on 
acceptable risk. Regulatory Toxicology and Pharmacology, 57 (2010), pp. 256–265.* 
This was a position paper from the EU-funded Europrevall Integrated Project on food 
allergy which involved regulators (Chan, Hattersley), allergy clinicians (Dubois, 
Hourihane, Vlieg-Boerstra), food scientists/toxicologists (Madsen, Crevel, Pfaff), social 
scientists and psychologists (DunnGalvin, Flokstra-de Blok, Nørhede, Rowe) and expert 
patients / consumers (Schnadt and Gowland). The purpose was to review progress 
towards agreed allergen thresholds which could be used by the food industry and 
supported by regulators to protect consumers at risk. Gowland’s roles were a) to present 
and to represent the consumer / patient interest, b) to support ethics and the patient 
perspective for related studies and c) to contribute to writing and editing the final paper.  
(Certified by R W R Crevel) (Gowland’s contribution c 8%) 
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This paper has 29 citations on Science Direct (Elsevier). (Accessed 31st March 2018) 
P7 – 2010 
Monks, H., Gowland, M.H., Mackenzie, H., King, R., Lucas, J.S., Roberts, G. (2010). How 
do teenagers manage their food allergies? Clinical & Experimental Allergy, 40 (10), pp. 
1533-1540. * 
Gowland was expert project adviser on this study into teenager behaviour relating to 
food allergies conducted by Monks, a fourth year medical student at Southampton 
University. Mackenzie is a research psychologist who provided expertise in developing 
the study questionnaire and data interpretation, Roberts and Lucas are university 
professors and consultant paediatric allergy physicians and King is a paediatric allergy 
nurse. Their teenage clinic patients were the study subjects. Gowland contributed to the 
study ethics and questionnaire, reviewing the data and co-writing and editing the paper.  
(Certified by Professor J S Lucas) (Gowland’s contribution c 10%) 
This paper has 60 citations on Wiley Online Library. (Accessed 31st March 2018) 
P8 - 2011 
Leftwich, J., Barnett, J., Muncer, K., Shepherd, R., Raats, M.M., Hazel Gowland, M., Lucas, 
J.S. (2011). The challenges for nut-allergic consumers of eating out. Clinical and 
Experimental Allergy, 41 (2), pp. 243–249.* 
This paper was one of a series of publications from the Food Standards Agency funded 
project conducted by the University of Surrey, then Brunel University and then the 
University of Bath with the University of Southampton. The project aimed to understand 
the behaviour of consumers with peanut and tree nut allergies and those buying food 
for them. This paper examined issues when eating out. Barnett is a professor of health 
psychology who led the project, Leftwich and Muncer are psychology researchers, 
Shepherd and Raats are experienced consumer behaviour expert academics, Lucas is a 
paediatric allergy physician and professor who provided clinical insight. Gowland’s roles 
included a) representing the consumer / patient interest for project ethics and data 
interpretation, b) briefing all project participants at the scoping stage to understand the 
key research issues, c) training the researchers to conduct interviews, d) reviewing the 
results and e) contributing to the project reports and publication writing and editing. 
(Certified by Professor J S Lucas) (Gowland’s contribution c 15%) 
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This paper has 24 citations on Wiley Online Library. (Accessed 31st March 2018) 
P9 – 2011 
Barnett, J., Leftwich, J., Muncer, K., Grimshaw, K., Shepherd, R., Raats, M.M., Gowland, 
M.H., Lucas, J.S. (2011). How do peanut and nut-allergic consumers use information on 
the packaging to avoid allergens? Allergy, 66 (7), pp. 969–978. * 
This paper was one of the publications from the Food Standards Agency funded project 
conducted by the University of Surrey, then Brunel University and then the University of 
Bath. The project aimed to understand the behaviour of consumers with peanut and 
tree nut allergies and those buying food for them. This paper examined issues when 
buying prepacked foods. Barnett is a professor of health psychology who led the project, 
Leftwich and Muncer are psychology researchers, Shepherd and Raats are experienced 
consumer behaviour academics, Lucas is a paediatric allergy physician and professor 
who provided clinical insight.  
Gowland’s roles included a) representing the consumer / patient interest for project 
ethics and data interpretation, b) briefing all project participants at the scoping stage to 
understand the key research issues, c) training the researchers to manage the 
accompanied shop and interviewing subjects, d) reviewing the results and e) 
contributing to the project reports and publication writing and editing.  
(Certified by Professor J S Lucas) (Gowland’s contribution c 15%) 
This paper has 38 citations on Wiley Online Library. (Accessed 31st March 2018) 
P10 – 2011 
Barnett, J., Muncer, K., Leftwich, J., Shepherd, R., Raats, M.M., Gowland, M.H., 
Grimshaw, K., Lucas, J.S. (2011). Using “may contain” labelling to inform food choice: A 
qualitative study of nut allergic consumers. BMC Public Health, 11 (734), pp. 1-9. * 
This paper was one of the publications from the Food Standards Agency funded project 
conducted by the University of Surrey, then Brunel University and then the University of 
Bath and supported by the University of Southampton. The project aimed to understand 
the behaviour of consumers with peanut and tree nut allergies and those buying food 
for them. This paper examined issues when buying prepacked foods carrying ‘may 
contain’ labelling. Its purpose was to provide evidence for policy development by the 
FSA and other regulators, as well as food suppliers and consumers. Barnett is a professor 
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of health psychology who led the project, Leftwich and Muncer are psychology 
researchers, Shepherd and Raats are experienced consumer behaviour academics, 
Grimshaw is an experienced clinical and research dietitian, Lucas is a paediatric allergy 
physician and professor. Both Grimshaw and Lucas provided clinical and practical 
insight.  
Gowland’s roles included a) representing the consumer / patient interest for project 
ethics and data interpretation, b) briefing all project participants at the scoping stage to 
understand the key research issues, c) providing expertise on ‘may contain’ labelling and 
nut / peanut allergic consumer behaviour, d) reviewing the results and e) contributing 
to the project reports and publication writing and editing.  
(Certified by Professor J S Lucas) (Gowland’s contribution c 15%)  
This paper has 27 citations on Springer - BMC Public Health. (Accessed 31st March 2018) 
P11 – 2012  
Barnett, J., Botting, N., Gowland, M.H., Lucas, J.S. (2012). The strategies that peanut and 
nut-allergic consumers employ to remain safe when travelling abroad. Clinical and 
Translational Allergy, 2 (12), pp. 1-7. *   
This paper was one of the publications from the Food Standards Agency funded project 
conducted by the University of Surrey, then Brunel University and then the University of 
Bath. The project aimed to understand the behaviour of consumers with peanut and 
tree nut allergies and those buying food for them. This paper examined the particular 
challenges faced by these people during travel abroad, including avoiding nuts and 
peanuts on journeys, finding safe food and accessing medical support in other countries 
Botting was a medical student during the research period. Barnett is a professor of 
health psychology who led the project and Lucas is a paediatric allergy physician and 
professor who provided clinical and practical insight.  
Gowland’s roles included a) providing expert patient / consumer about living with a nut 
/ peanut allergy, b) reviewing the study data on travel and staying abroad, and c) 
contributing to the project reports and publication writing and editing.  
(Certified by Professor J S Lucas) (Gowland’s contribution c 15%) 
This paper has 13 citations on Springer. (Accessed 31st March 2018) 
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P12 - 2013 
Barnett, J., Vasileiou, K., Gowland, M.H., Raats, M.M., Lucas, J.S. (2013). Beyond 
Labelling: What Strategies Do Nut Allergic Individuals Employ to Make Food Choices? A 
Qualitative Study. PLoS ONE, 8 (1), pp. 1-7.* 
This paper was one of the publications from the Food Standards Agency funded project 
conducted by the University of Surrey, then Brunel University and then the University of 
Bath. The project aimed to understand the behaviour of consumers with peanut and 
tree nut allergies and those buying food for them. This paper examined the additional 
strategies employed to avoid nuts and peanuts when buying food. It presented evidence 
for policy development by the FSA and other regulators, as well as informing food 
suppliers and consumers. 
Barnett is a professor of health psychology who led the project, Vasileiou is a psychology 
researcher, Raats is a professor of psychology with experience in consumer behaviour 
and Lucas is a paediatric allergy physician and professor who provided clinical insight.  
Gowland’s roles included a) providing expert patient / consumer insight about living with 
a nut / peanut allergy, b) suggesting additional strategies which consumers may use c) 
reviewing the study data and d) contributing to the project reports and publication 
writing and editing. (Certified by Professor J S Lucas) (Gowland’s contribution c 15%) 
This paper has 7 citations on the PloS One and Scopus. (Accessed 31st March 2018) 
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P13 – 2013 
Cochrane, S.A., Gowland, M.H., Sheffield, D., Crevel, R.W.R. (2013). Characteristics and 
purchasing behaviours of food-allergic consumers and those who buy food for them in 
Great Britain. Clinical and Translational Allergy, 3 (31), pp. 1–8. * 
This project was commissioned by Unilever, a leading food manufacturer, and 
undertaken by Mintel, a leading market research organisation. Its purpose was to 
characterise food-allergic consumers in Great Britain and find out more about the foods 
they avoid as well as how they manage and report their reactions. An online consumer 
research survey targeted at a wide demographic was designed with a filter question 
which aimed to focus upon those people experiencing symptoms typical of 'true’ food 
allergy.  
Cochrane and Crevel are research scientists with expertise in toxicology, allergen risk 
management and allergy consumer behaviour whilst Sheffield provided expertise in 
statistical analysis for data collection and reporting. Gowland provided expert 
consumer,   patient and ethical insight throughout the project, guidance on structuring 
the questions and interpreting the results, and contributed to publication writing and 
editing.  
(Certified by R W R Crevel) (Gowland’s contribution c 15%) 
This paper has 14 citations on Springer - Clinical and Translational Allergy (Accessed 31st 
March 2018) 
P14 – 2013  
Gowland, M.H. (2013). Reactions, Regulation and Risk: Protecting consumers with food 
allergies and intolerances. Perspectives in Public Health, 133 (6), pp. 306-307.* 
This article was commissioned by the journal of the Royal Society for Public Health. Its 
purpose was to update a wide public health audience, and particularly those involved in 
food safety and health and safety on new food allergy regulation and how to support 
consumers at risk. (Sole author) 
This article has 3 citations on CrossRef. (Accessed 31st March 2018) 
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P15 – 2014 
Muraro, A., Hoffmann-Sommergruber, K., Holzhauser, T., Poulsen, L.K., Gowland, M.H., 
Akdis, C.A., Mills, E.N.C., Papadopoulos, N., Roberts, G., Schnadt, S., Van Ree, R., Sheikh, 
A., Vieths, S. (2014). EAACI Food Allergy and Anaphylaxis Guidelines. Protecting 
consumers with food allergies: Understanding food consumption, meeting regulations 
and identifying unmet needs. Allergy, 69 (11), pp. 1464–1472.* 
This publication was one of a series of papers from the European Academy of Allergy 
and Clinical Immunology which aimed together to promote awareness of the issues 
facing those with food allergies and to propose initiatives to reduce allergy risks.  
Muraro, Akdis, Papadopoulos, and Roberts are allergy physicians, Hoffmann-
Sommergruber, Holzhauser, Poulsen, Mills, Van Ree and Vieths are research scientists, 
Sheikh is a physician and epidemiologist. Schnadt and Gowland acted as expert 
consumer / patient researchers and advocates.  
Gowland was invited to contribute to this publication a) as an expert food allergic patient 
/ consumer, b) as an established consumer researcher, c) to provide expertise in food 
allergen management and food regulation and d) to contribute to shaping and editing 
the title and the publication.  
(Gowland’s Contribution c 8%) 
This article has 32 citations on Wiley Online Library. (Accessed 31st March 2018) 
P16 – 2014  
Le, T.M., Kummeling, I., Dixon, D., Barreales Tolosa, L., Ballmer-Weber, B., Clausen, M., 
Gowland, M.H., Majkowska-Wojciechowska, B., Mustakov, T., Papadopoulos, N.G., 
Knulst, A.C., Potts, J., Stukas, R., Burney, P. (2014). Low preparedness for food allergy 
as perceived by school staff: A EuroPrevall survey across Europe. Journal of Allergy and 
Clinical Immunology: In Practice, 2 (4), pp. 480–482.* 
This publication was commissioned through the EU-funded Europrevall Integrated 
Project examining the preparedness of schools in different countries to manage food 
allergies. The project was led by Le (physician and researcher) and Kummeling 
(epidemiologist) supported by Dixon, Potts and Stukas who undertook the data analysis 
supervised by Burney at Imperial College, London. Allergy physicians (Barreales Tolosa, 
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Ballmer-Weber, Clausen, Majkowska-Wojciechowska, Mustakov, Papadopoulos and 
Knulst) led recruitment, questionnaire translation and data collection in different 
countries.  
(Gowland’s contribution c 5%) 
This publication has 3 citations on Sciencedirect / Elsevier. (Accessed 31st March 2018) 
P17 – 2014 
Walker, M., Gowland, H. (2014). Food allergy - A forensic perspective. Food Science and 
Technology (London), 28 (3), pp. 33-36. 
This article was written for the Journal of Food Science and Technology, for which the 
primary audience is food scientists and technologists, and also public analysts, 
regulators and food industry consultants with an interest in food integrity and reducing 
food risks. Walker was acting as a Subject Matter Expert for a major UK-wide review into 
food supply chains conducted by Professor Chris Elliott, to which Gowland also gave 
evidence – see W18. Walker and Gowland have monitored the forensic aspects of food 
allergy evidence and prosecutions since 1996 and this work continues. 
(Certified by Dr M J Walker) (Gowland’s contribution c 45%) 
P18 – 2015  
Gowland, M.H., Walker, M.J., (2015). Food allergy, a summary of eight cases in the UK 
criminal and civil courts: Effective last resort for vulnerable consumers? Journal of the 
Science of Food and Agriculture, 95 (10), pp. 1979–1990.* 
Walker and Gowland reviewed court cases involving food allergy in the UK. Selections 
were made to represent prepacked and non-prepacked foods, fatal and non-fatal 
reactions and criminal and civil action. Gowland had been involved in some of the 
investigations, as well as supporting some of the individuals and families involved so was 
able to supply detailed insight into the circumstances of each case. As an analytical 
chemist (and previous Public Analyst) with experience in food legislation and preparing 
court evidence, Walker provided the forensic context. This publication reached a multi-
disciplinary audience which included a) food allergic consumers and representative 
patient / consumer organisations, b) the analytical and food technical community c) 
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national and local regulators, d) food businesses including manufacturers, retailers and 
caterers and e) lawyers and others involved in public protection and civil litigation.  
(Certified by Dr M J Walker) (Gowland’s contribution c 55%) 
This publication has 8 citations on Wiley Online Library. (Accessed 31st March 2018)  
P19 – 2015 
Turner, P.J., Gowland, M.H., Sharma, V., Ierodiakonou, D., Harper, N., Garcez, T., 
Pumphrey, R., Boyle, R.J. (2014). Increase in anaphylaxis-related hospitalization but no 
increase in fatalities:  An analysis of United Kingdom national anaphylaxis data, 1992-
2012. Journal of Allergy and Clinical Immunology, 135 (4), pp. 956–963. * 
This collaborative project involved the allergy and immunology physicians managing the 
UK Fatal Anaphylaxis Registry in Manchester (Sharma, Harper, Garcez and Pumphrey) 
and those from Imperial College, London (Turner, Ierodiakonou and Boyle) who have a 
major research interest in the severity of allergic reactions. Gowland’s contributions 
were as follows: a) collection and scrutiny of data about UK fatal allergic reactions since 
1988 with Dr Pumphrey and then with Drs Boyle and Turner, b) analysis of 
hospitalisation admissions data in England associated with allergy c) case by case 
examination of symptoms and cause and d) editing the publication.  
(Certified by Dr P J Turner) (Gowland’s contribution c 20%) 
This publication has 122 citations on Scopus. (Accessed 31st March 2018) 
P20 – 2015 
Walker, M., Gowland, H. (2015). Food fear. Chemistry & Industry, 79, p28. 
The primary audience for this article is the food technological and analytical community, 
though it is also of interest to food regulators and the wider food industry. Gowland 
describes health risks associated with food allergies in Great Britain and the need to 
label foods correctly to reduce inadvertent allergen consumption and consequential 
reactions. Walker focuses on analytical methods to detect food allergens using enzyme-
linked immunosorbent assay, polymerase chain reaction, and mass spectrometry.  
(Certified by Dr M J Walker) (Gowland’s contribution c 40%) 
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P21 - 2016 
Walker, M.J., Burns, D.T., Elliott, C.T., Gowland, M.H., Mills, E.N.C. (2016). Is food 
allergen analysis flawed? Health and supply chain risks and a proposed framework to 
address urgent analytical needs. The Analyst, 141, pp. 24–35.* 
This publication in The Analyst involved a collaboration between analytical chemists 
(Burns and Walker) and biologists (Elliott and Mills) with expertise in food allergens, food 
fraud, the food supply chain, food regulation and forensics. Gowland devised a survey 
of the analytical community on allergen-related activity and contributed to the final 
publication. 
(Certified by Dr M J Walker) (Gowland’s contribution c 10%) 
This publication has 12 citations on CrossRef and RSC Journals. (Accessed 31st March 
2018) 
P22 – 2016 
Turner, P., Baumert, J.L., Beyer, K., Boyle, R., Chan, C., Clark, A., Crevel, R., DunnGalvin, 
A., Fernandez-Rivas, M., Gowland, M. H., Grabenheinrich, L., Hardy, S., Houben, G. F., 
Hourihane, J. O'B., Muraro, A., Poulsen, L. K., Pyrz, K., Remington, B. C., Schnadt, S., 
van Ree, R., Venter, C., Worm, M., Mills, E. N. C., Roberts, G., Ballmer-Weber, B. K. 
(2016). Can we identify patients at risk of life-threatening reactions to food? Allergy, 
71 (9), pp. 1241–1255. * 
Following work to establish food allergen thresholds for different allergens, across 
different ages, populations and within different food matrices, it was recognised that 
people reacting to the same amount of allergen might have markedly different 
symptoms. Further work to better understand the impact and possible severity of 
symptoms continues. This publication for the European Academy of Allergy and Clinical 
Immunology (EAACI) involved a large consortium of allergy physicians, regulators, food 
scientists (toxicologists, protein chemists, analysts), dietitians, psychologists and 
consumer / patient representatives. Gowland’s role was to represent the consumer / 
patient interest and to provide expertise from recording and examining life-threatening 
reactions to food. She also contributed to writing and editing the publication.  
(Certified by Dr P J Turner) (Gowland’s contribution c 5%) 
26 
 
This publication has 10 citations on PubMed and 23 on Wiley Online Library.  
(Accessed 31st March 2018) 
P23 – 2016 
Begen, F., Barnett, J., Payne, R., Roy, D., Gowland, M. H., Lucas, J. S. (2016). Consumer 
Preferences for Written and Oral Information about Allergens When Eating Out. PloS 
One, 11 (5), pp. 1-12.* 
Following the previous project (See P8 - P12 above) to understand consumer behaviour 
relating to buying food for people with nut and peanut allergies, the UK Food Standards 
Agency commissioned a team led by Professor Julie Barnett (previously at Surrey and 
Brunel Universities and now at Bath University) to assess how people with a range of 
food avoidance needs (food allergies, intolerances and coeliac disease) across the UK 
cope with finding safe food before and after the implementation of new food labelling 
legislation in December 2014. The focus was on non-prepacked foods including catering. 
Begen, Barnett and Roy are health psychology researchers, Payne provided expertise in 
consumer research, devising the survey, recruiting and interviewing the subjects, and 
Lucas is an allergy physician who helped with characterising subjects and providing 
clinical insight.  
As previously, Gowland acted as expert project adviser, devising and shaping the 
methodology, developing the survey questions and interview strategies, reviewing the 
data, reporting, and co-writing the publications.   
(Certified by Professor J S Lucas) (Gowland’s contribution c 15%) 
This paper has been cited 3 times on Scopus. (Accessed 31st March 2018) 
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P24 – 2016 
Turner, P.J., Gowland, M.H. (2016). Precautionary allergen labelling: NO MORE TRACES! 
Allergy, 71 (10), pp. 1505-1507. *  
This letter to Allergy, the journal of the European Academy of Allergy and Clinical 
Immunology followed an international survey undertaken by a consortium of patient / 
consumer groups in different countries. Its purpose was to provide background 
information and expertise to a mainly clinical audience about ‘may contain’ labelling and 
consumer / patient / physician perception of the relative risks of allergen cross 
contamination as indicated by precautionary labelling.  Gowland co-wrote and edited 
the publication. 
(Certified by Dr P J Turner) (Gowland’s contribution c 30%) 
This publication has 4 citations on Wiley Online Library. (Accessed 31st March 2018) 
P25 – 2017 
Begen, F.M., Barnett, J., Barber, M., Payne, R., Gowland, M.H., Lucas, J.S., (2017). 
Parents’ and caregivers’ experiences and behaviours when eating out with children 
with a food hypersensitivity. BMC Public Health, 18 (38), pp. 1-10. * 
Following the previous project (See P8 - P12 above) to understand consumer behaviour 
relating to buying food for people with nut and peanut allergies, the UK Food Standards 
Agency commissioned a team led by Professor Julie Barnett (previously at Surrey and 
Brunel Universities and now at Bath University) to assess how people with a range of 
food avoidance needs (food allergies, intolerances and coeliac disease) across the UK 
cope with finding safe food before and after the implementation of new food labelling 
legislation in December 2014. Contributors’ roles were as in P23 above. As expert 
project adviser, Gowland provided insight into eating out with food hypersensitive 
children, reviewing the data, reporting, and co-writing the publications.   
Evidence from the survey and interviews indicated particular challenges for people 
eating out with children with food hypersensitivity. The publication brings these issues 
to the attention of allergy clinicians, regulators, food businesses and families, and may 
help to shape practice and policy.   
(Certified by Professor J S Lucas) (Gowland’s contribution c 10%) 
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This publication has 1 citation on CrossRef. (Accessed 31st March 2018)  
P26 – 2018 
Begen, F.M., Barnett, J., Payne, R., Gowland, M.H., DunnGalvin, A., Lucas, J.S. (2018). 
Eating out with a food allergy in the UK: Change in the eating out practices of 
consumers with food allergy following introduction of allergen information legislation. 
Clinical & Experimental Allergy, 48 (3), pp. 317–324.* 
Following the previous project (See P8 - P12 above) to understand consumer behaviour 
relating to buying food for people with nut and peanut allergies, the UK Food Standards 
Agency commissioned a team led by Professor Julie Barnett (previously at Surrey and 
Brunel Universities and now at Bath University) to assess how people with a range of 
food avoidance needs (food allergies, intolerances and coeliac disease) across the UK 
cope with finding safe food before and after the implementation of new food labelling 
legislation in December 2014. Contributors’ roles were as in P23 and P25 above. 
Psychologist DunnGalvin provided expert input on Quality of Life assessment for food 
allergy and intolerance.  Once again, Gowland acted as expert project adviser, devising 
and shaping the methodology, developing the survey questions and interview strategies, 
reviewing the data, reporting, and co-writing the publications.   
(Certified by Professor J S Lucas) (Gowland’s contribution c 10%) 
P27 – 2018 
Walker, M.J., Gowland, M.H., Points, J. (2018). Managing Food Allergens in the U.K. 
Retail Supply Chain. Journal of AOAC International, 101 (1), pp. 45–55.  
AOAC International (previously the Association of Official Analytical Chemists) is an 
internationally recognised non-profit organisation engaged in scrutinising and 
publishing standardised scientific analytical methods. A special edition of the AOAC 
Journal included papers on a range of allergen-related subjects, of which this was one. 
Walker provided the perspective of an analytical chemist and referee analyst, and 
experience from his forensic roles assessing risks, developing methods and reporting 
results to courts, Points is an experienced food scientist who has set industry standards 
and undertaken allergen risk assessment and management for a leading UK retailer. 
Gowland’s early research into UK retail foods for the Food Standards Agency (see W4), 
29 
 
and on-going partnership with food manufacturers and retailers also contributed. The 
publication describes influences on the UK food retail market which have led to the 
integration of allergen controls throughout the supply chain, and examines individual 
retailer policies and strategies to deal with the on-going challenge of providing 
information to food allergic and intolerant consumers, precautionary allergen labelling, 
and the effective management of associated product recalls and alerts.   
(Certified by Dr M J Walker) (Gowland’s contribution c 20%) 
P28 – 2018 
Dubois, A.E.J., Turner, P.J., Hourihane, J., Ballmer-Weber, B., Beyer, K., Chan, C.-H., 
Gowland, M.H., O’Hagan, S., Regent, L., Remington, B., Schnadt, S., Stroheker, T., Crevel, 
R.W.R. (2018). How does dose impact on the severity of food-induced allergic reactions, 
and can this improve risk assessment for allergenic foods? Allergy, 2018 (00), pp. 1-10.* 
This paper followed a project (managed by ILSI Europe – an industry supported science 
organisation) which brought together representatives from different stakeholder 
interests to review and update understanding, not just on food allergen thresholds 
(dose) but also on the impact of allergic reactions (severity). Allergy physicians were 
represented by Dubois (who led the project and writing the paper), Turner, Hourihane, 
Ballmer-Weber and Beyer. Their experience of managing clinical food allergy challenges 
for both adults and children contributed significantly to the understanding of severity, 
and the impact of co-factors. O’Hagan, Stroheker and Crevel represented the industry 
regulatory and scientific community, having a particular interest in working towards the 
practical implementation of allergen thresholds in the food supply chain. Chan 
represented the regulatory perspective – both for food safety and food labelling. 
Remington brought expert scientific insight. Regent and Schnadt represented patient / 
consumer groups in EU member states. Gowland contributed to the concept and 
conduct of the research; in particular a) data on perceived and actual reaction severity 
from her own and other people’s ‘near miss’ and fatal reactions, b) consumer research 
experience c) risk modelling (including Figure 1 in the paper), and d) to editing the final 
paper.  
(Certified by R W R Crevel) (Gowland’s contribution c10%)  
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P29 – 2018  
Barnett, J., Begen, F. M., Gowland, M. H., Lucas, J. S., (2018). Comparing the eating out 
experiences of consumers seeking to avoid different food allergens BMC Public 
Health 2018 18, pp. 1263-1275. * Published November 16th, 2018 
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Abstracts for oral presentations and conference posters A1-12 
A1 - 2010 
Cochrane, S. A., Gowland, M. H., Sheffield, D., Crevel, R. W. R., (2010). An online survey 
of food allergic consumers and people buying for such individuals in the UK. EAACI 2010 
Congress Programme – London, UK, Abstract for poster 1043, p157. 
This poster was first presented at the EAACI Congress in London in 2010 from the project 
commissioned by Unilever and undertaken by Mintel. (See also P13 above). Gowland 
was project adviser and reviewed and edited the final poster.  
(Gowland’s contribution c10%) 
A2 – 2011 
Gowland, M. H. (2011). How to manage food allergy in restaurants, cafeterias and fast 
food outlets? Oral presentation EAACI Food Allergy and Anaphylaxis Meeting (FAAM) 
Venice 2011. Clinical and Translational Allergy, 2011, 1 (Suppl 1), S21. * 
Gowland was invited to give an oral presentation on food allergy risks and controls at 
this EAACI international food allergy and anaphylaxis meeting as part of a workshop for 
a multi-disciplinary audience including consumer / patient representatives, allergy 
clinicians, food industry representatives, food scientists and regulators.   
A3 – 2011 
Gowland, M. H., Walker, M. J. (2011). Food allergy, a summary of recent cases in the 
criminal and civil courts of the UK Poster EAACI Food Allergy and Anaphylaxis Meeting 
(FAAM) Venice and BSACI 2011. Clinical and Translational Allergy, 2011, 1 (Suppl 1) O1.* 
Gowland and Walker have collected data about food regulation and court cases relating 
to food allergy since 1996, and continue to do so. This poster described a sample of 
recent cases and was presented at the EAACI international food allergy meeting in 
Venice and the UK BSACI meeting in 2011. Further work was described in P17 and P18 
above.  
This abstract has 3 citations on CrossRef.  
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A4 – 2011 
Gowland, M. H., (2011). How to tackle allergies at school. Abstract 2337780 for Oral 
presentation EAACI PAAM Barcelona (2011). Clinical and Translational Allergy, 2011, 
1(Suppl 1), S21.* See http://www.eaaci-
paam2011.com/scientific_programme/thursday/5375/Page.html - Accessed May 6th, 
2018. 
As a previous school teacher with considerable experience in advising on allergen 
management in schools, Gowland was invited to the EAACI international paediatric 
anaphylaxis and allergy meeting in Barcelona  to make this presentation as part of a 
workshop for a multi-disciplinary audience including consumer / patient 
representatives, allergy clinicians, food industry representatives, food scientists and 
regulators.   
A5 – 2011 
Gowland, M. H., (2011). Eating out in a restaurant:  (Abstract 2337781 for Oral 
presentation) EAACI PAAM Barcelona 2011. Clinical and Translational Allergy, 2011, 
1(Suppl 1), S21. * See http://www.eaaci-
paam2011.com/scientific_programme/saturday/5378/Page.html - Accessed May 6th, 
2018.   
As an expert patient and food industry consultant advising on allergen management in 
catering and other food outlets, Gowland was invited to the EAACI international 
paediatric anaphylaxis and allergy meeting in Barcelona  to make this presentation as 
part of a workshop for a multi-disciplinary audience including consumer / patient 
representatives, allergy clinicians, food industry representatives, food scientists and 
regulators.   
A6 – 2012 
Botting, N., Barnett, J., Gowland, M. H., Lucas, J. S., (2012). The problems that peanut 
and tree nut allergic people encounter when travelling abroad. Clinical & Experimental 
Allergy, 42 (12), p. 1831. * 
The research team involved in P11 above also presented this poster at the UK BSACI 
meeting in 2012 for allergy health care professionals. Gowland reviewed the travel data 
and edited the poster.  
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(Gowland’s contribution c10%) 
A7 – 2012 
Gowland, M. H., Ledford, C. L., Austin, M. M., (2012) Which food allergies are most 
common in the UK? Using Anaphylaxis Campaign member data and case files to indicate 
prevalence. Clinical & Experimental Allergy, 42 (12), pp. 1834–1835. * 
From 1999 (as food adviser to the Anaphylaxis Campaign), Gowland collected and 
collated data from membership records about the number of campaign members 
avoiding particular foods. This included both allergens for which there was specific 
labelling regulation and other food allergens. These data were of particular interest to 
the food industry and regulators for horizon-scanning and future planning. Ledford 
continues to maintain the member database and Austin was the campaign’s information 
manager from 1997-2017. Gowland prepared the poster and presented it at the UK 
BSACI meeting. 
(Gowland’s contribution c50%)   
A8 – 2014 
Turner, P. J., Sharma, V., Tang, M. L. K., Gowland, M. H., Harper, N., Garcez, T., 
Pumphrey, R., Boyle, R. J., (2014). Age as a Risk Factor for Fatal Food-Induced 
Anaphylaxis: An Analysis of UK and Australian Fatal Food Anaphylaxis Data. Journal of 
Allergy and Clinical Immunology, 133 (2), Suppl. AB19. * 
Turner prepared and presented this poster at the international American Academy of 
Allergy, Asthma and Immunology (AAAAI) meeting in the USA in 2014. Gowland’s 
primary contribution was background detail of fatal food anaphylaxis cases in the UK 
collected from 1988.  
(Gowland’s contribution c 10%) 
A9 – 2015 
Walker, M., Gowland, H. (2014). Deadly fraud – Food allergen substitution in the food 
chain. Clinical and Translational Allergy, 5 (Suppl 3), p. 137. * 
Gowland and Walker prepared and presented this poster at the 2014 EAACI 
international food allergy and anaphylaxis meeting in Dublin. Related publications for 
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this project are P18, P20 and P21 above as well as W18, Gowland’s evidence to the Elliott 
Review of food supply networks.  
(Gowland’s contribution 40%) 
A10 – 2016 
Boer, R.D., Hunter, H., Stedman, C., Chalmers, R., Gowland, M.H., Van der Poel, L.-A. 
(2016). Precautionary allergen labelling (PAL) - nuts about getting it right. Poster 130, 
BSACI Meeting 2016. CLINICAL AND EXPERIMENTAL ALLERGY, 46, p. 1669. * 
Gowland advised Dr Lauri-Ann van der Poel and the dietetics team at Guy’s and St 
Thomas Hospitals / King’s College London for this poster about an intelligent digital 
portal tool for healthcare professionals designed to help food allergic consumers make 
informed choices when buying foods, and in particular biscuits, confectionery, cereal 
bars and breakfast cereal for people with nut / peanut allergies. Gowland also edited 
the poster which was presented at the UK BSACI meeting.  
(Gowland’s contribution c10%) 
A11 – 2016 
Gowland, M.H., Stratford, L.J., Austin, M.M. (2016). Can I help you? - Horizon-scanning 
allergy priorities using enquiries to the Anaphylaxis Campaign. Poster 132, BSACI 
Meeting 2016. CLINICAL AND EXPERIMENTAL ALLERGY, 46, pp. 1669–1670.* 
From 1997, the Anaphylaxis Campaign has collected details of enquiries made by letter, 
phone and more recently email and social media. These provide a useful indicator for 
current concerns and priorities for people living with allergy risks. As food adviser to the 
Anaphylaxis Campaign, Gowland collected and collated data provided by information 
manager Austin and her assistant Stratford, prepared the poster and presented it at the 
UK BSACI meeting.  
(Gowland’s contribution c40%) 
A12 - 2016 
Gowland, M.H., Walker, M.J. (2016). Food allergy law and consumer protection - an 
update from UK courts. Poster 133, BSACI Meeting 2016. CLINICAL AND EXPERIMENTAL 
ALLERGY, 46, p. 1670. * 
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Following research leading to the publication of P18, P27 and A3 above, Gowland and 
Walker continue to support investigations following severe and fatal allergic reactions 
and to examine cases in the UK courts. In 2016, a key prosecution led to the conviction 
and imprisonment of a caterer following a food allergy death. This poster presented at 
the BSACI meeting presented factors associated with taking legal action in such cases.  
(Gowland’s contribution c50%) 
 
Figure 2: Impact factors of journals in which Gowland’s work has been published 
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Book chapters B1 - B4 
B1 – 2002 
Gowland, M. H., (2002). Food Allergen Risk Management - A matter of Life or Death. In 
V. Emerton, ed., Food Allergy and Intolerance Current Issues and Concerns, 1st ed. 
Leatherhead Food Research Association / Royal Society of Chemistry, pp. 81-92. 
This book was written for food industry and scientific audiences to present the 
proceedings of an international food allergy conference. This was also an early example 
of Gowland’s role as a ‘hub’, bringing together and developing partnerships with key 
stakeholders involved in allergen risk assessment, management and control. These 
included leading allergy clinical researchers, food scientists and technologists, regulators 
and consumer / patient support organisations. 
B2 - 2010 
Gowland, M. H., (2010).  Chapter 7: Allergen Management and Control in the Food 
Service Industry. In: J. Boye, ed., Allergen Management in the Food Industry. 1st ed. 
Hoboken, New Jersey:  Wiley, pp. 167-204.  
This book was published by the Canadian government (Health Canada) in association 
with Wiley. As an experienced expert adviser to a range of catering businesses, and as a 
food allergic individual, Gowland was invited to contribute the chapter on foodservice – 
catering and buying non-prepacked foods.  
B3 – 2014 
Gowland, M. H., (2014). Chapter 7:  In: Flanagan, S. (ed.) Handbook of Food Allergen 
Detection and Control. Ist ed. Cambridge UK. Woodhead Publishing, pp. 133-160. 
This book is a handbook for the food industry. Its primary audience is food technologists, 
scientists, suppliers, manufacturers, retailers and regulators. Gowland was invited to 
contribute this chapter, presenting and classifying the range of consumers avoiding 
different allergens and the reasons why they do so. The chapter summarises the impact 
of different conditions, including data about fatal and ‘near miss’ reactions, the foods 
people are avoiding, risk factors in food supply, communicating information about 
ingredients and the possible inadvertent presence of other allergens, changes in 
consumer behaviour, particularly regarding allergen consumption to prevent allergy in 
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early life, the new Food Information Regulation and resources available to support best 
practice.  
B4 – 2017 
Walker, M. J., Gowland, M. H. (2017). Chapter 24: Food Allergy: Managing Food 
Allergens. In:  Yiu Chung Wong, ed., Analysis of Food Toxins and Toxicants. 1st ed. Hong 
Kong: Wiley, pp. 711-742.   
This book was commissioned by the Government Laboratory in Hong Kong in association 
with the publisher, John Wiley. As an international publication with contributors from 
around the world, its primary audience is the food analytical community, as well as food 
industry representatives, scientists, technologists, policymakers and regulators.  
Walker and Gowland were commissioned to write this definitive and up to date chapter 
on food allergens, including current developments in allergen and allergy management. 
Gowland provided expert input on recent changes in food labelling, progress on 
establishing allergen thresholds in light of improved understanding of reaction severity, 
and the impact of food allergy and related conditions on quality of life.   
(Gowland’s contribution c30%) 
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Other work and achievements W1 - W24 
W1 – 1997 
MAFF – (1997) Be Allergy Aware – government allergy awareness initiative for caterers: 
Joint Project Adviser and media (radio and TV) Hazel Gowland 
W2 – 1998 
The Katherine Baker Appeal – project to collect funds with the Bradford and Bingley 
Building Society, and Boots the Chemist and engage with schools and nurseries to send 
out videos about Anaphylaxis: Project Manager – Hazel Gowland 
W3 – 2000 
BBC Radio 4 Food Programme Hazel Gowland Finalist: Campaigner / educator for the 
first awards in 2000 
W4 – 2002 
Research study and report  
Food Standards Agency UK (2002) ‘May Contain’ Labelling – The Consumer’s 
Perspective Hazel Gowland, Allergy Action for the Anaphylaxis Campaign. Food 
Standards Agency, London. Ref: FSA/0582/0502  
W5 – 2003 
Allergy - the unmet need - Diagram on Page 22 by M H Gowland Royal College of 
Physicians Working Party on Allergy. Earlier versions prepared for meeting in 1998 with 
the Minister for Public Health, and used in Ewan, P. (2000).  
W6 – 2004 
The Provision of Allergy Services – House of Commons Health Committee 6th Report 
of Session 2003-04, Volume 1 Diagram W5 – 2003 above from RCP Allergy: the unmet 
need - by M H Gowland (2003) re-used in report – Page 20. House of Commons 
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W7 – 2004 
Investigating deaths from allergen-induced anaphylaxis and asthma. Dr Richard 
Pumphrey and Mrs Hazel Gowland. The Coroners' Society of England and Wales Annual 
Report 
W8 – 2006 
Voluntary food industry guidance – Guidance on Allergen Management and Consumer 
Information. Food Standards Agency Voluntary Guidance FSA/1064/0606 M H Gowland 
- member of working group  
W9 – 2006 
SoFHT award-winning (Best New product) and RIPH accredited DVD training tool 
Allergy awareness: an introductory pack for food handlers. Hazel Gowland and Dr Lisa 
Ackerley allergytraining.com  
W10 – 2006 
Food Standards Agency – creating and managing the delivery of online pre-course 
learning and 49 interactive workshops for 1043 local authority food standards and food 
safety officers throughout the UK. Hazel Gowland and Dr Lisa Ackerley 
W11 – 2007 
House of Lords Science Committee on Allergy. Evidence to enquiry Hazel Gowland 
W12 - 2008 
Irish cross-border food safety project for safefood to deliver online pre-course learning 
and interactive workshops to 295 EHOs, 12 Public Analyst laboratory staff and 172 
catering lecturers Online and workshop content - also two conferences. Hazel Gowland 
and Dr Lisa Ackerley 
W13 - 2008 
Voluntary food industry guidance The Provision of Allergen Information for Non Pre-
packed Foods. Food Standards Agency Voluntary Guidance M H Gowland member of 
working group. FSA/1226/0108 Food Standards Agency 
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W14 - 2009 
Food Allergy training course for James Watt College Hazel Gowland (Allergy Action) and 
Graeme Kerr 
W15 – 2009 
Living with Allergy - Lecture on the MSc in Allergy at Southampton University delivered 
on every course since. Hazel Gowland for University of Southampton School of Medicine 
W16 – 2011 
Qualification in Allergy Awareness: REHIS Joint Award. Hazel Gowland and Graeme 
Kerr. Royal Environmental Health Institute in Scotland partnership 
W17 – 2012 
New food allergy guidance published for caterers. Hazel Gowland for Sustain - the 
alliance for better food and farming for the London 2012 Olympics 
W18 – 2013 
Food supply networks: integrity and assurance review - Elliott Review. Note of Meeting 
with Hazel Gowland DEFRA - UK Government report by Professor Chris Elliott 
W19 - 2014 
Updated and revised DVD training tool Allergy awareness: an introductory pack for 
food handlers. Hazel Gowland for allergytraining.com  
W20 - 2014 
Food fraud: the dangerous allergens lurking in the supply chain. Michael Walker and 
Hazel Gowland. The Guardian 
W21 - 2014 
New EU allergy rules could mean life or death this Christmas. The Guardian Hazel 
Gowland 
W22 - 2014 
Film - 12 days before Christmas - Hazel Gowland Vimeo film about the resources for the 
new Food Information Regulation https://vimeo.com/114715790  
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W23 - 2016 
Imperial College School of Medicine, London - Lecture on MSc / PG certificate in 
Allergy: Risk Management in Food Allergy: Regular lecturer on these courses Hazel 
Gowland 
W24 - 2016 
British Hospitality Association, Industry Guide to Good Hygiene Practice. Guide to 
compliance with Regulation (EC) 852/2004 on the Hygiene of Foodstuffs and HACCP. 
2016. Chapter 4 - Allergens - Hazel Gowland and working group members.  
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3 Career progression 
 
Mrs M Hazel Gowland BA, PGCE, MSoFHT, MREHIS, FIFST, FRSPH 
Expert patient representative, researcher, lecturer and trainer specialising in food 
allergies  
Also Food Adviser - UK Anaphylaxis Campaign (registered charity) since 1994 
Website: www.allergyaction.org  
Employment 
Sole Trader – Allergy Action since 2000 
 Working for and with the Anaphylaxis Campaign as Food Adviser and 
independently as Allergy Action for the Food Standards Agency, the Universities 
of Southampton, Manchester, Surrey, Bath and Imperial College London, and 
project partners including the Laboratory of the Government Chemist, Hygiene 
Audit Systems and the Royal Environmental Health Institute of Scotland and 
many food manufacturers, retailers, caterers and other food suppliers 
 Previously secondary school teacher and youth leader 
 UK, France and Germany: hotels and restaurants, food manufacture, language 
teaching, office administration and children’s holiday camps 
Key activities  
 2016 Contributed to the Allergens section of the new Industry Guide to Good 
Hygiene Practice Catering Guide – British Hospitality Association  
 2016 Lecturer on the MSc Allergy course - Imperial College Medical School, 
London 
 2014 Member of International Life Sciences Institute (ILSI) Expert Group: 
Severity of allergic reactions to foods; work to assess allergen thresholds   
 2014 Examiner for the Royal Society of Public Health (RSPH)  – developing 
qualification: Level 2 Qualification in Identifying and controlling Food Allergy 
Risks 
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 2014 Advising HM Coroners and the police, particularly on issues relating to 
food labelling and failed allergen avoidance – Also Expert Witness  
 2014 Wrote and produced information video on the resources available to 
implement allergen controls required in the new Food Information Regulation 
https://vimeo.com/114715790  (W22 – 2014) 
 2013 Project Adviser – FSA funded study – Bath and Surrey Universities: How do 
food allergic and intolerant consumers make food choices when eating out? – 
the impact of the new Food Information Regulation 
 2013 Lecturer on Allergy Academy courses – Guy’s and St Thomas Hospitals, and 
King’s College London 
 2012 Consultancy work for leading food businesses to review the impact of the 
Food Information Regulation 1169/2011 EC and implement additional controls 
and guidance  
 2012 Expert Trainer – delivering training materials and advice to food safety 
trainers and consultants to implement the new Regulation 1169/2011 EC 
 From 2012 Member of Trial Steering Committee for TRACE study into the 
Extrinsic factors of allergic reactions – FSA funded and coordinated by 
Addenbrooke’s Hospital, Cambridge and St Mary’s Hospital / The Brompton 
Hospital, London  
 2012 EAACI (European Academy of Allergy and Clinical Immunology) Annual 
Meetings and Food Allergy Summer Schools: Faculty member 
 2012 NHS Scotland Briefing clinicians and delivering training workshops to 
catering and nursing staff 
 2012 Developing E-learning on food allergies with Dr Lisa Ackerley 
 2012 Expert adviser to the Food Standards Agency on implementing food 
legislation in practice 
 2012 Royal College of Paediatrics and Child Health – tutor on food allergy 
training course for paediatricians 
 2011 Royal Environmental Health Institute of Scotland Joint Award in Allergy 
Awareness for food handlers, nursery, school and hospital staff 
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 From 2009 Lecturer on the MSc in Allergy (University of Southampton School of 
Medicine) ‘Living with Allergy’ and ‘Lessons learned from bereaved families’  
 From 2008 Laboratory of the Government Chemist – project adviser - 
development of analytical methods for the presence of food allergens. Research 
with Dr Michael Walker on court cases relating to food allergies  
 From 2004 Support for investigations into fatal anaphylaxis cases: undertaking 
family liaison, working with Dr Richard Pumphrey and Manchester clinical 
colleagues.  
 From 2003 to date  Media work – Advising programme producers, undertaking 
live and recorded interviews, work with the BBC and independent broadcasters 
and newspaper / website journalists to raise public awareness of Food Allergy 
 April 2000 BBC Radio 4 Food Programme Awards – Finalist – Campaigner / 
Educator 
 1994 - 2000 – Member of the National Executive of the Anaphylaxis Campaign  
Qualifications:  
BA (Hons), French – Leeds University, 1982 
Youth Leader’s Certificate – London Borough of Hillingdon 1984 
Postgraduate Certificate in Education – University of Hertfordshire, 1985 
Member of the Society of Food Hygiene and Technology from 2004 
Member of the British Society of Allergy and Clinical Immunology from 2009 
Fellow of the Institute of Food Science and Technology from 2014 
Member of the Royal Environmental Health Institute of Scotland from 2014 
Fellow of the Royal Society of Public Health from 2018 
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Table 1: Gowland’s Career Progression by theme 
 
Gowland's career 
Progression Key to Output     
Ti
m
e
lin
e 
Protecting 
consumers with 
food allergies P = Journal Paper A = Abstract 
 B = Book 
Chapter W = Other Work   
(Not 
to 
scale) 
Investigating impact 
Developing 
partnerships 
Shaping 
Regulation and 
Best practice 
Setting 
standards to 
reduce risk 
Skills developed 
O
u
tp
u
t 
1988 
Collecting details of 
fatal reactions 
    
Data collection 
and 
management 
Fatal allergy 
data collection 
and analysis 
  
1994 
Recruiting subjects 
for peanut oil study  
Anaphylaxis 
Campaign 
member 
MAFF Codex 
Food Labelling  
Milk and egg 
Ethical aspects of 
leading a patient 
/ consumer 
member 
organisation.  
Questionnaire 
development 
and survey 
management 
  
1995 Milk and egg survey 
Anaphylaxis 
Campaign 
representative, 
speaker, executive 
member 
  
Taking notes 
from people who 
have had 
reactions 
Bereavement 
and pastoral 
support 
  
    
Allergy clinicians 
at Great Ormond 
Street, 
Southampton 
General, St 
Thomas’, St 
Mary’s London, 
Addenbrooke’s, 
Cambridge and 
Manchester 
Central Hospitals 
    
Preparing slides 
for different 
audiences 
  
    
British Allergy 
Foundation - later 
Allergy UK 
    
Public speaking - 
preparing and 
delivering 
presentations 
  
  
Listening to food 
allergic individuals  
Coeliac UK   
Setting up and 
managing 
databases 
Completing and 
reviewing 
reaction records 
  
  
Collecting data 
about reactions 
  
Replying to 
MAFF 
consultations 
Clear and 
accessible 
language 
Networking   
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  Early sesame survey MAFF - officials 
MAFF Codex 
Food Labelling  
Sesame  
Timely and 
collaborative 
response to 
member, media 
and colleague 
enquiries and 
requests 
Managing a 
patient / 
support 
organisation  
  
1996 
Learning from early 
contacts - food 
manufacturers and 
caterers 
Food industry 
contacts - 
manufacturers, 
retailers, caterers, 
technologists, 
professional and 
scientific 
associations  
  
Pastoral 
advocacy and 
supporting 
bereaved 
families 
Research and 
advocacy - 
Collaboration 
with clinicians 
and scientists 
  
  
Early site visits to 
factories, catering 
operations 
Journalists - print, 
radio, television 
  
Integrity of 
patient support 
activities 
Press liaison - 
writing, 
interviews - tv 
and radio 
  
  
Further site visits - 
schools, nurseries, 
care scenarios 
Consumer 
champions  
Setting learning 
aims and 
objectives for 
chefs, front of 
house and other 
food handlers 
Setting learning 
aims and 
objectives for 
chefs, front of 
house and other 
food handlers 
Literature 
reviews 
W1 
    
Dr Lisa Ackerley 
and Hygiene Audit 
Systems 
  Website content  
Allergy Action 
website, 
building, 
designing, 
managing 
  
  
The relationship 
between allergy and 
the pharmaceutical 
industry  
Cranfield 
University  
    
Understanding 
and working 
with the 
pharmaceutical 
sector 
  
1997 
Further sesame 
allergy survey 
Coroners, 
bereaved families 
    
Attending 
inquest, family 
support 
  
  
Manufacturing 
controls for food 
allergens 
Institute of Food 
Science and 
Technology  
IFST Good 
Manufacturing 
Practice - 
Dealing with 
allergens  
Trusted 
authoritative 
consultancy 
Consultancy 
work including 
training 
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Review of personal 
allergy history for 
conference and 
publications 
European allergy 
clinicians, journal 
editors, scientists 
Close 
partnership with 
Food Standards 
Agency 
  
Writing 
abstracts and  
first journal 
paper 
  
1998 
Mapping allergy 
care pathways 
Meeting with 
Minister of Public 
Health, work with 
Nutritionists 
    
Responding to 
reviewer 
comments 
  
  
Survey of 
community 
pharmacists into 
readiness to deliver 
adrenaline auto-
injectors 
Royal 
Pharmaceutical 
Society of Great 
Britain 
The 'Red Book' 
for pharmacists  
Allergy 
management in 
professional 
standards for 
community 
pharmacists 
Writing 
information 
leaflets for 
Katherine Baker 
Project and 
Boots the 
Chemist 
W2 
2000   
BBC Radio 4 Food 
Programme 
Awards Finalist  
Replying to FSA 
consultations 
  
Setting up and 
running a small 
business 
W3, 
P1, 
  
Reviewing the life-
long impact of food 
allergy and related 
conditions - 
personal perspective 
    
Clear and 
accurate food 
labelling 
Devising 
research 
methodologies  
Presenting 
research data 
P2, 
W4 
  
Presenting the 
consumer and 
patient perspective - 
also understanding 
of different food 
industry 
perspectives 
Leatherhead Food 
Research 
Association  
Call for more 
recognition of 
information and 
food safety 
needs of 
consumers with 
allergies and 
intolerances 
  
First Book 
Chapter 
B1 
2001 
‘May contain' report 
into shopping for 
people with nut and 
peanut allergies  
Royal College of 
Physicians  
  Research ethics  
Giving  written 
and oral  
evidence 
W5 
    
European 
Academy of 
Allergy and 
Clinical 
Immunology 
    
Speaking at 
international 
conference 
  
2002         
Modelling – 
presenting novel 
research 
methods 
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2003 
Data collection on 
patient care 
pathways  
  
Giving evidence 
for House of 
Commons 
Report into 
Allergy 
  
Producing 
graphical 
illustrations for 
advocacy and 
training 
W6, 
W7 
    
Anaphylaxis 
Campaign 
Strategic Review 
of partnerships 
and identification 
of potential 
partners 
    
Reviewing 
activity and 
Strategic 
Planning 
  
          
Tender 
application for 
training 
programmes 
P3 
2004 
Data collection for 
House of Commons 
report 
     
Project 
management - 
training 
programme 
W8, 
W9, 
W10 
2005 
Full sesame allergy 
survey 
  
Shaping FSA 
guidance for 
consumers with 
allergies and 
intolerances 
  
Conference and 
events 
management 
  
2006       
Content of 
Allergytraining 
DVD Training 
Pack  
Film making - 
script writing, 
editing, 
production, 
managing 
actors, sourcing 
music, artwork, 
locations, 
marketing, 
online sales, 
ethics 
  
          
Creating online 
learning 
materials and 
project logistics 
UK and Ireland 
  
    
British Retail 
Consortium (BRC) 
and Food and 
    
Writing industry 
guidance in FSA 
working group 
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drink Federation 
(FDF) 
  
Data collection for 
House of Lords 
Report 
  
Giving evidence 
for House of 
Lords Report 
into Allergy  
  
Giving oral 
evidence 
P4, 
W11 
          
Interactive CPD 
training 
workshops  
  
2007 
Review of fatal food 
reactions 1999-2007 
    
Allergy audits for 
catering 
operations 
Reviewing fatal 
food reactions 
  
   
Discussing EU 
Labelling at 
French 
conference  
 
Addressing 
French 
clinicians’ 
conference  
 
2008   
Work to set up 
the UK Fatal 
Anaphylaxis 
Registry with 
Central 
Manchester 
Hospitals 
  
Ethics and 
working methods 
for the UK Fatal 
Anaphylaxis 
Registry 
Building 
collaborative 
research teams 
  
          
Submitting 
applications for 
research funding 
P5, 
W14, 
W15 
          
Designing and 
presenting study 
posters 
  
    
LGC - Laboratory 
of the 
Government 
Chemist - 
developing 
analytical 
methods 
    
Project adviser - 
development of 
analytical 
methods for the 
presence of 
food allergens. 
Research on 
court cases 
relating to food 
allergies  
  
2009 
In-depth FSA study 
into wide range of 
issues related to 
living with nut / 
peanut allergy 
Allergy and 
Hygiene Systems 
Ltd - Graeme Kerr 
- Training partner 
in Scotland  
Short course in 
Allergy 
Awareness 
Making learning 
accessible, 
Supplying 
practical learning 
tools 
Preparing 
publications  
collaboratively 
P6, 
P7,  
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Southampton 
University Medical 
School 
    
Lecturer on the 
MSc in Allergy at 
Southampton 
University  
  
2010 
Reviewing allergen 
management and 
controls in 
foodservice  
Health Canada 
and Wiley  
Presenting the 
need for further 
consumer 
information for 
people eating 
out and buying 
non-prepacked 
foods 
Population 
Consumer 
research with 
Mintel and 
Unilever 
Book chapter 
Allergen 
Management 
and Control in 
the Food Service 
Industry.  
B2, 
A1 
2011 
Reviewing food 
allergen controls in 
NHS Scotland 
Royal 
Environmental 
Health Institute of 
Scotland 
Support for 
Environmental 
Health Officers 
in Scotland to 
control allergy 
risks 
Royal 
Environmental 
Health Institute 
of Scotland Joint 
Award in Allergy 
Awareness for 
food handlers, 
nursery, school 
and hospital staff 
Risk assessment 
and training for 
hospitals 
P8, 
P9, 
P10, 
A2, 
A3, 
A4, 
W16 
  
Research into how 
to make the new 
legislation practical 
and helpful for 
businesses and 
consumers 
  
Expert adviser 
to the Food 
Standards 
Agency on 
implementing 
food legislation 
in practice 
Writing 
accessible exams 
for food handlers 
to ensure 
competence 
Faculty member: 
EAACI Summer 
School for 
allergy clinicians 
– Vienna 
P11, 
A5, 
W17 
2012   
Royal College of 
Paediatrics and 
Child Health 
  
Improved 
understanding of 
food allergies for 
paediatric 
clinicians  
Royal College of 
Paediatrics and 
Child Health – 
tutor on food 
allergy training 
course for 
paediatricians 
P12, 
P13, 
P14, 
A6, 
A7, 
W18 
  
Extrinsic factors of 
allergic reactions 
TRACE Study - 
looking at peanut 
allergen thresholds 
and understanding 
symptom severity 
Addenbrooke’s 
Hospital, 
Cambridge and St 
Mary’s Hospital / 
The Brompton 
Hospital, London  
  
Member of Trial 
Steering 
Committee for 
TRACE Study - 
Project integrity 
and ethics  
Acting as Trial 
Steering 
Committee 
member for 
clinical research  
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2013       
Expert Trainer – 
delivering 
training 
materials and 
advice to food 
safety trainers / 
professionals to 
implement the 
new Regulation 
1169/2011 EC 
Adapting 
materials to 
include new 
regulation and 
for different 
audiences 
P15, 
P16, 
P17,  
W19, 
W20, 
W21,  
       
Consultancy 
work for leading 
food businesses 
implementing 
additional 
controls and 
guidance  
    
    
Allergy Academy - 
Guy's and St 
Thomas' clinical 
training 
programme  
London 2012 
Olympics – 
allergy risk 
assessment for 
on-site caterers 
Food allergy risk 
assessment for 
Sustain for the  
London 2012 
Olympics 
 
Lecturer on 
Allergy Academy 
courses – Guy’s 
and St Thomas 
Hospitals, and 
King’s College 
London 
  
  
FSA funded study:  
How do food allergic 
and intolerant 
consumers make 
food choices when 
eating out?   
Surrey, Brunel, 
Bath and Cork 
Universities and 
Creative Research 
Ltd 
Study to 
examine impact 
of Food 
Information 
Regulations 
1169/2011 EC  
Informing policy 
from consumer 
behaviour 
research looking 
into eating out 
with food 
allergies and 
intolerances  
Project Adviser – 
the impact of 
the new Food 
Information 
Regulation 
  
2014 
ILSI working group: 
Severity of allergic 
reactions to foods; 
work to assess 
allergen thresholds   
Member of 
International Life 
Sciences Institute 
(ILSI) Expert 
Group  
Impact review  
Food 
Information 
Regulation 
1169/2011 EC 
  
Understanding 
symptoms 
severity  
 A8 
  
Review of consumer 
attitudes to 
allergens in food for 
book chapter  
RSSL Editor Simon 
Flanagan  
  
Consumer 
attitudes to 
allergens in food. 
Chapter 7. 
Handbook of 
Food Allergen 
Contributing 
chapter on 
consumer 
attitudes to 
allergens in 
foods 
B3 
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Detection and 
Control. 
    
Royal Society of 
Public Health  
  
Royal Society of 
Public Health 
(RSPH)  – 
developing 
qualification: 
Level 2 
Qualification in 
Identifying and 
controlling Food 
Allergy Risks 
Examiner for 
accredited 
qualification: 
RSPH Level 2 - 
creating 
question bank 
P18, 
P19, 
P20,  
  
Further fatal 
reactions and 
lessons learned 
H M Coroners and 
others 
investigating fatal 
allergic reactions  
Reviewing 
legislation which 
may be 
applicable 
following fatal 
reactions 
Modelling 
investigation 
protocols into 
food allergy 
reactions  
Properly 
interested 
person and 
expert witness 
for fatal allergic 
reactions 
  
  
Reviewing the 
effectiveness of 
materials available 
to implement the 
new Food 
Information for 
Consumers 
Regulation  
  
Wrote and 
produced 
information 
video on the 
resources 
available 
Practical 
implementation 
of allergen 
controls required 
in the new Food 
Information 
Regulation  
Making an 
awareness 
cartoon video 
and uploading 
to Vimeo  
W22 
2015 
Further investigation 
into consumer 
behaviour following 
the Food 
Information for 
Consumers 
Regulation  
University of Bath, 
Creative Research 
Ltd 
    
Lecturing on 
MChemA Public 
Analysts 
Training course 
P21, 
P22, 
P23, 
P24,  
A9 
2016 
Further 
understanding of 
severity of allergic 
reactions  
Imperial College 
London 
    
Lecturer in MSc 
in Allergy at 
Imperial College 
P25, 
A10, 
A11, 
A12, 
B4, 
W23 
  
Review of current 
best practice in 
catering and 
regulatory context 
British Hospitality 
Association  
Contributed to 
the Allergens 
section of the 
new Industry 
Contributed to 
the Allergens 
section of the 
new Industry 
Updating 
understanding 
of managing 
food allergies in 
W24 
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Guide to Good 
Hygiene Practice 
Catering Guide 
Guide to Good 
Hygiene Practice 
Catering Guide 
catering 
businesses  
2017 
Re-examining food 
allergen regulations 
worldwide 
  
International 
oversight of 
food allergen 
regulation and 
controls 
Food Allergy: 
Managing Food 
Allergens 
Chapter 24 of 
Analysis of Food 
Toxins and 
Toxicants. 
Writing book 
chapter with Dr 
Michael Walker 
P26, 
P27, 
P28  
2018 
Allergy in 
adolescents 
EAACI Task Force 
partner 
Codex working 
group 
incorporating 
allergen 
management 
into Food 
Hygiene 
  
Online 
teleconferences, 
meetings and 
live data 
handling, 
webinars 
 (P29) 
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4 Allergy and associated conditions – Discussion 
 
Gowland’s role in allergy has always included support and advocacy for people 
sensitive to medication and insect stings as well as food. She has taken histories, 
undertaken investigations, provided support and worked on coroner’s investigations 
for people who suffered fatal reactions to medication, bee and wasp stings. For some 
people, anaphylaxis may be idiopathic – ie with no known cause, or perhaps triggered 
by exercise alone, or with co-factors. She is committed to improving access to 
specialist allergy healthcare and diagnosis, and ensuring that injectible adrenaline is 
available and accessible to those who may need it, whatever may trigger their 
symptoms. Training courses and management protocols developed and delivered by 
her always recognise the needs of anybody who may have a severe reaction, whether 
from medication, insect stings, food or other cause.  
At the same time, her work to improve the identification and control of food allergens 
continues to benefit those with a range of conditions; primarily food allergy, food 
intolerance and coeliac disease, as well as other less common conditions which require 
food allergen avoidance.  
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4.1 Food allergen avoidance 
Figure 3: Who is avoiding foods and why? (Published in book chapter B2 – 2010) 
 
Gowland used the diagram (Figure 3) in her training courses from 2000 – 2008 to help 
food business staff understand food allergy, food intolerance and coeliac disease in the 
wider context of all the food avoidance requests they receive from customers. 
Although more is understood now about some of the medical conditions associated 
with food hypersensitivity, and this information is more effectively communicated to 
students through the use of images and photos, this simplified format helped staff to 
appreciate and address the potential risk to health associated with different dietary 
requests.  
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4.2 Food hypersensitivity 
Figure 4: Food hypersensitivity 
(Much of section 4 from this point and section 5 are abridged from the book chapter 
Walker, M. J., Gowland, M. H. (2017). Chapter 24: Food Allergy: Managing Food 
Allergens. In:  Yiu Chung Wong, ed., Analysis of Food Toxins and Toxicants. 1st ed. Hong 
Kong: Wiley, pp. 711-742. B4 – 2017). 
People may suffer a range of adverse reactions to food (Figure 4). Anybody who 
consumes food containing a large number of Salmonella enterobacteria will become ill. 
Other reactions to food are not predictable and will not affect everybody. Until a 
reaction happens, the person affected does not know that it will happen. If such 
reactions occur almost every time the person eats that food, their reactions are 
‘reproducible’. Food hypersensitivity is the general term for such reproducible adverse 
reactions to particular foods, defined more formally as: ‘objectively reproducible 
symptoms or signs initiated by a defined stimulus at a dose tolerated by ‘normal’ 
subjects’ (Johansson et al., 2001).  
There are many forms of food hypersensitivity. One of these is ‘allergy’, a term 
introduced in 1906 by Clemens von Pirquet (1874–1929) (Igea, 2013). ‘Food allergy’ is 
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a hypersensitivity to food protein(s) involving the immune system. The immune system 
ensures human survival by producing antibodies to recognise, fight and help to destroy 
harmful antigens such as parasites, bacteria or viruses. Antibodies are immunoglobulin 
glycoproteins produced by plasma cells (white blood cells). There are five main 
isotypes: IgA, IgD, IgE, IgG, and IgM, (Schroeder and Cavacini, 2010). Food allergy is 
mediated by immunoglobulin E, IgE, discovered in 1967 (Johansson, 2016).   
4.2.1 Food Allergy 
Food allergy develops in two separate stages: a) sensitisation and b) elicitation of signs 
and symptoms. Sensitisation occurs in susceptible individuals as the development of an 
immunological response to specific food proteins. It is possible for somebody to be 
sensitised ie produce allergen specific IgE, sIgE without allergic symptoms.  Food 
allergy is therefore defined as the sensitisation and elicitation of an adverse reaction 
on subsequent exposure. This means that individuals sensitised to a food protein who 
consume or have other contact with it may experience symptoms. These are caused by 
IgE cross linking with allergenic epitopes leading to the release of potent inflammatory 
mediators such as histamine from tissue mast cells and peripheral basophils. IgE 
mediated food allergy involves acute symptoms, generally within 2 hours of ingestion 
of the provoking food, and sometimes within minutes. Symptoms include lip tingling, 
nausea, diarrhoea, vomiting, pruritus (itch), erythema (red rash), asthma, urticaria 
(hives, a raised, itchy rash), and angioedema (swelling caused by fluid released from 
the circulatory system to protect the organs). The most severe allergic reaction is 
anaphylaxis which can become life threatening (see section 4.4 below). 
4.2.2 Oral allergy or pollen-food allergy syndrome 
Some people have oral allergy or pollen-food allergy syndrome. They are sensitised 
(via the respiratory system) to pollen proteins which are similar in size and shape to 
certain fruit and vegetable proteins leading to IgE binding. Symptoms may include 
localised mouth itching and intermediate gastrointestinal hypersensitivity.  
4.2.3 Other mechanisms 
Mixed IgE and cell-mediated mechanisms are involved in chronic conditions such as 
atopic dermatitis, also known as eczema and also in eosinophilic gastro enteropathies, 
such as eosinophilic esophagitis and eosinophilic gastritis. Non–IgE-mediated 
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gastrointestinal food-induced allergic disorders (non-IgE-GI-FAs) account for an 
unknown proportion of food hypersensitivity and include food protein–induced 
enterocolitis syndrome (FPIES), food protein–induced allergic proctocolitis (FPIAP), and 
food protein–induced enteropathy (FPE). Non-IgE-GI-FAs have considerable overlap 
among themselves and with eosinophilic gastro enteropathies. FPIES is probably the 
most actively studied non-IgE-GI-FA, potentially because of acute and distinct clinical 
features. FPIAP remains among the common causes of rectal bleeding in infants, while 
classic infantile FPE is rarely diagnosed. The most prominent clinical features of FPIES 
are repetitive emesis (vomiting), pallor, and lethargy; chronic FPIES can lead to failure 
to thrive. FPIAP manifests with bloody stools in well-appearing young breast-fed or 
formula-fed infants. Features of FPE are non-bloody diarrhoea, malabsorption, protein-
losing enteropathy, hypoalbuminemia, and failure to thrive. Non-IgE-GI-FAs have a 
favourable prognosis; the majority resolve by 1 year in patients with FPIAP, 1 to 3 years 
in patients with FPE, and 1 to 5 years in patients with FPIES, with significant differences 
regarding specific foods. Much work remains to be done to understand these conditions 
(Sicherer and Sampson, 2010, Burks et al., 2012, Järvinen and Nowak-Węgrzyn, 2013, 
Caubet et al., 2014, Nowak-Węgrzyn, et al., 2015). See also Heiner syndrome, milk-
induced pulmonary disease in infants (Moissidis et al., 2005).  
4.2.4 Coeliac disease and ‘food intolerance’ 
Food hypersensitivity also includes auto-immune conditions such as coeliac disease 
(Kennedy and Feighery 2000) and the spectrum of conditions grouped together as ‘food 
intolerance’. Food intolerance includes pharmacological effects of food components, eg 
vasoactive amines such as histamine, non-coeliac gluten sensitivity, enzyme and 
transport defects, eg lactose intolerance, the potential adverse effects of some food 
additives eg tartrazine, annatto, sulphites, benzoic acid, and short chain fermentable 
carbohydrates (FODMAPs) (Lomer, 2015). 
The primary focus of Gowland’s work to reduce risks from food allergens and support 
patients and consumers has been IgE mediated food allergy, an increasing global health 
problem with considerable associated morbidity (Prescott and Allen, 2011, Nwaru et al., 
2014, Chan et al., 2015a).  
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4.3 Food Allergy Prevalence  
Food allergy may persist from childhood or follow newly acquired sensitisation in 
adulthood. Some childhood food allergies eg to milk, egg, soya, or wheat are often 
outgrown, whereas allergies to tree nuts or peanut in children beyond age 6-7 tend to 
persist. Allergies to fish or crustacean shellfish, which most commonly develop in 
adulthood, usually persist. Hence the prevalence of food allergy varies, data may be 
lacking and studies exhibit heterogeneity. The double-blind, placebo-controlled food 
challenge (DBPCFC), the most reliable indicator of allergy to a food, has proved difficult 
to apply in many prevalence studies (Burks et al., 2012). 
Rona et al., (2007) first identified the main problems in prevalence studies; out of 934 
articles identified by these authors from 1990 onwards, only 51 were appropriate for 
inclusion in their prevalence meta-analysis. Information sources were classified into 5 
categories: self-reported symptoms, specific IgE positive, specific skin prick test positive, 
symptoms combined with sensitisation, and food challenge studies. The high prevalence 
of self-reported food allergy compared with objective measures was also noted. 
Nwaru et al., (2013) studied the prevalence and epidemiology of food allergy in 25 
countries of Europe in a systematic review of the literature 2000 – 2012. The protocol, 
search strategy, inclusion and exclusion criteria and key terms were defined. The 
numbers of new cases of the various IgE-mediated, non-IgE-mediated or combination 
causes of food allergy that occur during a given period in a defined population were 
studied as: 
 Incidence rate: The number of new cases of food allergy that occur during a given 
period per unit of person-time; 
 Cumulative incidence: The number of new cases of food allergy that occur during 
a given period per the population at risk; 
Prevalence data were collected as: 
 Point prevalence: the proportion of the population that has experienced food 
allergy at a specific time; 
 Period prevalence: the proportion of the population that has experienced food 
allergy during a given period, and 
 Lifetime prevalence: the proportion of the population that at some point in their 
life will have experienced food allergy. 
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Seventy-five eligible articles (56 primary studies) were included and most of the studies 
were graded as at moderate risk of bias (Nwaru et al., 2014). There were significant 
differences between self-reported and other categories. Self-reported pooled lifetime 
prevalence of food allergy was 17.3% (95% CI: 17.0 – 17.6) accompanied by a self-
reported point prevalence of 5.9% (95% CI: 5.7 – 6.1). However the point prevalence of 
sensitisation to one or more foods also differed with category as shown in Table 2. 
 
Table 2:  Point Prevalence to ≥ allergen by diagnostic category (from Nwaru et al., 2014) 
 
Assessed by Point Prevalence 95 % Confidence Interval 
Specific IgE 10.1 % 9.4–10.8 
Skin prick test 2.7 % 2.4–3.0 
Food challenge 0.9 % 0.8–1.1 
 
Both self-perception and allergic sensitisation (specific IgE) are known to substantially 
overestimate the actual frequency of food allergy (FA). Overall the data reported by 
Nwaru et al., appear to indicate that food allergy affects some 1 – 2% of adults and some 
5 – 6 % infants and children in Europe. However more studies are needed. Prevalence 
was greater in north-western Europe than in southern Europe. While the incidence of 
FA appeared stable over time, there was some evidence that the prevalence may be 
increasing.  
Prevalence of food allergy to specific foods in Europe was investigated again showing 
significant heterogeneity across fewer studies, Table 3, (Nwaru, 2014b). Allergy to cow’s 
milk and egg was more common among younger children, while peanut, tree nut, fish, 
and shellfish were more common among older children.  
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Table 3: Overall pooled estimates for all age groups lifetime prevalence of allergy 
Food Self-reported lifetime 
prevalence allergy, mean and 
95 % Confidence Interval 
Lifetime prevalence of food 
challenge defined allergy, 
mean and 95 % Confidence Interval 
Cow’s milk 6.0 % (5.7 – 6.4) 0.6 % (0.5 – 0.8) 
Egg 2.5 % (2.3 – 2.7) 0.2 % (0.2 – 0.3) 
Wheat 3.6 % (3.0 – 4.2) 0.1 % (0.01 – 0.2) 
Soya  0.3 % (0.1 – 0.4) 
Peanut 0.4 % (0.3 – 0.6) 0.2 % (0.2 – 0.3) 
Tree Nuts 1.3 % (1.2 – 1.5) 0.5 % (0.08 – 0.8) 
Fish 2.2 % (1.8 – 2.5) 0.1 % (0.02 – 0.2) 
Shellfish 1.3 % (0.9 – 1.7) 0.1 % (0.06 – 0.3) 
 
Sicherer and Sampson suggested that food allergy in the USA probably affects nearly 5% 
of adults and 8% of children, with growing evidence of an increase in prevalence 
(Sicherer and Sampson, 2014).  
Mahesh et al., reported food allergy sensitisation prevalence (sIgE estimation for 24 
common foods) among South Indian adults of 26.5% (Mahesh et al., 2016), but actual 
food allergy was far less common.   
Australia appears to have some of the highest global prevalence of food allergy of up to 
10% in young children (Prescott et al., 2013). These authors conducted a global survey 
in 2012 to collect information from all the national member societies of the World 
Allergy Organization, and some of their neighbouring countries, (total n = 89). More than 
half of the countries surveyed (52/89) did not have any data on food allergy prevalence. 
Only 10% (9/89) of countries had accurate food allergy prevalence data, based on oral 
food challenges, (OFC). The remaining countries had data largely based on parent-
reporting of a food allergy diagnosis or symptoms, recognised to overestimate the 
prevalence of food allergy. 
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Food allergy in Asia has been reviewed based on the literature published between 2005 
and 2012 (Lee et al., 2013). The overall prevalence of food allergy in Asia was found to 
be somewhat comparable to that in the West with  egg and cow’s milk allergy the two 
most common food allergies among young children and infants. However, by contrast, 
shellfish allergy rather than peanut allergy is the most prevalent in Asia, in part due to 
the abundance of seafood in the diet. Lee et al., (2013) suggest that house dust mite 
tropomyosin may be a primary sensitiser. Differences also exist within Asia. Wheat 
allergy, though uncommon in most Asian countries, is the most common cause of 
anaphylaxis in Japan and Korea, and is increasing in Thailand. 
In large and rapidly emerging societies of Asia, such as China there are documented 
increases in food allergy. The prevalence of oral food challenge (OFC), proven food 
allergy is around 7% in pre-schoolers, comparable to the reported prevalence in 
European regions. Comparison of cross-sectional data collected in 1999 and again in 
2009 at the same clinic in Chongqing, China, showed a two-fold increase in the 
prevalence of food allergy, from 3.5% to 7.7% (p = 0.017), and skin prick tested, (SPT), 
sensitisation, from 9.9% to 18.0% (p = 0.02). The overall prevalence of challenge-proven 
food allergy in 0 to 1 year-old children in Chongqing, China was 3.8%, (Chen et al., 2011).  
The prevalence rates of adverse food reactions including food allergy were found to be 
8.1% (parent-reported) and 4.6% (doctor-diagnosed) in Hong Kong (Leung et al., 2009). 
The six leading causes of were shellfish (15.8%), egg (9.1%), peanut (8.1%), beef (6.4%), 
cow’s milk (5.7%), and tree nuts (5.0%). When compared with children born and raised 
in Hong Kong, children born in mainland China had statistically significantly lesser 
prevalence. The authors concluded adverse food reactions including food allergy are a 
common atopic disorder in Hong Kong pre-school children, and prevalence rates are 
comparable to those in Caucasians. Chan et al. (2015b) summarising what is known 
about food allergy prevalence in Hong Kong noted ‘probable’ food allergy in 2010 in 
children aged 7 – 10 was 2.8% while in 2012 the prevalence of food allergy in children 
from birth to 14 years old was 4.8% of which shellfish was by far the commonest 
alongside egg, milk, peanut and fruits (Chan et al., 2015b). Children with food allergies 
have 2 – 4 times higher rates of co-morbid conditions including asthma, rhino 
conjunctivitis and eczema. Interestingly Chan et al. (2015b) reported 15.6% of children 
with food allergies aged 14 years or less are estimated to have a risk of anaphylaxis 
which is high relative to other countries. 
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There are over 170 foods known to provoke allergic reactions. Of these, the most 
common foods responsible for inducing 90% of reported allergic reactions are peanuts, 
milk, eggs, wheat, nuts (eg, hazelnuts, walnuts, almonds, cashews, pecans, Brazil nuts 
etc.), soya, fish, crustaceans and molluscs (Boye, 2012). However as indicated above 
there are differences between regions in the patterns of prevalence. Gendel has 
helpfully collated the way in which different countries legislate for different allergens, 
(Gendel, 2012). 
A large study by the European Food Safety Authority in 2014 recognised the 
heterogeneity of prevalence studies but suggested that the most common foods 
triggering about 75% of allergic reactions among children are from egg, peanut, cow’s 
milk, fish and various nuts. In adults about half of allergic reactions are caused by fruits 
of the latex group and of the Rosaceae family, vegetables of the Apiaceae family, and 
various nuts and peanuts, (EFSA, 2014a). 
4.4 Anaphylaxis 
Anaphylaxis, a clinical emergency, is an acute, rapid onset, multi-organ systemic allergic 
reaction with life-threatening airway, breathing or circulatory problems. Anaphylaxis 
can be caused by any allergic reaction and is relatively common with considerable 
morbidity (Panesar et al., 2013; Dhami et al., 2014). First-line treatment for anaphylaxis 
is rapid intramuscular adrenaline (epinephrine) (usually into the thigh) typically, in the 
community, using the person’s own autoinjector. Emergency medical aid must be 
summoned for a range of second-line interventions (Muraro et al., 2014a). A patient 
with breathing difficulties should be placed in a sitting position, and if faint or dizzy 
should lie down with head and heart level and legs elevated. It is crucial that the patient 
does not stand up as this may result in death from “empty ventricle syndrome”. 
In children the most common cause of anaphylaxis is food allergy, and deaths from food 
induced anaphylaxis are particularly shocking. Although fatal food anaphylaxis is rarer 
than accidental death in the general population, (Umasunthar et al., 2013), hospital 
admissions from all causes of anaphylaxis increased by 615% between 1992 and 2012 in 
the UK. Admission and fatality rates for drug- and insect sting–induced anaphylaxis were 
highest in the age group 60 years and older. In contrast, admissions because of food-
triggered anaphylaxis were most common in teenagers and young adults, with a marked 
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peak in the incidence of fatal food reactions during the second and third decades of life 
(P19 – 2015 and Gibbison et al., 2012).  
It is not possible to predict with precision which allergic individuals are likely to have 
anaphylactic reactions; however some risk stratification is possible such as coexistent 
asthma, particularly in children, and a history of previous severe reactions. Adolescents 
are also at a higher risk of anaphylactic reactions owing to biological and social factors. 
Other factors such as exercise, presence of infection or alcohol consumption at the time 
of exposure to the allergen can have an influence and there is also a condition 
recognised as food-associated, exercise-induced anaphylaxis. Swan et al., (2016) review 
the prevention and management of anaphylaxis (Swan et al., 2016). The catering sector 
exhibits particular risks for food related anaphylaxis fatalities, (Leitch et al., 2005). 
4.5 Severity of allergic reaction 
From the perspective of possible application of thresholds as a risk management option 
the most important current issue is that of the severity of adverse reactions, including 
anaphylaxis. Not only does the threshold dose for symptoms vary between individuals 
and in the same individual over time but many other factors influence the severity of 
reaction. Timely, effective treatment limits, but does not control, all reactions and Smith 
et al., (2015) have reviewed the possible risk factors that prompt a mild or a severe 
reaction. Fatal and severe reactions appear more likely if there is a combination and 
alignment of risk factors. For a similar dose in patients with equivalent levels of severe 
food allergy it is possible to envisage different clinical outcomes. A mild reaction would 
be expected in a patient with less current allergic disease, fewer metabolic factors, 
fewer contributing medications and early effective use of adrenaline / epinephrine and 
the converse will amplify a severe allergic reaction. The factors include the following and 
the paper by Smith et al., should be consulted for further information on the underlying 
mechanisms: 
 asthma – is probably the most significant risk factor for death from food allergy 
anaphylaxis and pollen season is also implicated; 
 allergic disease burden - severe rhinitis and severe eczema appear to be 
correlated with increased risk of more serious symptoms in anaphylaxis events; 
 intercurrent illness –there is evidence of immunological vulnerability with 
infective illness; 
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 comprehension and education – will enhance the prevention, recognition and 
appropriate and timely treatment of anaphylaxis; 
 late or absent treatment – failure or delay in administering adrenaline / 
epinephrine, is considered to be an important and avoidable factor in fatal 
reactions; 
 medication – Beta-blockers, nonsteroidal anti-inflammatory drugs (NSAID) (eg 
cox-inhibitors), ACE inhibitors and aspirin have been reported as possible 
contributors to the severity of all forms of anaphylaxis;  
 physiological factors – the expression of multiple allergic mediators (eg 
histamine, interleukins-2, -6 and -10), and serum angiotensin converting enzyme 
l (ACE) and other enzymes, menstruation; 
 the allergen – peanut has been found to cause more severe reactions than other 
(hazelnut, egg and milk) foods studied; 
 concealment of allergen – delayed recognition of an allergenic food caused by 
lipid matrices gives rise to increased dose exposure; itch and burning from spices 
could mimic allergic symptoms and confuse the issue; 
 age – youth is a risk factor for fatal reactions for a variety of reasons including 
social and emotional, while older age has been associated with more severe 
hypoxemia with anaphylaxis episodes and higher risk of severe cardiovascular 
symptoms;  
 exercise – can cause anaphylaxis directly and is a co-factor for food anaphylaxis, 
best defined as food dependent exercise induced anaphylaxis (FDEIA), exercise 
is also a physiological state that increases release of mediators (eg serotonin, 
bradykinin and endorphins); 
 alcohol (ethanol) – brings psychosocial and physiological risk factors. 
It was also noted there seem to be important co-factors in the community that influence 
the severity of food allergic reactions outside the controlled clinical setting of a formal 
food challenge (Smith et al., 2015). A history of severe allergic events including 
anaphylaxis has been identified as a risk factor for fatal events but about half of a UK 
series of food anaphylaxis deaths occurred in patients with a history of mild reactions; 
thus there can be little reassurance based on a history of previous mild reactions (P4 - 
2007). 
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Publications from the Food Standards Agency funded TRACE Peanut Study should be 
available later in 2018. This study examined peanut thresholds in adults (18-45 years), 
symptom severity and the impact of two ‘extrinsic’ or co-factors, exercise and stress 
induced through sleeplessness, which are both known to influence allergen thresholds. 
(Gowland has contributed to this study as a member of the project’s Trial Steering 
Committee.) 
4.6 Quality of Life 
Food allergy results in well-documented detriments to the quality of life (QoL), for 
allergic consumers and their families and carers (King et al., 2009, Venter et al., 2015). 
Teenagers in particular do not feel that their peers appreciate the difficulties they face 
and a significant number demonstrate risk-taking behaviour in the management of their 
food allergies (Monks et al., 2010). DunnGalvin et al., (2015) categorised adverse QoL 
impacts in terms of social, dietary, and psychological factors. For those living with food 
allergy, social events are experienced differently with feelings of exclusion and 
difference. Children, teens, and parents need to cope with normal developmental 
changes as well as with the food allergy, placing them under increased psycho-social 
stress and leading to adverse effects on QoL and coping. Unsurprisingly parents and 
carers of food allergic children and teenagers ‘live on their nerves’ and find planning for 
and participation in school, activities and social occasions such as eating out challenging. 
Figure 5: Wordle – Stress and quality of life with food allergy 
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To address and attempt to alleviate such causes of stress, both quantitative and 
qualitative research suggests that targeting uncertainty should be a major goal for 
health professionals working with children, teens and families with a food allergy. 
Remarkable similarities in response to food allergy across countries suggest that policies 
and programmes that address quality of life issues may be relevant to many different 
populations. An in-depth understanding of the relationship between a diagnosis of food 
allergy and health-related quality of life, (HRQL), as well as the factors that impact it, will 
ultimately lead to the promotion of earlier, more effective preventive strategies and 
interventions that are focused on maximising optimal health development and quality 
of life (DunnGalvin et al., 2015). 
In 2017, both the European Academy of Allergy and Clinical Immunology (EAACI) and 
British Society of Allergy and Clinical Immunology (BSACI) meetings focused on stress 
and quality of life challenges for those living with food allergy and their carers. Gowland 
prepared the Wordle (Figure 5) to demonstrate this for a mixed clinical and lay audience.  
Individuals with nut allergies adopt strategies to make safer food choices. Three main 
examples were identified by Barnett et al., (2013) as (a) qualities of product such as 
the product category or the country of origin, (b) past experience of consuming a food 
product, and (c) sensory appreciation of risk. Risk reasoning and risk management 
behaviours were often contingent on the context and other physiological and socio-
psychological needs which often competed with risk considerations. Stakeholders 
could benefit from an understanding of these food choice strategies when designing 
and implementing allergen risk management policies. 
4.7 Is there a cure for food allergy? 
For those with food allergies, lifelong avoidance of the eliciting food(s) is required. 
Possible cures for food allergy remain experimental although promising. Studies suggest 
that peanut oral immunotherapy (OIT) might be effective in the treatment of peanut 
allergy. A team at Addenbrooke’s Hospital, Cambridge, UK, have established the efficacy 
of OIT for the desensitisation of children with allergy to peanuts. A randomised 
controlled crossover trial compared the efficacy of active OIT (using characterised 
peanut flour; protein doses of 2 – 800 mg/day) with control (peanut avoidance, the 
present standard of care). OIT successfully induced desensitisation in most children 
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within the study population with peanut allergy of any severity, with a clinically 
meaningful increase in peanut threshold. Quality of life improved after intervention and 
there was a good safety profile. Immunological changes corresponded with clinical 
desensitisation (Anagnostou et al., 2014). These authors recommended further studies 
in wider populations and that peanut OIT should not be done in non-specialist settings, 
but it was effective and well tolerated in the studied age group. For further information 
see Anagnostou and Clark, (2015). Parallel studies and clinical trials involving 
characterised peanut flour consumption and induced tolerance to peanut via skin 
patches are also underway.  
4.8 Prevention of food allergy 
Prevention of food allergy has been classified as primary, secondary or tertiary. Primary 
prevention would block the initial IgE sensitisation, secondary prevention would 
interrupt the development of food allergy in those sensitised and tertiary prevention 
would reduce the expression of end-organ allergic disease in patients with established 
food allergy. A large proportion of the allergy burden is probably inherited. However 
genetic predisposition alone cannot explain the disturbing increase in food allergy over 
an evolutionary short 20 year timespan. Studies on changes in gene function in relation 
to environmental influences (epigenetic modifications) are beginning to provide 
evidence to explain the mechanisms underlying the development of food allergy. (Du 
Toit et al., 2016a) 
Sensitisation can occur early in infancy, and it appears that prevention strategies should 
ideally commence during these early-life periods of immunologic vulnerability. Families 
can be provided with evidence-based advice about preventing food allergy, particularly 
for infants at high risk for development of allergic disease. The advice for all mothers 
includes a normal diet without restrictions during pregnancy and lactation. For all 
infants, exclusive breastfeeding is recommended for at least the first 4 – 6 months of 
life. If breastfeeding is insufficient or not possible, infants at high-risk can be 
recommended a hypoallergenic formula with a documented preventive effect for the 
first 4 months. There is no need to avoid introducing complementary foods beyond 4 
months. There is no evidence to support the use of prebiotics or probiotics for food 
allergy prevention. In 2014, the evidence did not justify recommendations about either 
withholding or encouraging exposure to potentially allergenic foods after 4 months once 
weaning has commenced, irrespective of atopic heredity, (Muraro et al., 2014c). 
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However two studies ‘LEAP-On’ and ‘EAT’ reported in early 2016 are important and 
reassuring additions to our knowledge about possible prevention of food allergy. ‘LEAP-
On’ studied infants at high-risk of developing peanut allergy (‘high risk’ was defined as 
infants at with suspected egg allergy based on skin prick testing, and /or with severe 
eczema based on a clinical evaluation that combined the extent, severity and subjective 
symptoms of the eczema, and the treatment required). 
The earlier Learning Early About Peanut Allergy (LEAP) study from 2015 found, 
somewhat counter-intuitively, that the majority of such high risk infants can be 
protected from peanut allergy at age 5 years if they eat peanut frequently, starting 
within the first 11 months of life.  The LEAP-On findings were that early peanut 
introduction protection is sustained even when peanut is no longer consumed for 12 
months. 
Enquiring about Tolerance (EAT) by contrast looked at breast fed infants from the 
general population and the early introduction of six major allergenic foods, peanut, 
cooked egg, cows’ milk, sesame, whitefish and wheat. There were very encouraging 
findings that peanut and cooked egg allergy in particular, and food allergies generally 
were lower with early introduction. Moreover, although not easy, such introduction was 
found to be safe. 
Taken together these are reassuring findings that may pave the way to stem the 
epidemic of peanut allergy. These studies were carried out under the close guidance of 
allergy doctors. Parents should not attempt to replicate what the studies did by 
themselves but should follow general guidance, for example that encourages mums to 
breast feed, and common sense attitudes to weaning, introducing a wide variety of 
foods as appropriate. Parents and carers, especially with infants at high risk, should bring 
any concerns to their family doctors or other medical advisors for advice (Du Toit et al., 
2016b, Perkin et al., 2016).  
The findings of EAT, LEAP and LEAP-On are currently being assessed and introduced into 
official guidance and widespread parental practice. 
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5  Food allergen management – Discussion 
 
Businesses too have found the emergence of food allergy challenging. New systems of 
traceability (Millard, 2015), management and segregation (Stein, 2015), cleaning 
(Nikoleiski, 2015), and communication (Flanagan, 2015) have been required. Key 
industry standards (eg BRC, 2015) emphasise greater transparency, traceability and 
integrity in the supply chain. At the same time incidents and recalls have burgeoned with 
associated management time, costs and reputational damage (Walker, 2012). The EU-
funded project developing Integrated approaches to food allergen and allergy 
management (iFAAM), found over 2000 food allergen recalls recorded in the period 
2011-2014 based on publicly available information in Europe, North America, Hong 
Kong, Australia and New Zealand. The biggest incidence of undeclared allergens was 
found to be for milk and milk products (16 – 31% of all products with recall or alert), 
followed by cereals containing gluten (9 – 19%), soya (5 – 45%) and egg and egg products 
(5 – 17%). Between 42 and 90% of the products with recalls/alerts were explained as 
being 'Not indicated on the label. However, 0 – 17% of products with recalls/alerts were 
coded as caused by the unintended presence in production of an allergen as the 
probable result of cross contamination, (described by some in the food industry as 
‘cross-contact’) (Bucchini et al., 2016).  
 
It is important to distinguish risk assessment and risk management of food allergy from 
risk assessment and risk management of food allergens. The former involves patients, 
families and carers and health care professionals. The latter is a task for all stakeholders, 
particularly the food industry, regulators, analytical service providers, and food suppliers 
eg caterers, carers and consumers. 
 
The responsibility for safe and properly labelled food rests with those who make and sell 
it. The Codex Alimentarius General Standard for the Labelling of Prepackaged Foods 
harmonises globally the concept of mandatory disclosure on prepacked food labelling 
of the presence of allergens, with a list of eight major allergens. Gendel has helpfully 
reviewed country-specific implementation of Codex requirements on allergens (Gendel, 
2012). The food industry seeking to provide safe products, consumer choice and subject 
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to the law must label products accurately and minimise cross-contamination in 
harvesting, storage, transport, processing of food and cleaning of equipment. The 
development of ‘allergen-free’ product lines places a particular burden of responsibility 
on allergen control. For food businesses there are potentially serious financial impacts 
and reputational risks of increased food recalls. Compensation in civil law for loss or 
damage caused by an allergic reaction to a food supplied is a foreseeable risk for food 
businesses. European food law aims for a high level of protection of human health and 
consumers’ interests. Article 8 of Regulation (EC) No 178/2002 prohibits adulteration of 
food and fraudulent, deceptive or any other practices which mislead consumers. Article 
14 (of the same regulation) prohibits the sale of unsafe food such as food injurious to 
health, including the particular health sensitivities of any specific category of consumers 
(eg but not exclusively people with food allergy) where the food is intended for that 
category of consumers. More specifically, Regulation (EU) No 1169/2011 addresses 
allergen avoidance risks relating to composition, labelling and food safety. The inclusion 
in prepacked food of any of 14 major allergens defined by Annex II to Regulation 
1169/2011 EC (replacing Annex IIIa to Directive 2000/13/EC) triggers, with certain 
limited exemptions, specific labelling requirements extended on 13 December 2014 to 
non-prepacked food, including catering establishments. Cross-contamination with 
allergens may trigger general principles of European and UK food law that make it an 
offence to sell food that is unsafe for, or not of the nature, substance, or quality 
demanded by, allergic consumers, particularly if specifically intended for their 
consumption. Hence the food industry must know whether allergens are present in their 
products and / or production environment and work out ways of controlling them or 
alerting consumers to the possible risk of their presence through advisory labelling. 
Allergens in the ‘wrong place’ can render food unsafe for people with food allergy. The 
effect of requiring certain allergens to be labelled / highlighted is to prioritise controlling 
them in the supply chain.  
However there are many other foods that provoke allergic reactions than are legislated 
for. Thus foods not listed in legislation as priority allergens must still be managed when 
known to be allergenic for some people. The UK Food Standards Agency (FSA) has 
published comprehensive best practice guidance on allergen cross-contamination and 
‘may contain’ labelling and innovative online food allergy training that is available via 
http://allergytraining.food.gov.uk/english/ . The training includes factory and non-
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prepacked food scenarios, including catering, and aims to provide a greater 
understanding of the issues surrounding enforcing relevant legislation in the area of 
food allergens for local authority enforcement officers. The online food allergy training 
course was launched in 2008. FSA guidance was published in August 2014 to help small 
and medium-sized enterprises (SMEs) comply with new rules on allergen labelling 
(Gowland and Walker, 2015 P18 - 2015). There is an urgent requirement for effective 
communication between healthcare professionals, patient organisations, food industry 
representatives and regulators to develop a better approach to protecting consumers 
with food allergies (Muraro et al., 2014b). A framework for categorisation and 
prioritisation of allergenic foods according to their public health importance has been 
proposed (Houben et al., 2016). 
5.1 Processing 
Food processing has many beneficial effects. However, processing may also alter the 
allergenic properties of food proteins. It is now well known that roasting increases the 
allergenicity of peanuts compared to raw. A wide variety of processing methods is 
available and their use depends largely on the food to be processed. Verhoeckx et al., 
(2015) reviewed the impact of processing (heat and non-heat treatment) on the 
allergenic potential of proteins, and on the antigenic (IgG-binding) and allergenic (IgE-
binding) properties of proteins. A variety of allergenic foods (peanuts, tree nuts, cows’ 
milk, hens’ eggs, soya, wheat and mustard) were reviewed. The overall conclusion was 
that processing does not completely abolish the allergenic potential of allergens. 
Currently, only fermentation and hydrolysis may have the potential to reduce 
allergenicity to such an extent that symptoms will not be elicited, while other methods 
might be promising but need more data. Literature on the effect of processing on 
allergenic potential and the ability to induce sensitisation is scarce. This is an important 
issue since processing may impact on the ability of proteins to cause the acquisition of 
allergic sensitisation, and the subject should be a focus of future research. Thus, there 
remains a need to develop robust and integrated methods for the risk assessment of 
food allergenicity (Verhoeckx et al., 2015). Processing may also have a profound impact 
on protein structure influencing solubility and hence extractability in an analytical 
process. (Walker et al., 2016) 
5.2 Precautionary Allergen Labelling 
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A consequence of the absence of an accepted risk assessment and risk management 
framework for allergens has been the proliferation of precautionary allergen, ‘may 
contain’, labelling (PAL). Wide variation persists in PAL wording, with an estimated 25 
different variants of PAL in use, see for example, Hirst, (2014). Within the wide variation 
there are two principal formats for PAL:  
 May contain (X) – this is the simplest format, providing information and with 
fewer words to take up packaging space, 
 Not suitable for people avoiding (X) – the food supplier adopting a more directive 
approach. 
A qualitative study (Barnett et al., 2011 P9 – 2011) indicated consumers with peanut 
and/or tree nut allergies adopt a complex range of responses and strategies to interpret 
PAL. They take into account not only the detail of the labelling but also external factors 
such as the nature of the product, the perceived trustworthiness of the producer and 
the previous experience of the person affected. 
 
Analytical methods for the presence of allergens in food have been used to assess foods 
on sale carrying PAL to determine the actual presence of unintended allergens. Hirst, 
(2014), indicated that of foods carrying PAL the total percentage of samples tested in 
which no allergen was detected was 19% for gluten, 18% for milk, 44% for hazelnut and 
45% for peanut. It is therefore understandable that some consumers, basing their 
decision-making on previous experience may choose to ignore PAL warnings. Thus the 
prevalence and variation of precautionary labelling, although intended to assist the 
consumer in their food choices, is increasingly considered as problematic for food 
allergic consumers. It is vital that food producers continue to undertake risk assessment 
for allergen contamination and seek to use clear ‘contains’ or ‘does not contain’ labelling 
wherever possible, using the advice available (Health Canada, 2012, Boye and Godefroy, 
2010, FSA, 2006, FSA 2016). It is also clear we need to take into account the rich range 
of reasoning that consumers draw on to make and justify their decisions to consume 
products bearing PAL (Barnett et al., 2013). 
 
It is not surprising therefore that recent global stakeholder reviews view PAL in its 
current form as counter-productive for consumers with food allergies and call for 
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standardisation of PAL, (DunnGalvin et al., 2015, Zurzolo et al., 2016, Turner and 
Gowland, 2016 P2 - 2016). Stakeholders agree that the lack of agreed reference doses 
has resulted in inconsistent application of PAL and withdrawal action by enforcement 
authorities. This has led to a loss of trust in PAL, reducing the ability of consumers with 
food allergies to make informed choices. The result has been reduced avoidance, 
reduced quality of life and increased risk-taking by consumers who often ignore PAL. All 
contributing stakeholders agree that PAL must reflect actual risk. PAL should be 
transparent and consistent with rules underpinning decision-making process being 
communicated clearly to all stakeholders. The use of PAL should indicate the possible, 
unintended presence of an allergen in a consumed portion of a food product at or above 
any proposed action level. This will require combined work by all stakeholders to ensure 
everyone understands the approach, and its limitations. Marchisotto et al., (2016) in a 
study of global perceptions of food allergy thresholds in 16 countries found that 
understanding of food allergen thresholds and precautionary allergen labelling is limited 
and consumers may develop their own risk assessment strategies based on interpreting 
labels, which are not based on clinical validation. Improved awareness of thresholds, 
standardisation of PAL, and clinical validation are needed globally. Consumers with food 
allergy will then need to be advised and empowered to undertake individualised risk 
assessments in relation to any PAL present. 
Before looking at reference doses, action limits and thresholds, we should consider 
some traditional toxicology. 
5.3 Basic Toxicology 
Although for the majority of the population food allergens are not hazards for those with 
food allergy the allergen to which they are sensitised acts as a toxin when ingested. The 
assessment and management of the risks that potentially hazardous compounds may 
pose if present in food are dealt with by the science of toxicology. Examples include food 
additives, and contaminants including metals, pesticides, veterinary residues and 
naturally occurring toxins such as mycotoxins (Walker and Wong, 2014). International 
and national bodies that deal with food and consumer safety include the Joint Expert 
Committee on Food Additives (JECFA) of the Food and Agriculture Organization (FAO), 
the World Health Organization (WHO), the US Food and Drug Administration (FDA) and 
the European Food Safety Authority (EFSA). Although the toxicology paradigm has not 
always been viewed as suitable to deal with allergy various authors have investigated its 
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application to attempt risk assessment and risk management of food allergens (Crevel, 
2015). A full treatment of toxicology is beyond the scope of this section. However some 
discussion of basic concepts may be helpful.  
The process of risk assessment is shown in Figure 6 which shows the inter-relationship 
with risk management and risk communication. 
 
Figure 6: Risk assessment, management and communication 
 
Toxicological risk assessment begins with the identification of the hazard – “the 
identification of the type and nature of adverse effects that an agent has an inherent 
capacity to cause in an organism, system or (sub)-population‟ (EFSA, 2014b) – usually 
through epidemiological or animal studies. Food allergy differs in the availability of 
human clinical data. Recognition of a clinical allergy hazard occurred over 100 years ago 
(Igea, 2013) but only since the mid-1990s has food allergy been widely regarded as a 
public health issue (Crevel, 2015). The Codex Alimentarius General Standard for the 
Labelling of allergens lists eight major allergens of global significance (Codex 
Alimentarius, 2010) while country-specific variations exist, (Gendel, 2012). The 
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European Union lists the largest number of allergens that are considered sufficiently 
serious to warrant legislative attention (Table 4). Traditional toxicological exposure 
assessment attempts to identify potential or completed exposure pathways resulting in 
contact between the toxin and at-risk populations. It also includes demographic analysis 
describing the properties and characteristics of at-risk populations that potentiate or 
mitigate concern and description of the magnitude, duration, and frequency of exposure 
(Baynes, 2010). Thus, although cumulative exposure appears not to be an issue, many 
aspects of exposure assessment are problematic for food allergy, such as prevalence, 
severity, actual cross-contamination concentrations and unbiased analysis. 
Table 4: Food Allergens 
Codex Alimentarius1 European Union2 
Cereals containing gluten; i.e., wheat, 
rye, barley, oats, spelt or their 
hybridized strains and products of 
these 
Cereals containing gluten, namely: wheat 
(such as spelt and Khorasan wheat), rye, 
barley, oats or their hybridised strains, and 
products thereof 
 
Crustacea and products of these Crustaceans and products thereof 
 
Eggs and egg products Eggs and products thereof 
 
Fish and fish products Fish and products thereof  
 
Peanuts, soybeans and products of 
these 
Peanuts and products thereof 
 
Milk and milk products (lactose 
included) 
Soybeans and products thereof 
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Tree nuts and nut products Milk and products thereof (including 
lactose) 
 
Sulphite in concentrations of 10 mg/kg 
or more 
Nuts, namely: almonds (Amygdalus 
communis L.), hazelnuts (Corylus 
avellana), walnuts (Juglans regia), 
cashews (Anacardium occidentale), pecan 
nuts (Carya illinoinensis (Wangenh.) K. 
Koch), Brazil nuts (Bertholletia excelsa), 
pistachio nuts (Pistacia vera), macadamia 
or Queensland nuts (Macadamia 
ternifolia), and products thereof 
 
 Celery and products thereof 
 
 Mustard and products thereof 
 
 Sesame seeds and products thereof 
 
 Sulphur dioxide and sulphites at 
concentrations of more than 10 mg/kg or 
10 mg/litre in terms of the total SO2 which 
are to be calculated for products as 
proposed ready for consumption or as 
reconstituted according to the instructions 
of the manufacturers 
 
 Lupin and products thereof 
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 Molluscs and products thereof 
 
1. CODEX STAN 1-1985, General Standard for the Labelling of Pre-packaged Foods 
2. Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 
October 2011, Annex II. Please see Annex II for certain exemptions to some of the 
entries. 
These are subject to change and the latest versions should be examined in Codex 
Alimentarius and Eur Lex respectively 
NB – At the time of writing, there is a proposal being addressed by the Codex 
Committee on Food Hygiene (CCFH) to develop a code of practice to provide guidance 
to governments and food businesses to manage allergens in food production (Codex 
Alimentarius 2018) 
Hazard characterisation is “the qualitative and, wherever possible, quantitative 
description of the inherent properties of an agent or situation having the potential to 
cause adverse effects‟ (EFSA, 2014b). Hazard characterisation should, where possible, 
include an assessment of dose-response and an evaluation of uncertainties (WHO, 
2009). Dose-response is one of the fundamental concepts in toxicology “…the dose 
makes the poison…” attributed to Paracelsus (1493 – 1541), (Borzelleca, 2000).   
 
Figure 7: Typical Dose response curve  
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A typical dose-response curve is illustrated in Figure 7 in which the percentage of 
responding organisms is plotted against the dose or concentration of the compound. 
The focus of risk assessment is generally on the lower regions of the dose response curve 
where it is expected that people are realistically exposed. This is often below the 
experimentally observable range. Chemicals that pose a cancer risk are dealt with 
differently, but for many chemicals which do not pose a cancer risk there are 
concentrations below which no response is observed. This is because protective 
mechanisms are believed to exist that must be overcome before an adverse effect is 
manifested. The extent to which this is the case for food allergy and the mechanism(s) 
that underlie any such tolerance are interesting questions.  
The aim in risk assessment is to identify the upper bound of this tolerance range to 
obtain a no observable adverse effect level (NOAEL). The NOAEL is the highest dose level 
that does not produce a significant elevated increase in an adverse response Significance 
refers to biological and statistical criteria and depends on factors such as dose levels 
tested, number of animals exposed in animal studies, and background incidence in the 
non-exposed control groups. Sometimes, there are insufficient data to arrive at a 
NOAEL, and a LOAEL (lowest observed adverse effect level) is derived. The NOAEL is the 
key datum obtained from the study of the dose – response relationship and is known as 
the threshold dose. This concept is of significance because it implies that a NOAEL can 
be used to determine intakes for food additives and contaminants that should be 
protective of the majority of consumers. 
In mainstream toxicology the NOAEL is used to calculate a reference dose (RfD) for 
chronic oral exposures and, divided by a ‘safety factor’ or ‘uncertainty factor’ to 
calculate acceptable daily intakes, (ADI), for food and feed additives and pesticides and 
the Tolerable Daily Intake, TDI, for contaminants and chemicals in food contact 
materials. For acute effects, the Acute Reference Dose (ARfD) can also be calculated. 
The safety / uncertainty factor is often 100 to allow for inter-species and inter-individual 
variability in toxicokinetics and toxicodynamics. 
The RfD is an estimate, with uncertainty spanning perhaps an order of magnitude, of a 
daily exposure to the human population, including sensitive subgroups that is likely to 
be without appreciable deleterious effects during a lifetime. The calculated RfD is based 
on the selected critical study and selected critical end point. The risk assessor may obtain 
numerous studies where the toxicant may have more than one toxic end point and thus 
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there may be many NOAELs to choose from in the literature. In some instances, even 
poor data quality may be used to exclude some end points from consideration. Also at 
issue is determining what is considered an adverse effect, ranging from reversible 
cellular changes to death. In effect, the RfD is based on the less serious effects rather 
than serious effects.  
Chemicals that are difficult to deal with by traditional toxicology are those that are both 
genotoxic and carcinogenic where in theory one molecule may initiate a tumour. This 
tumour initiation may not in practice happen, it is thought, owing to DNA repair and 
other protective mechanisms. To address these compounds a ‘Margin of Exposure’ 
(MOE) approach has been developed. MOE can be used to support prioritisation of risk 
management action and, if the MOE is very large, communication of a low level of 
human health concern. However it is essential that the selection of the cancer endpoint 
and mathematical treatment of the data are clearly described and justified if the results 
of the MOE approach are to be trusted and of value to risk managers.  
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5.4 Allergen Reference Doses, Action Limits and Thresholds  
There is a general duty of care on the food industry and obligations in global legislation 
to reduce and manage the presence of allergens alongside other food hazards. Current 
evidence appears to enable the establishment of allergen reference doses which might 
be translated into action limits or population thresholds to underpin reliable food safety 
management plans for some foods. However, further work is required to include a wider 
variety of foods and to understand the impact of the food matrix as well as additional 
factors which affect the progression and severity of symptoms as a function of dose. 
There is an urgent requirement for effective communication between healthcare 
professionals, patient organisations, food industry representatives and regulators to 
develop a better approach to protecting consumers with food allergies (Muraro et al., 
2014b). Below we examine the development of ‘thresholds’ and speculate on their 
future development. 
A reminder or introduction of some definitions may assist at this point. 
 Threshold – “dose or exposure concentration of an agent below which a stated 
effect is not observed or expected to occur. It lies in an interval bounded by the 
LOAEL (upper) and NOAEL (lower)”. Taylor et al. (2002) defined the threshold 
dose as “ … the lowest amount of the offending food that would elicit mild, 
objective symptoms (eg, mild urticaria, erythema, and oral angioedema) in the 
most sensitive individuals.” Thus it is important to note that we are discussing 
thresholds of elicitation rather than thresholds of sensitisation (Crevel et al., 
2014a). The latter topic is one which is important but much more difficult and 
outside the scope of this work. 
 Reference dose – an estimate of the daily exposure dose that is likely to be 
without deleterious effect even if continued exposure occurs over a lifetime. In 
the case of allergens, since acute exposure defines risk for adverse deleterious 
effect, the exposure estimate is derived from amount per eating occasion. 
 Dose distribution – A plot of the cumulative proportion of (allergic) individuals 
reacting as a function of dose, based on their minimum eliciting doses. 
 Eliciting dose – the dose (in a dose distribution) which is predicted to provoke 
reactions in a defined proportion of allergic individuals, commonly stated as the 
eliciting dose (EDp) for a percentage of the allergic population p. Thus ED50 is the 
dose of an allergen that will cause a reaction in 50% of the population. ED5 and 
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ED1 are the respective eliciting doses that would be expected to be protective of 
95 % and 99 % of the allergic population. A ‘minimum eliciting dose’ is the 
minimum dose that elicits an effect in an individual in a challenge study – 
equivalent to an individual’s LOAEL. 
 Action level – the concentration of an allergen in a product above which some 
risk management must be carried out, eg further efforts to eliminate cross 
contamination and  below which a precautionary label is deemed unnecessary. 
In a series of studies Crevel and colleagues have developed the concepts of risk 
assessment for food allergens that are not used as ingredients in food but arise through 
cross contamination at harvest, transport, storage or processing. This is also known as 
‘cross contact’ or ‘adventitious presence’ but the term ‘cross contamination’ suggests 
the unwanted nature of the allergen, although the concepts developed to deal with 
these issues are also applicable to low concentrations of deliberately added ingredients. 
Towards the latter part of the 20th century it was questioned whether the nature of food 
allergens precluded risk assessment by classical toxicology such as dose-response 
relationships. This was challenged by studies by Hourihane and colleagues working 
initially on highly refined peanut oil (Hourihane et al., 1997a). This was followed by the 
first study of peanut allergic subjects deliberately to attempt to determine a threshold 
dose, (Hourihane et al., 1997b) and a paper on the threshold concept in food safety and 
its applicability to food allergy (Hourihane, 2001). Hourihane et al. administered peanut 
to 14 subjects in doses from 10 μg to 50 mg, in the form of a commercially available 
peanut flour. The highest dose of peanut, 50 mg was well below previous published 
levels of reactivity (Hourihane et al., 1997b). The other innovation was the interspersing 
of placebo doses between the active doses so that in total 12 active and 12 placebo 
doses were given in random sequence. This contrasted with previous routine challenge 
practice of two separate active and placebo challenge series. These authors concluded 
that even in a group of well-characterised, highly sensitive subjects with peanut allergy, 
the threshold dose of peanut protein varies. As little as 100 μg of peanut protein 
provoked symptoms in some subjects with peanut allergy. 
  
A review of the introduction to toxicology indicates that the ‘toxicology’ of allergens may 
be described in similar terms. Thus hazard identification occurs retrospectively because 
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individuals are reported to react to a food it in a manner consistent with an allergic 
reaction mediated by IgE. Hazard identification may then be undertaken through 
demonstrating IgE binding to individual proteins in the food and confirmatory tests 
including clinical controlled oral challenges in affected individuals. In this respect 
allergen hazard identification resembles microbiological hazard identification, which 
relies principally on epidemiological and surveillance data rather than prospective 
studies in animals. Hazard characterisation for food allergens thus relies on human data, 
obviating the uncertainties of animal to human extrapolation of toxicological studies. 
However, human data also brings ethical and practical constraints in conducting studies 
that rely on volunteer participants which limits both the amount and type of data that 
can be generated.  Exposure assessment to allergens differs from chemical risk 
assessment in that it relates to the amount consumed on a single eating occasion, or 
within a relatively short period of time, rather than long-term exposure; again this 
resembles microbiological risk assessment. 
Nevertheless, the work of Hourihane and colleagues described above paved the way for 
Taylor and colleagues to ask the question “How much is too much?” Taylor et al. (2002) 
described a 1999 roundtable discussion among clinical allergists and other interested 
parties to share data on threshold doses and to discuss clinical approaches for the 
acquisition of such data (Taylor et al., 2002). It is worth discussing this work in detail 
because several key concepts were articulated that merit consideration now and in the 
future. 
 
Although Taylor et al. identified considerable clinical data on threshold doses for peanut, 
cows’ milk, and egg, with limited data for other foods, such as fish and mustard, these 
data were often obtained by means of different protocols. Hence the estimation of a 
threshold dose proved difficult and development of a standardised protocol for clinical 
experiments to allow determination of the threshold dose was recommended. This 
subsequently was developed (Bindslev-Jensen et al., 2004). 
 
Taylor et al. noted for all practical purposes, allergists had always assumed that the 
threshold dose for the food to which a patient was allergic was zero and prudently 
advised patients to adhere to specific avoidance diets. Clinicians thus needed thresholds 
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adequately to advise their patients. Equally, such zero tolerance created enormous 
practical problems for the food industry, eg shared equipment necessitates clean down 
to prevent cross contamination. This led Taylor and colleagues to a second question: “ 
… how clean is clean enough?”  
 
Taylor et al. defined the threshold dose as “ … the lowest amount of the offending food 
that would elicit mild, objective symptoms (eg, mild urticaria, erythema, and oral 
angioedema) in the most sensitive individuals” (Taylor et al., 2002). They also noted the 
threshold as variable, possibly over an order of magnitude or more between different 
individuals with the same type of food allergy. Factors contributing to this variability 
were considered to include exercise, alcohol, and acetylsalicylic acid and the threshold 
doses for different allergenic foods were recognised as not necessarily equal. 
Anecdotally, threshold doses were recognised as very small but little or no quantitative 
information was available. Presciently Taylor et al. attributed paucity of quantitative 
data to the lack of simple methods for the analysis of the implicated food product for 
residues of commonly allergenic foods and absence of validated, collaboratively studied, 
standard methods. The best estimates of the threshold dose for various allergenic foods 
can be obtained from controlled clinical challenge trials. In only a few cases were such 
trials intended specifically to determine the threshold dose. More frequently, challenges 
have been conducted for diagnostic purposes rather than for determining the lowest 
provoking dose. 
 
Taylor et al. listed the lowest provoking doses they had found from the clinical data 
gathered from DBPCFCs, some single-blind, placebo controlled food challenges 
(SBPCFCs) and open challenges used for diagnostic purposes. The data were cited as the 
whole food and in terms of protein. For peanut protein lowest provoking doses ranged 
from 0.25 mg to 100 mg peanut protein, data for egg protein ranged from 0.13 mg to 
200 mg and data for milk spanned 0.6 mg milk protein to 180 mg milk protein. 
Interestingly data for fish were cited only as the food itself, no conversion to protein 
having proved possible owing to lack of data on the protein content of the fish used. 
Taylor et al. concluded that threshold doses for commonly allergenic foods are finite, 
measurable, and above zero, however, no attempt to reach consensus on the threshold 
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doses was made at that time. This was owing to the different protocols used to obtain 
the data but largely because data were mainly LOAELs rather than the more useful 
NOAELs, the highest dose in the DBPCFCs that did not elicit an adverse reaction. The 
most sensitive patients involved in these challenge trials reacted to the first and lowest 
dose used. These authors questioned if the acknowledged exclusion of some of the most 
seriously affected patients (i.e., those with histories of anaphylaxis) from the trials 
implied that the patients selected for DBPCFC may not be representative of the entire 
population of individuals with allergies. They speculated if uncertainty factors might 
need to be applied to NOAELs to the determine threshold doses to account for this. The 
age and body weight of the patients and the nature of the challenge materials were 
other factors to be considered - standardisation of challenge materials and the vehicles 
in which they were presented were recommended. Importantly Taylor et al. listed the 
typical amounts of protein in challenge materials noting conversion between doses 
expressed as the food and as allergen protein required some important assumptions 
regarding appropriate conversion factors. For example, the proportion of the major egg 
allergens Gal d 1 and Gal d 2 as a function of total protein would be higher in egg white 
than in whole egg. More reassuringly for peanut, little difference appeared to occur in 
the specific allergen content as a function of variety or agronomic conditions. The 
conversion data used by Taylor et al. included: 
 Peanut flour is assumed to contain 50% protein unless the value is specifically 
known; 
 Liquid egg white has an average protein content of 10%; 
 Dried egg white has an average protein content of 90%; 
 Whole egg has an average of 13% protein on a liquid basis and 50% protein on a 
dry basis; 
 Cows’ milk formula is estimated to contain 15 g of milk protein per litre. 
The fullest possible reporting of such data and trial conditions (eg single or double blind, 
or open) remain essential to current and future derivation of useful threshold data. 
Taylor et al. concluded that the threshold doses for peanut, egg, and cows’ milk 
appeared to be in the low milligram range or higher for most individuals with allergies 
to those particular foods. Thus these individuals can (and probably do) ingest foods, on 
occasion, containing lower amounts of their offending food without any untoward 
reactions. They recommended international efforts to establish threshold doses for 
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commonly allergenic foods using standardised clinical challenge protocols and as wide 
a range of affected patients as possible. 
Much work has been done since the initial investigations of Hourihane, Taylor and 
colleagues culminating in a series of papers in the first two decades of the 21st century 
that appear to point the way forward  in risk assessment for food allergens.  
In a 2007 workshop organised by EuroPrevall, the U.K. Food Standards Agency, and 
International Life Sciences Institute (ILSI)-Europe, three main, non-mutually exclusive 
risk assessment approaches were identified (Madsen et al., 2009): 
(1) Use of the NOAEL and/or the LOAEL with application of uncertainty factors,  
(2) the Benchmark dose and margin of exposure (MOE) approach, and 
(3) the use of probabilistic models 
 
In the U.S. in 2008, the Threshold Working Group of the FDA also considered multiple 
approaches: 
(1) defining a limit by statute,  
(2) applying analytical limits of detection (as was done for the sulphites group in the 
European list of legislated allergens) 
(3) a deterministic approach with uncertainty factors, and 
(4) quantitative approaches including probabilistic modelling. 
It is clear that quantitative probabilistic risk assessment provides the strongest scientific 
approach but is the most data-intensive, with current lack of sufficient data for many 
allergens and the least transparent to all stakeholders, particularly non-scientists. 
 
Hattersley et al., (2014) reviewed developments in allergen risk assessment. The first 
author was at the time head of the Food Allergy and Food Intolerance team at the UK 
Food Standards Agency and widely trusted for as a transparent precautionary member 
of the regulatory community. FSA has maintained a position at the forefront of food 
allergy research and regulation. Hattersley et al. concluded that all stakeholder groups 
now recognise that zero risk is unrealistic. It is to be noted that not all those with food 
allergy, or their parents or carers are prepared to accept that zero risk is unrealistic. 
However Hattersley et al. felt it was accepted that classical toxicological assessment and 
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management principles of risks from chemicals or microorganisms in food could be 
applied to allergens in foods. Crevel and colleagues (Crevel et al., 2014) have described 
two approaches – ‘deterministic’ and ‘probabilistic’. In the deterministic approach 
action levels are derived from reference doses, food intake and contamination data by 
a simple arithmetical method explained below. In the probabilistic approach modelling 
is used to derive action levels using food intake and minimum eliciting dose 
distributions, as well as a certain accepted residual risk level as a starting point.  
5.5 Deterministic allergen risk assessment 
This approach can be used when no or limited data are available on the consumption of 
the food of interest or its distribution. It is also more practical for the food industry. 
Action levels can be calculated from an ED value derived from a reference dose and an 
assumed intake (portion size). This is the approach used by the Allergen Bureau, 
established on a membership basis in 2005 by the Australian Food and Grocery Council. 
The Allergen Bureau Food Industry Guide to the Voluntary Incidental Trace Allergen 
Labelling (VITAL) Programme is a standardised allergen risk assessment process for food 
industry (Taylor et al., 2014, Allen et al., 2014, http://allergenbureau.net/about-us/). It 
is used in Australia and New Zealand but has yet to gain widespread acceptance globally. 
The VITAL system is free to download and should be consulted in full. It operates under 
the following broad principles: 
• Intentionally added allergens must be declared on the product label (eg in the 
List of Ingredients according to local law). 
• Action Levels are the concentrations which define the labelling outcomes for 
each concentration of cross contact allergen. They are determined using the 
Reference Dose and the Reference Amount / Serving Size.   
• Cross contact must be reviewed for opportunities to reduce or eliminate cross 
contaminant allergens from the product.  
• Where cross contaminant allergens cannot be eliminated, they should be 
labelled as specified by the appropriate Action Level:  
• Action Level 1 – precautionary cross contact statement is not required for the 
relevant allergen under evaluation  
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• Action Level 2 – precautionary cross contact labelling statement is required for 
the relevant allergen using the standard VITAL statement.  
• Precautionary labelling should only be used after a thorough assessment of the 
risk. Precautionary cross contact statements must NEVER be used as a substitute 
for good manufacturing practice (GMP) or as a generic disclaimer. Every attempt 
must be made to eliminate or minimise cross contact by adhering to GMP 
• The ONLY precautionary statement to be used in conjunction with VITAL is: “May 
be present: name of allergen” 
The calculation of action levels is as follows. 
 
𝐿𝑎 = 1000 ×
𝑅𝑑
𝐴𝑟
 
 where 
La is the Action Limit above which risk management must take place and below 
which risk management is less likely to be required; Rd is the reference dose, in 
milligrams, mg, i.e. the milligram protein level (total protein from an allergenic 
food) below which according to current data only the most sensitive individuals 
(between 1% and 5% depending on the quality of the data set available) in the 
allergic population are likely to experience an adverse reaction, and Ar is the 
reference amount (in grams, g) – usually defined by manufacturer and the 
maximum amount of a food eaten in a typical eating occasion. This may be the 
same as the “serving size”. 
 
A table of reference doses for 12 major allergens can be found in Muraro et al. (2014b). 
As a worked example let us estimate an action level for peanut in a 400 g meal containing 
meat and 100 g of sauce. Let us suppose there is a risk of peanut flour gaining access to 
the sauce in the supply chain of the ingredients. How can we use an action level to 
appraise the results of analytical testing of the product? The data need to use the above 
equation are: 
Rd for peanut is ED01 for peanut protein of 0.2 mg; Ar is 100 g 
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Thus La = 1000 ×
0.2
100
  = 2 mg kg-1 peanut protein. 
That is to say, a concentration of more than 2 mg kg-1 (ppm) peanut protein in the sauce 
is a risk for at least 1 % of the peanut allergic population and risk management measures 
are required. The ‘dilution’ of the sauce by the meat, which could be separately tested 
and assessed may give a margin of error but bear in mind the uncertainty in the ability 
to measure peanut protein in the sauce may approach ± 50%. 
Does this mean that if we find less than 2 mg kg-1 (ppm) peanut protein in the sauce the 
meal is safe for peanut allergic consumers? This is not so easy a question to answer, 
especially if the inadvertent presence of peanut is not homogenous – particulate peanut 
fragments rather than peanut flour.  
In practice, the food industry may be nervous of the deterministic approach. An ED01 has 
an underlying risk that 1 in 100 allergic individuals will have a reaction; Is this an 
acceptable balance of risk? It may be acceptable to a food business selling 1,000 units a 
week, but not to a food business selling 100,000 units a week. Food retailers may be 
tempted to, and probably do, opt for the analytical limit of detection as a default action 
limit, which may not bear any relation to true risk. Thus we need to factor in sales and 
consumption as a measure of exposure, and the percentage of the population who have 
the allergy. 
5.6 Probabilistic allergen risk assessment 
Some of the above questions may be addressed by the probabilistic approach. 
Spanjersberg et al. (2007) developed a quantitative risk assessment model for allergens 
based on probabilistic techniques and presented a case study, hazelnut proteins in 
chocolate spread. 
Kruizinga, et al. (2008) performed a sensitivity analysis on a previously developed 
probabilistic model to predict the likelihood of an allergic reaction due to unintended 
exposure to food allergens to identify which parts of the model most influence the 
output (Kruizinga, et al., 2008). The model included the proportion of the population 
which is allergic, the proportion consuming the food and the amount consumed, the 
likelihood of the food containing an unintended allergen and its concentration, and the 
minimum eliciting dose distribution for the allergen. A shift in the distribution of the 
minimum eliciting dose reflecting a more potent allergen, and an increase in the 
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proportion of the population consuming a food, increased the number of estimated 
allergic reactions considerably. In contrast, the number of estimated allergic reactions 
hardly changed when the minimum eliciting doses were based on a more severe 
response, or when the amount of food consumed was increased. 
Spanjersberg et al. (2010) prompted by a severe allergic reaction in a cow's milk protein 
allergic patient to a dark chocolate product containing undeclared milk protein applied 
probabilistic modelling to investigate to what extent allergen concentrations of 
unlabelled products reach levels that are of public health relevance. The concentrations 
of milk proteins in the complaint sample and a collection of products of other batches 
and brands purchased from different stores were determined. Together with 
appropriate threshold and food consumption data, the risks of allergic reactions and the 
severity of these reactions within the adult milk-allergic population were determined 
using probabilistic risk assessment techniques. The results showed that milk protein 
concentrations in unlabelled products reach levels that may elicit allergic reactions in up 
to 68% of the adult milk allergic consumers. 
Rimbaud et al. (2010) reported a quantified risk assessment of the consumption of 
peanut in chocolate products. The occurrence of unintended peanut protein in 
chocolate and the dose-response relationship were estimated with a Bayesian approach 
using available published data. The consumption pattern was described by a French 
individual consumption survey. Risk simulations were performed using second-order 
Monte Carlo simulations, which separately propagated variability and uncertainty of the 
model input variables. Peanut allergens were found to occur in approximately 36% of 
the chocolates, leading to a mean exposure level of 0.2 mg of peanut protein per eating 
occasion. The estimated risk of reaction averaged 0.57% per eating occasion for peanut-
allergic adults. The 95% values of the risk were between 0 and 3.61%, which illustrates 
the risk variability. The conclusion was that unintended peanut allergens induce a risk of 
reaction for a part of the French peanut-allergic population. The method was considered 
to be capable of generalised development to assess the risk due to the consumption of 
every foodstuff potentially contaminated by allergens. 
Rimbaud et al. (2013) revisited this topic. Food products analysed for the possible 
presence of peanut traces in scientific literature were selected. For each foodstuff, the 
allergic risk associated with their consumption was estimated using the French 
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individual food consumption survey, representative of the general French population. 
An internet survey on the attitudes of peanut-allergic individuals toward food 
precautionary labelling was conducted. For three foodstuffs, the allergic risk was then 
refined integrating the information on specific food behaviours of French allergic 
individuals. Considering the mean probability, inadvertent presence of peanuts was 
identified in 20% to 37% of products. Adults were exposed to up to 12.5 mg of peanut 
protein on 97.5% of their eating occasions. The mean risk of reaction ranged from 0.2 % 
to 2.4%. Considering eating occasions for all the products, 1.5% of the peanut-allergic 
adults would have at least one allergic reaction in a week. This demonstrated the 
benefits of integrating all available information to underpin decision making in the area 
of food allergen cross-contamination and highlighted the need to generate more data 
to further refine the risk assessment for the benefit of allergic consumers. 
Crevel et al. (2014a) reviewing the development of risk assessment for food allergens 
noted dose distribution modelling of minimum eliciting doses permitted the 
quantification of the risk of reaction at the population level and has been readily 
integrated with consumption and contamination data through probabilistic risk 
assessment approaches to generate quantitative risk predictions. These authors discuss 
the strengths and limitations of this approach and identify important data gaps, which 
affect the outcomes of these predictions. These include consumption patterns among 
allergic individuals, analytical techniques and their application, severity-dose 
relationships, and the impact of extraneous factors which alter an individual’s 
physiology, such as infection or exercise. Nevertheless, Crevel et al. conclude application 
of these models has provided valuable insights, leading to further refinements and 
generating testable hypotheses. 
Crevel et al. (2014b) also identified challenges relevant to each component of the risk 
analysis: risk assessment (data gaps and output interpretation); risk management (clear 
and realistic objectives); and risk communication (clear articulation of risk and benefit) 
(Crevel et al. 2014b). It was noted that translation of the outputs from risk assessment 
models into risk management measures must be informed by a clear understanding of 
the model outputs and their limitations. Crevel et al. (2014b) considered this would lead 
to feasible and achievable risk management objectives, grounded in a level of risk 
accepted by the different stakeholders, thereby avoiding potential unintended 
detrimental consequences. Clear, consistent and trustworthy communications actively 
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involving all stakeholders were recognised as necessary to underpin these objectives. 
The conclusions, integrating the perspectives of different stakeholders, offer a vision 
where clear, science-based benchmarks form the basis of allergen management and 
labelling, cutting through the current confusion and uncertainty. Finally, these authors 
recognised that the proposed framework must be adaptable to new and emerging 
evidence. 
Crevel et al. (2014a) have given a comprehensive analysis of the research and knowledge 
gaps of both the deterministic and probabilistic approaches to quantitative allergen risk 
assessment (Crevel et al. 2014a). Deterministic allergen risk assessment is already 
carried out however given the considerable resource implications it is unlikely that the 
food industry will routinely adopt probabilistic allergen risk assessment in the near 
future. 
However, if, as is currently the case, different measurement approaches give different 
results, sometimes markedly so, for the same sample, and results cannot be anchored 
by reference materials, it will be impossible to make use of thresholds properly. 
Moreover, progress towards using thresholds in practice, voluntarily or through 
regulation will depend on consumer understanding, confidence and trust. Food allergen 
thresholds are complex and difficult to explain, particularly for those making risk 
decisions about their own food, or food for those in their care.  
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6 The early days - advocacy and the foundation of the Anaphylaxis 
Campaign – Discussion 
 
In 1993, seven young British adults (aged 16-26) died from food allergy.  Their deaths 
were reported in the media (newspapers) and came to wider public attention. One was 
Sarah Reading (17) whose father David was a journalist on a local newspaper in 
Hampshire. He became the focal point for media attention, writing news articles and 
eventually receiving substantial daily correspondence from people living with the risk of 
severe allergy, as well as other families of people who had died.  
This coincided with interest in, and wider recognition of food allergies and intolerances 
in the UK (Young et al., 1994).  
Early in 1994, David and others living with family members at risk from severe allergy 
set up the Anaphylaxis Campaign as a voluntary charitable organisation. Its earliest 
slogan was “fighting for those with potentially fatal allergies.” Resources were limited 
and the small committee met at David’s house. The Campaign became more widely 
known, primarily through written media – local and national newspapers.  
David and Erik Brown, another parent member who was also a journalist and public 
relations expert compiled the first newsletter in spring 1994. It was a professionally 
produced 8-page glossy document. Contact had already been made and meetings held 
with the Chief Medical Officer, the Food Minister and leading clinicians. Advocacy was 
underway at the highest level. Letters from subscribers described people’s experiences 
getting support for their children, and also called for subjects to participate in clinical 
research. There were contact details for 25 volunteers throughout the UK who were 
willing to provide support in their local areas. Importantly, there was also guidance on 
managing allergic emergencies and how to get hold of adrenaline devices.   
Hazel Gowland joined the Anaphylaxis Campaign as a subscription member in April 1994. 
It was clear that although a small voluntary charitable organisation, it was already a 
recognised, influential and effective advocate for people living with potentially fatal 
allergies. The primary focus was on food allergy, which affected the majority of member 
families, but support was also available for people with allergy to insect stings and 
medication.  
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At this point Gowland was still a secondary school teacher. Her early work with David 
Reading and others shaped the Campaign’s policies to support food allergic children in 
schools.  She also realised that although (like her) many Campaign members were 
parents of young children, there were fewer allergic adult members. She was able to 
provide reassurance and practical advice about growing up with, and living with a severe 
allergy.  
By 1995, volunteers at the heart of the Campaign were taking responsibility for different 
priority areas. With family members in the food industry, Gowland started to develop 
expertise in food allergen labelling and allergen controls throughout the food supply 
chain, and became the Campaign’s Food Adviser. She took a secondary role on the 
Campaign’s management committee and later National Executive, representing the 
patient / consumer / member perspective and shaping strategy and policies.  
In retrospect, the need for advocacy for people living at risk of anaphylaxis and / or with 
food allergies had become increasingly apparent in the early 1990s. Establishing a 
specialist organisation to support growing numbers of children and champion severe 
allergy would begin to meet this need. There were two main priorities: a) improved food 
description and allergen controls in food production, and b) improved access to 
specialist allergy health care and patient allergy management. In its earliest days, the 
Campaign had made significant progress in both of these.  
6.1 Developing skills and knowledge 
When she started working in allergy, Gowland was a trained secondary teacher and 
qualified youth worker. She had some experience of working with local news 
journalists and writing press releases and copy for school and musical events. In 
addition to teaching French and German, she was also delivering a Business Studies 
NVQ. She had worked in food retail and catering in the UK, France and Germany. Her 
sister (C J Derby – see P3 - 2005 Sesame allergy paper above) was then a food scientist 
with insight into food production. Other family members worked in quality and safety, 
and for a major food manufacturer.  
 
By 1995, and perhaps as a result of the fatal reactions in 1993, and the public profile of 
the Anaphylaxis Campaign, the Women’s Institute (WI) made food allergies one of the 
priority topics for wider discussion, which would eventually be brought to government 
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attention. Gowland was asked to deliver a presentation to the leaders of WI branches 
throughout Hertfordshire and Bedfordshire. This was her first speaking engagement, for 
which she developed a set of acetate overhead projector slides. It was followed by a 
lengthy question and answer session, and individual audience members had personal 
questions and comments after the meeting.  
Most work for the Anaphylaxis Campaign at this time was by telephone, usually during 
evenings and weekends, or by letter and sometimes fax. Contact was established with 
the British Allergy Foundation (later Allergy UK) and Gowland worked with them on a 
set format for translations to help people travelling abroad with food allergies.  
All those involved in the Campaign at this time were volunteers. Gowland was invited to 
attend food industry, clinical and regulatory conferences, exhibitions and meetings (with 
expenses paid), making notes, providing feedback to David Reading and colleagues and 
developing strategy.  
As Food Adviser, and with a teaching background, Gowland started to work out how to 
get food allergies onto the standard training curriculum for food handlers, and 
particularly chefs and front of house staff. She established contact with the Hotel and 
Catering Industry Management Association (HCIMA) now the Institute of Hospitality, 
and the Hotel and Catering Training Company (HCTC) later the Hospitality Training 
Foundation (HTF), the Sector Skills training council. Following a meeting with their 
training committee, agreed text was inserted into relevant training modules to ensure 
that all professionally trained chefs and foodservice personnel were aware of food 
allergies and would know how to respond to customer enquiries and control allergen 
risks. Further relationships were established with leading chefs and hospitality 
organisations.  
In 1996 Gowland was the guest speaker for the Académie Culinaire’s update meeting in 
London attended by leading chefs. She spoke from notes, followed once again by a 
lengthy question and answer session. A pattern emerged that there would be people in 
any audience who, having listened to the talk would begin to realise that they or a family 
member had a food allergy or associated condition, so that such events became life-
changing for them and those around them. Even with improved allergy awareness and 
public information, in 2018, this still happens after training courses, presentations and 
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lectures. Those delivering talks and training need to be ready to give time and on-going 
support if necessary in such situations.  
6.2 Early research 
As described above, the first Anaphylaxis Campaign newsletter produced in its earliest 
days in 1994 included a call for subjects for a research study. At this time, Gowland had 
no academic or clinical research experience.  
The growing membership of food allergic individuals and families began to be 
considered as a useful research resource. Research questions to assess the impact of 
allergy and related atopic conditions were also discussed by the Campaign’s 
management committee and others. The Ministry of Agriculture, Fisheries and Food 
(MAFF) government scientists were engaged with the international Codex Committee 
on Food Labelling (CCFL) on improving food labelling for the benefit of people with 
allergies, intolerances and coeliac disease. They asked the Campaign to obtain member 
data about allergies to milk and egg which could be used to shape CCFL policy and 
eventually regulation.  
Unfortunately at this time, the Campaign had no experience of research methodology. 
A note in the Campaign’s newsletter invited members to send in their experiences of 
milk and egg allergy. Over 300 letters were received representing 330 people, some 
extending to 8 pages of handwritten text. These were forwarded to Gowland who 
highlighted key points and did her best to collate and report the results. Many lessons 
were learned, not least that such surveys would benefit from a proper questionnaire 
and systematic data capture!  
However, it was also established that: 
 Anaphylaxis Campaign members were more than willing to participate in such 
research 
 Living with food allergy and related chronic conditions provides a longitudinal 
perspective 
 People are ready to provide prolific amounts of information in the hope of 
helping their own family members and others 
 In the absence of wider scientific, clinical or consumer research, such data may 
be the best available evidence to influence policy and regulatory decision-
making 
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 It would be likely that members of patient / consumer support organisations 
such as the Anaphylaxis Campaign might be informed through their Campaign 
membership to the extent that their perspective on some issues may be different 
from that of the wider population.  
A further survey followed in 1997 – this time using a standardised questionnaire. Allergy 
specialist clinician, Dr (now Professor) Jonathan Hourihane helped to shape the 
questionnaire and provided guidance on reporting the data for a survey on sesame 
allergy. Early results were shared with MAFF for the Codex Committee on Food Labelling 
(CCFL), and also with leading retailers including Marks and Spencer who funded a further 
study leading to the eventual publication of P3 above in 2005.  
6.3 Work with the media 
In the early days of the Campaign, as well as attending key meetings with 
parliamentarians, government officials, allergy clinicians, scientists, industry 
representatives and others, and writing articles and correspondence, David Reading 
became the Campaign’s figurehead. His name and face were well-known and he would 
undertake television or radio interviews as required. In 1996, Gowland started to share 
this role. Interviewers would often want details of symptoms and ‘what it feels like’ to 
have an allergic reaction. Interviews followed - by phone and in person for the BBC 
consumer programmes ’You and Yours’, ‘Watchdog’, local radio stations and television. 
She and Reading would also brief journalists and others writing specialist articles on 
allergy-related issues.  
Reading and Gowland were invited to contribute to publicity surrounding a key study 
into peanut oil allergenicity undertaken by Dr Jonathan Hourihane and the team at 
Southampton University.  It was recognised that industry processing methods 
(Neutralising, Bleaching and Deodorising - NBD) would remove or denature allergenic 
proteins. This study also involved the industry body, the Seed Crushers and Oil Producers 
Association (SCOPA). 
(See: Hourihane et al., 1997a).  
6.4 Developing as a researcher and consumer / patient advocate 
From 1995, Gowland took an active role in the Campaign’s food industry related 
initiatives, and acted as the point of contact for food queries from consumers as well as 
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manufacturers, retailers and caterers. A permanent staffed office was established in 
1997, and Moira Austin became the full time helpline manager. Gowland would receive 
requests to make contact with families reporting an allergic reaction and would work 
with Austin to identify the relevant product, and then contact the retailer or 
manufacturer.  At that time, calls from the Campaign would often be put through 
directly to a food technologist or member of staff working on the factory production 
line, and together an investigation would follow. The results of such investigations 
would be explained to the family reporting the problem, and if necessary, the product 
might be withdrawn from sale. The Campaign began to send out postal alerts to 
members who had listed the relevant food allergies on their membership renewal forms.  
There were four important outcomes of this investigative work: 
 The person or family making the complaint would be fully informed by a trusted 
support organisation about what had happened  
 Gowland and colleagues became very well informed about food production 
throughout the supply chain from field, to factory, retail and catering 
 They would negotiate for better practice in the medium and longer term on 
behalf of those at risk so that the wider public would be protected from 
consuming products containing unlabelled allergens  
 The practice of targeting food allergy alerts at high risk food allergic consumers 
was established.  
6.5 The Anaphylaxis Campaign member database and allergy product alerts 
From 1999, Campaign members who had declared particular food allergies on their 
membership forms would be notified by post if there was a relevant allergy product 
alert. In the absence of more formal prevalence data, summary information about the 
number of members avoiding particular allergens, as well as the frequency of alerts 
concerning those allergens supported other impact assessment initiatives. There was a 
steady increase in both the number of times allergy product letters were sent, and the 
number of members receiving them for different foods from 1999 – 2003. See Figure 8. 
Gowland continues to review Campaign member data as one indicator of UK allergy 
prevalence for different foods.    
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Figure 8: Anaphylaxis Campaign product alert letters sent 1999 - 2003 
 
The Campaign also funded subscriptions to industry journals, for example Caterer and 
Hotelkeeper, the Grocer and Tolley’s Food Safety which were read by Gowland who 
reported back to the Campaign’s National Executive. At first, this was primarily a fact-
finding activity, but Gowland started to enter into correspondence to raise food allergy 
issues, and was soon recognised as an expert in this field and asked to write for these 
and other publications. Such widely-read publications brought food allergies, the 
Campaign and Gowland’s role into a more public arena and led to invitations to attend 
and then to speak at food industry and research events.  
Further invitations were extended to visit sites, review and advise on allergen controls 
and to deliver training. An early client was the National Exhibition Centre in Birmingham. 
Gowland and the technical manager visited the on-site production unit, as well as fine 
dining, counters, vending and events management, examining the information available 
for people with food allergies, intolerances and coeliac disease, as well as ways to reduce 
cross contamination and implement best practice. Staff at all levels were included in an 
advisory and consultation activity leading to a bespoke allergy training programme 
delivered by Gowland in support of the organisation’s new allergy policy and practice.  
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In 1997, following dialogue with Sir Cranley Onslow MP (who became the Campaign’s 
chairman) and Jeff (now Lord) Rooker, the government food allergy team at MAFF 
supported by the Anaphylaxis Campaign (Reading and Gowland) and foodservice 
industry led a national campaign for the catering industry to raise awareness of the 
needs of people with food allergies, intolerances and coeliac disease, and to provide 
best practice guidance, window and counter stickers (W1 – 1997). Gowland was 
interviewed on television and radio as a food allergic consumer and as a project adviser. 
This was a pioneering initiative. Packs of materials were addressed to catering 
businesses using the Yellow Pages database. Unfortunately, the turnover of small food 
businesses can be quite high and the database was not up to date so many packs were 
not used. A review was undertaken and lessons learned about optimising information 
distribution for future campaigns.   
Following complaints from families with food allergic children about the letterbox 
distribution of cereal packets and sweets given to children in supermarkets, Gowland 
worked with the Direct Marketing Association and the Advertising Association to 
communicate allergy risks and to develop policies and best practice for sampling 
through letterboxes, and also in shops and other situations where people are offered 
food and drink samples to try.  
Gowland established working relationships with people who would become useful allies 
and introduce her to others. These included (now Professor) Dr Lisa Ackerley, leading 
Environmental Health consultant whose local food safety and health and safety 
consultancy Hygiene Audit Systems supported a number of leading restaurant, leisure 
and hospitality clients for 25 years.  Networking became increasingly significant, as did 
establishing a reputation as the leading UK allergy expert adviser in catering and 
hospitality. Long-standing relationships were also established with key individuals at 
Sainsbury’s and Whitbread as well as with professional bodies such as the Institute of 
Food Science and Technology and the industry research organisations; Leatherhead 
Food Research Association,  Campden and Chorleywood Food Research Association and 
the Institute of Food Research. The Institute of Grocery Distribution working group 
(including Gowland) produced an early guide; This product may contain nuts – Voluntary 
labelling guidelines for food allergens and gluten in May 2000.   
101 
 
She was approached by a food technologist master’s student for help with his thesis on 
allergen management in the commercial bakery sector – the first of many master’s 
students to receive her encouragement and guidance. 
By mid-1996, Gowland was no longer teaching. Allergy work became her main 
occupation, and she started to accept fees for consultancy. This led to the 
establishment of Allergy Action, her sole trader organisation in 2000, with its 
associated website www.allergyaction.org .  
Working with Ackerley and with other local authority and private sector environmental 
health and trading standards officers initiated a campaigning and research interest in 
the regulatory protection available for people with food allergies, intolerances and 
coeliac disease. A landmark prosecution in 2000 following the hospitalisation of a 
student in Hull (who had eaten a curry containing peanut, having asked for it to be 
peanut free) led to close working partnerships with a number of local authorities and 
Public Analysts who undertook sampling projects, advised businesses including many 
takeaways, and supported consumers making food allergy complaints.  
One high profile sampling project looking at undeclared peanut in curry was led by Dr 
Ian Leitch in Northern Ireland, assisted by (now Dr) Michael Walker, Public Analyst in 
Belfast. This work received considerable media attention including an episode of the 
BBC consumer programme, The Food Police (Leitch et al., 2005). Undeclared or 
unrecognised peanut in curries and similar dishes has caused a number of fatal and 
many more ‘near miss’ reactions and remains a focus of regulatory attention in 2018.   
From 1998 Gowland started to make contact with professional bodies involved in food 
safety and standards, health and safety and public health starting with the Chartered 
Institute of Environmental Health (CIEH), the Society of Food Hygiene and Technology, 
the Royal Institute of Public Health and Hygiene (RIPHH), the Association of Public 
Analysts (APA) and the Royal Environmental Health Institute in Scotland (REHIS).  
  
102 
 
6.6 Understanding fatal and ‘near miss’ allergic reactions to food 
From 1994 – 1998 Gowland’s work focused on reducing risks from food. Other 
volunteers and paid staff (Reading and Austin) focused more closely on work with allergy 
clinicians and researchers. The Campaign had a news subscription service for allergy and 
anaphylaxis stories in newspapers and magazines. Gowland had collected cuttings and 
notes from fatal allergic reactions since 1988. Reading attended early inquests, 
maintained contact with bereaved families and acted as spokesman when necessary. 
Calls and letters to the Campaign helpline reporting reactions were reviewed by Austin 
who passed cases onto Gowland. Phone calls, letters and eventually emails with families 
and friends provided information and support. Austin and Gowland both became very 
experienced in recording full details of reactions reported, and worked in partnership to 
establish ethical standards and working methods to obtain consent to share some 
details with clinicians for research purposes. 
In February 1998, Gowland became closely involved with one particular family whose 
daughter, Katherine Baker had died in her home town. Gowland attended the funeral 
and provided family support at the inquest and afterwards. Money raised for the 
Anaphylaxis Campaign at Katherine’s funeral was used to print leaflets (W2 – 1998) 
which were distributed through the Bradford and Bingley Building Society where her 
mother worked.  These provided information about potentially fatal allergies and were 
used to raise further funding (c £7000) to buy and distribute the Anaphylaxis Campaign’s 
information video to schools in Hertfordshire, Bedfordshire, north London and the 
surrounding areas where funds had been raised. Further copies were given to nurseries 
and to local authority under eights officers for people to view and pass on. Gowland also 
supported the family in a number of media initiatives including newspaper and magazine 
articles and television.  
An issue arising from this fatal case was the likelihood that people experiencing a severe 
allergic reaction might walk into a community pharmacy for help. It was therefore 
important for community pharmacists to be trained and ready to recognise symptoms 
and source and deliver injectible adrenaline as the first line community treatment. The 
family worked with Gowland, Boots the Chemist and Dr Pamela Ewan (consultant 
allergist) to draft an information leaflet (W2 – 1998) for distribution in Boots stores. This 
team also worked with the Royal Pharmaceutical Society of Great Britain (professional 
body for pharmacists) on text for the Red Book – a handbook on managing a number of 
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key medical emergencies, including anaphylaxis and severe asthma, for which people 
may seek help in a community pharmacy.  
Following the Baker case, Gowland began to work more closely with Dr Richard 
Pumphrey on investigating, reviewing and attributing fatal reactions supposedly caused 
by or exacerbated by food allergy. Dr Pumphrey was a consultant immunologist at St 
Mary’s Hospital, Manchester with a long-standing interest in collecting data about 
severe and fatal allergic reactions to foods, drugs and insect stings. He had maintained 
a confidential clinical database since the 1980s and was often called by coroners to 
support investigations and give expert evidence at inquests. He published a series of 
fatal anaphylaxis cases (Pumphrey, 2000) and further work with Gowland (who was able 
to provide background information from inquests, news reports and family members) 
led to improved understanding of circumstances and risk factors.  Over time, Gowland 
has maintained contact with many of these families. Lessons learned have been shared 
to protect others and reduce risks.  
6.7 Media recognition – further awareness 
In 2000, the BBC called for nominations for the first Radio 4 Food Programme Awards. 
Gowland was nominated in the Campaigner / Educator category, and as a Finalist was 
invited to St James Palace where she met H R H Prince Charles. It was significant at this 
time that food allergies and associated conditions were recognised in the wider context 
of best practice in food production (W3 – 2000). 
6.8 Expert patient – early journal papers  
Gowland’s early research partnerships with Pumphrey and Hourihane led to an 
invitation to speak at the European Academy of Allergy and Clinical Immunology (EAACI) 
Symposium on Immunological, Chemical and Clinical Problems of Food Allergy in Venice 
in March 2001. Although Gowland was used to preparing lecture and training slides (still 
on acetate), she needed guidance from academic clinical colleagues to draft the 
necessary abstract and research paper. The proceedings were published (P1 – 2001) in 
Allergy, the Academy journal. Gowland’s contribution as an atopic and food allergic 
patient and consumer was written from a life-long personal perspective. It has been 
widely cited, and set the scene for expert patient involvement in allergy advocacy, and 
improved clinician understanding of quality of life and everyday management and 
quality of life issues for food allergic individuals.  
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In 2001, Gowland was also invited to present at the (UK and Ireland) Nutrition Society 
meeting in Coleraine. The audience were primarily academic and clinical practitioners in 
nutrition and dietetics. Once again, the audience were interested in Gowland’s personal 
perspective of living with food allergy for over 40 years. In addition, Gowland, Reading, 
Pumphrey and others had now established a modus operandi for collecting and 
analysing reaction data. This paper examined some recent fatal and ‘near miss’ reactions 
and also called for improved food control by local authority officers to support 
consumers and reduce risks (P2 – 2002).  
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7 Allergy Action – Discussion 
 
By 2000, Gowland had established a reputation as an expert consultant to the food 
industry. She worked regularly with Dr Lisa Ackerley at Hygiene Audit Systems for high 
profile clients including the BBC, John Lewis Partnership and Mitchells and Butlers and 
independently for many others. At the same time, the Anaphylaxis Campaign offered 
her a regular consultancy arrangement, focusing on two key areas: 
 Representing the Campaign with the Food Standards Agency, and on matters 
relating to food labelling, food safety, manufacturing, retail and catering 
including investigating complaints following reactions or poor allergen controls 
 Continuing to support families and friends of people who have died from 
possible food allergy, and to investigate, collect, collate and communicate 
information about the circumstances surrounding fatal and ‘near miss’ reactions 
These parallel roles led to Gowland setting up Allergy Action as a sole trader 
organisation, registering the business name and acquiring associated domain names and 
a website.  
 
Figure 9: Allergy Action website from 2000 
 
As a starting point, Gowland made translations available for people travelling with food 
allergies. They were supplied free of charge by friends and contacts who are native 
speakers of the relevant languages.  
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The translation format could be printed onto paper or card. In recent years, they are 
more likely to be downloaded on mobile phones.  
Figure 10: Allergy Action website - Translations page: 2018 
 
7.1 ‘May contain’ labelling – assessing the impact of nut and peanut warnings 
on prepacked foods 
The MAFF programme to commission and fund food allergy research continued towards 
the end of the 1990s under the Joint Food Standards and Safety Group which included 
officials from MAFF and the Department of Health who together formed the Food 
Standards Agency (FSA) in April 2000. Gowland was invited to attend the annual food 
allergy and intolerance research review meeting in autumn 2000 and has attended all 
meetings since to date as a patient / consumer representative, an expert in food allergy 
risks and a contractor.  
One key research question which remained unanswered was to find out how people 
with nut and peanut allergies (the most common allergies reported to the Anaphylaxis 
Campaign then and still in 2018) managed when buying everyday prepacked foods in 
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supermarkets. There was a perception among food allergic people that certain food 
items (cereals, biscuits, confectionery, bakery items) were increasingly likely to have 
‘may contain’ precautionary allergen labelling (PAL) for nuts and peanuts, possibly due 
to shared production environments and processes.  
Gowland and FSA officials devised a novel methodology to undertake a shopping survey 
to assess the impact of such labelling. 16 everyday prepacked food items were chosen 
and a shopper went into 8 UK supermarkets to try to buy 
their ‘own brand’ versions. The selection time and price 
paid were noted. The shopper then returned to the store 
and tried to buy the same items for a person with a nut / 
peanut allergy.  A similar exercise compared the leading 
brands for the 16 items. It was found to take 39% longer 
to choose the items for the nut / peanut allergic person, 
and cost 11% more. In some cases the allergic consumer’s 
item was plainer or cheaper. Further work was 
undertaken to examine the presentation of ingredients and ‘may contain’ precautionary 
allergen labelling for nuts and peanuts – colour, text size and style, shiny packaging, 
colour contrast, and proportion of the packaging surface. Lastly packets were examined 
by a number of individuals who had to decide whether or not the product would be 
suitable for a person with a nut / peanut allergy. One in ten ‘may contain’ precautionary 
allergen labels was missed (W4 – 2001). The study report was published by the Food 
Standards Agency and attracted national and international interest. It set a standard for 
accessible quantitative and qualitative food allergy consumer research. Gowland 
presented this study at the FSA Food Allergy and Intolerance research meeting in 
November 2002.  
7.2 Consumer advocacy 
From its earliest days, the Anaphylaxis Campaign (Reading, Austin and Gowland) was 
invited to participate in Food Standards Agency consultations, for example advising on 
the Agency’s Strategic Plans for the 5 years ahead and commenting on food labelling, 
food safety and food enforcement proposals. Gowland also contributed to a 360 
degree appraisal of board members and participated in tender evaluation for food 
allergy research projects (when she wasn’t a possible contractor herself.) The 
Campaign, (usually represented by Gowland) was trusted by other consumer and 
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patient advocacy organisations on food allergy issues, and worked closely with 
associated charities eg Coeliac UK and Allergy UK on FSA Consumer committees and 
panels, and drafting consumer information. 
7.3 Improving access to allergy health care 
From 1998, Gowland worked with consultant allergist Dr Pamela Ewan to understand 
and map allergy patient care pathways for policy makers, health care commissioners 
and patients. Together with Keith Gowland, they mapped out the model (W5 – 2003 and 
W6 – 2004). A version of this diagram was first prepared for a meeting with Tessa Jowell 
MP, Minister for Public Health in 1998, and used by Dr Ewan in her paper The Provision 
of allergy care for optimal outcome (Ewan, 2000). It was reused in two further reports 
lobbying for improved allergy patient care by the Royal College of Physicians in 2003, 
and the House of Commons Select Committee on Health report; The provision of allergy 
services in 2004.   
Figure 11: Mapping care pathways for allergic disease 
 
From its earliest days, the Anaphylaxis Campaign participated in government and 
industry food allergy initiatives. David Reading reviewed the MAFF booklet (Food Allergy 
and other unpleasant reactions to Food (Foodsense 1994). In 1998 the Institute of Food 
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Science and Technology (IFST) invited Gowland to review a new chapter Dealing with 
allergens in Good Manufacturing Practice – A guide to its responsible management in 
1998. This is a widely used industry guide and the inclusion of this chapter reflected work 
underway across all sectors of food supply to develop and adopt best practice for 
effective allergen control. (Gowland was invited to address the IFST conference in 2002, 
and worked with David Reading to prepare an article for the IFST journal in 2004.) 
In 2002, Gowland was invited to speak at an international food industry conference 
organised by the Leatherhead Food Research Association. By this time, working 
partnerships had been established between leading allergy clinical researchers, food 
scientists and technologists, regulators, particularly the Food Standards Agency and 
consumer / patient support organisations. Victoria Emerton and the Leatherhead team 
organised the conference and then commissioned the speakers to write chapters for 
Food Allergy and Intolerance Current Issues and Concerns (B1 – 2002). Gowland’s role 
now extended beyond representing the expert patient and consumer interest. She had 
recognised expertise in collecting, managing and reporting data about severe allergic 
reactions, consumer research into shopping with an allergy and strategies to control and 
communicate the presence of food allergens throughout the food supply chain.  
Another partnership was established with the Coroners' Society of England and Wales 
following a number of fatal reactions in 2003. Pumphrey and Gowland had contributed 
to coroner’s investigations including giving expert evidence. One of the coroners with 
whom they had worked edited the Society’s annual report in 2004 and invited them to 
submit an article, Investigating deaths from allergen-induced anaphylaxis and asthma 
(W7 – 2004). 
7.4 Sesame allergy  
Data from early surveys undertaken by Gowland for the Anaphylaxis Campaign into 
sesame allergy remained unpublished. Following the ‘May contain’ study into shopping 
with a nut / peanut allergy (W4 – 2001), there was interest in assessing the impact of 
other food allergies. Sesame was chosen a) because some people with nut and peanut 
allergies reported being allergic to it b) because reactions to sesame were being 
reported and c) because food industry representatives needed a clearer understanding 
of the controls they needed to implement to protect those at risk.  
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Industry funding was made available to revise the previous questionnaire, to send it out 
to Campaign members reporting sesame allergy, and for Gowland, Derby and Hourihane 
to collect, collate, review and report the findings.  It also provided an opportunity to 
phone subjects to obtain more details of the foods thought to have triggered symptoms 
and the timing and progression of those symptoms (P3 – 2005). 
Collecting and recording details of allergic reactions was increasingly standardised. 
Gowland contributed to developing the Anaphylaxis Campaign Reaction Record form 
which was used in further studies including Uguz et al. (2005).   
It was also recognised that improved understanding of the quality of life aspects of life 
with food allergy could be useful in patient and consumer advocacy. One innovative 
early study undertaken by a Southampton medical student was Avery et al. (2003), 
which used diaries and disposable cameras to record food allergy-influenced events in 
the lives of primary aged children.   
7.5 Developing resources and training tools 
The Anaphylaxis Campaign had produced a general 
information video about anaphylaxis in 1997 and its 
printed catering guidance was available by post, and 
online, but a need was identified for a video and linked 
training resources for use in food businesses and 
particularly for caterers and those selling non-prepacked foods. In 2006, Gowland, Dr 
Lisa Ackerley and colleagues at Hygiene Audit Systems developed and produced a DVD 
Training Pack for Food Handlers. Environmental Health Officer, Dr Ian Leitch was the 
script editor for this project.  
Filming began in January 2006. Ackerley’s contacts at the John Lewis Partnership 
catering department provided a working kitchen and workplace dining area. Other 
locations included the local market, restaurants and takeaways. The actors included the 
kitchen staff, drama students and family members. A professional actor (who had lost a 
family member from severe food allergy) narrated the film.  
Accessible learning was made possible through a 17 minute mini drama featuring a 
range of food preparation and catering scenarios and a severe allergic reaction, followed 
by a 6 minute review, and then tutor’s notes and a short multiple choice assessment 
with an aide-mémoire for students to keep. Recognising that people providing food 
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training come from a range of backgrounds and experience, the pack allowed more 
experienced trainers to use it flexibly, whilst less confident trainers could adhere more 
closely to the suggested lesson plan.  
The Allergytraining DVD Training Pack Allergy awareness: an introductory pack for food 
handlers won the Society of Food Hygiene and Technology ‘Best new product’ award in 
2006 and was also accredited as a training tool by the Royal Institute of Public Health 
(W9 – 2006). 
7.6 Work to ensure food law protection for consumers with food allergies, 
intolerances and coeliac disease 
Early surveys on milk and egg allergies and sesame allergy (as described above) provided 
UK officials at MAFF with evidence to support initiatives undertaken by the international 
Codex Committee on Food Labelling (CCFL) from mid-1990s to improve food allergen 
information and to prioritise the needs of consumers at risk. One particular issue was 
the 25% rule. If a product (eg a biscuit) contained toffee pieces which made up less than 
25% of the biscuit, it was not necessary to list the ingredients of the toffee pieces, even 
if they included key allergen ingredients eg milk or nuts. This presented significant 
challenges to allergen avoiding consumers, as did the absence of ingredient and allergen 
information for catered and non-prepacked foods, and the growing presence of 
precautionary allergen labelling (PAL) also described as ‘may contain’ labelling  
EU Directive 2000/13/EC on the labelling, presentation and 
advertising of foodstuffs established principles which began 
to benefit these consumers, but were far from adequate. For 
the first time businesses supplying ‘mass caterers’ needed to 
provide ingredients information, but as yet, there was no 
specific requirement to label allergens.  
Whilst work was underway to develop legislation at EU level 
to protect these consumers, the Anaphylaxis Campaign 
(Gowland) and the Food Standards Agency worked together and independently to 
develop consumer and business guidance to improve understanding and reduce risks. 
The FSA produced a catering booklet, Be allergy aware, and associated posters in English 
and other community languages in 2001.  
112 
 
Gowland attended stakeholder meetings to develop and review these resources. She 
also established working relationships with two Food Standards Agency board members, 
chef and restaurateur, Robert Rees and Public Analyst, (now Dr) Michael Walker who 
became a collaborator and co-researcher (see above). In 2003, Gowland and EHO, Dr Ian 
Leitch gave evidence on food allergens and controls to the FSA Board. This was an 
important period in the development of principles and practice leading to 
improvements in both food standards and food safety for food allergic and intolerant 
consumers.   
Food allergies were now more widely recognised. The deaths of young adults from 
food (usually peanut / nut) allergy received national media attention, more often on 
television and radio at this time. Parallel initiatives were underway to improve access 
to expert patient care, and to support children and young adults in childcare, school 
and leaving home. Gowland and Reading were often called to give interviews and 
support journalists writing comment articles. A Mintel survey in 2003 looking into food 
safety identified food allergies as the most important food safety concern for young 
people aged 15-24 (Daily Research News Online (UK) High concerns over food safety in 
UK 2003). 
7.7 Evidence to the House of Lords enquiry into Allergy 
By 2006, the framework of food allergy stakeholders and advocates was well-
established and many were working collaboratively. Work (with which Gowland was 
not directly involved) had been underway since 1994 to improve access to specialist 
allergy healthcare and better management of all allergy-related symptoms. David 
Reading, and the Anaphylaxis Campaign National Coordinator, Mandy East (who also 
worked for the National Allergy Strategy Group parliamentary organisation) worked 
closely with Dr Pamela Ewan and leading clinicians, regulators, officials and others at 
parliamentary level. The House of Lords Science Committee called for evidence in 
2006, and held face to face sessions in 2007. Gowland was called to give evidence with 
Dr Richard Pumphrey with whom she worked on understanding and reporting fatal 
allergic reactions, and Dr Ian Leitch with whom she was working on the role of local 
authority officers and measures to improve training and understanding for food 
businesses (W11 – 2007). The House of Lords Evidence and Report helped to shape 
policy in public health, NHS specialist provision and FSA and local authority activity. 
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7.8 Further work to ensure food law protection for consumers with food 
allergies, intolerances and coeliac disease  
Feedback from Campaign members and others also indicated that EU Directive 
2000/13/EC was not meeting the information needs of consumers at risk of reactions to 
foods. It was recognised that they depended not only on accurate food information (ie 
labelling or ‘standards’) but also on food safety, for example that food should be 
prepared safely and protected from cross contamination.  
Food law - national and EU regulation and much local authority food control activity 
separated these two key areas, not least in parts of the UK where food composition 
(labelling or standards) was (and is still) controlled by Trading Standards Officers (TSOs), 
usually operating at county level, whilst food safety (managing risks) was (is) controlled 
by Environmental Health Officers (EHOs) working at city or district level. In other areas 
EHOs also controlled food standards (Scotland, Northern Ireland, London Boroughs and 
some unitary authorities). Early food allergy-related prosecutions (eg in Hull in 2000 – 
see above) had been taken by TSOs using the Food Safety Act 1990, which includes an 
offence of ‘selling food not of the substance demanded’ and another one of ‘misleading 
consumers’.  
Figure 12: Food Allergy involves both Food Standards and Food Safety  
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Both TSOs and EHOs had undertaken sampling and awareness projects, often working 
closely with Gowland to target areas with high risk populations (eg students and young 
adults) and foods (eg takeaways) and raise awareness of the findings. It was obvious that 
the protection of food allergic / intolerant consumers crossed both food labelling and 
safety. Gowland prepared the diagram above to demonstrate this. However, there was 
resistance to including food allergen control with other food hygiene / food safety 
controls. TSOs were not usually trained in food safety, and some were reluctant to 
advise on allergen controls, whilst EHOs had traditionally focused their attention on 
microbiological foodborne disease.  
New food safety legislation (Regulation (EC) No 178/2002 of the European Parliament 
and of the Council of 28 January 2002), placed emphasis on food safety being dependent 
on the accuracy of information supplied with the food. For the first time, businesses 
selling food were required to take into account the needs of people with food avoidance 
needs who might consume it. In determining whether any food is injurious to health, 
regard shall be had: … (c) to the particular health sensitivities of a specific category of 
consumers where the food is intended for that category of consumers (Article 14).This 
law has been used to prosecute food business operators who served food containing an 
allergen to which the consumer was allergic / intolerant, in cases where the avoidance 
need had been explained in advance.  
From 2001 the principle of identifying priority allergens was established. Gowland 
worked closely with a group of stakeholders representing the UK and wider EU food 
industry, allergy clinicians, other consumer advocates, scientists, regulators including 
EHOs and TSOs, the Food Standards Agency Allergy and Labelling teams and the 
Directorate General for Health and Consumer Protection (DG SANCO) in Brussels in 
shaping the new food labelling regulation. Directive 2003/89 EC (published in November 
2003 and in force from November 2005) amended Directive 2000/13 EC so that key food 
allergens (listed in Annex IIIa) would need to be declared on prepacked foods. Eight tree 
nuts were listed by name.  
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(This list was extended to include molluscs and lupin in Directive 2006/142 EC in 2006.)  
In addition the principle was established that certain processing methods, not least the 
oil processing method (Neutralising, Bleaching and Deodorising - NBD) would eliminate 
the risk of allergic reactions by denaturing or removing the allergenic proteins, and that 
labelling the allergen as present when it was no longer present in active form was not 
only misleading, but may also lead to people believing falsely that their allergy had 
resolved. An expert panel at the European Food Safety Authority (EFSA) was able to 
review portfolios of evidence and supply opinions on whether a particular food allergen 
(in a particular form) should be added to or removed from the Annex IIIa. During the 
drafting period, Gowland (as a consumer representative) was asked by industry and 
regulatory colleagues to make contact with DG SANCO officials to ensure that the 
regulation would ensure this flexibility.  
Although Directive 2003/89 EC enabled consumers and caterers to identify allergen 
ingredients in foods they had bought, there were a number of key areas where food 
allergic, intolerant and coeliac consumers were still at risk.  
 The Directive did not enable consumers to obtain allergen or other ingredients 
information when eating out or buying non-prepacked foods 
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 The possibility of unintended allergen presence and associated precautionary 
allergen labelling - PAL) were not regulated for prepacked or non-prepacked 
foods.  
 Food Safety Regulation (EC) No 178/2002 was useful but usually depended on a 
consumer having declared their allergy or intolerance before ordering their food 
 Other legislation (eg 852/2004 EC) requiring food businesses to undertake 
hazard analysis to assess and control risks to ensure a high level of consumer 
protection with regard to food safety did not specifically include allergen risks 
In practice, like manufacturers and major retailers, many larger foodservice businesses 
were already managing food allergens within their Hazard Analysis and Critical Control 
Points (HACCP) systems, or in a parallel but separate allergen management system. 
Gowland wrote to David Byrne, EU Commissioner for DG SANCO, in September 2004 to 
ask for allergen risk assessment to be included in hazard analysis (HACCP). The 
practicalities of implementing even simple hazard analysis and risk management in 
smaller food businesses proved a challenge. Allergen information and controls were 
addressed inconsistently in food safety policies and inspection reports.  
  
117 
 
8 Implementing an action plan - Discussion 
 
In 2003, Gowland undertook a strategic review of progress to date on reducing allergy 
risks, for the Anaphylaxis Campaign. Recent fatal reactions from takeaways and at 
weddings and parties led to a focus on catering and foods consumed away from the 
home, as well as the need for improved education and training in nurseries, schools and 
universities. This involved recognising all current partners, and also identifying others 
with whom we might work. The partners were classified under these headings:  
Gowland then prepared the Action Plan below, using this colour coding 
 
An action plan with aims and objectives under these headings was drawn up and agreed 
with Campaign colleagues. It was also shared with the Allergy team at the Food 
Standards Agency, and other key partners, and became the focus for Gowland’s 
Campaign and independent work from 2003 until 2008.  
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Figure 13: Gowland’s Action Plan identifying partners 2003 
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8.1 Work with local authority environmental health and trading standards 
officers  
It was recognised that local authority food officers (EHOs and TSOs) had a key role in 
supporting consumers with food allergies, intolerances and coeliac disease, and 
Gowland and Campaign colleagues had worked closely with some key individual officers 
and teams around the UK since the mid-1990s.   
Gowland had given presentations at EHO and TSO Continuing Professional Development 
(CPD) and FSA update programmes and other events in England, Scotland, Wales and 
Northern Ireland. She spoke at Chartered Institute of Environmental Health (CIEH) and 
Trading Standards Institute (TSI) conferences and contributed articles to professional 
journals including that of the Royal Environmental Health Institute in Scotland (REHIS). 
In all, it was likely that over 750 of the estimated 1400 UK food enforcement officers 
may have attended an event which included a presentation on food allergies and 
supporting those at risk, either delivered by or with content produced by Gowland 
during this period. 
Some officers had been involved in investigating fatal and other reactions or undertaking 
follow-up projects to identify undeclared allergens, particularly in takeaway meals. 
Others were developing materials to raise awareness among food businesses through 
cascaded training events and publicity campaigns. It became increasingly clear that 
there were differences in policy and practice between local authority teams.  
Gowland’s strategic review had identified these officers as critical to supporting 
consumers and food businesses so in September 2004, a questionnaire was circulated 
by email to find out what UK Local Authority food enforcement officers were doing to 
protect allergic consumers, what training they had received and what resources they 
were using. This followed the first survey undertaken by Dr Ian Leitch in 1999 which 
established that only 6 of 37 of Northern Ireland officers surveyed were engaged in any 
activities to protect allergic people, and that only one officer had received previous 
training in food allergen controls (Leitch et al,. 2001). 
Although the survey was not formally published, the results were shared with the FSA 
Allergy Branch and shaped a number of key initiatives to train local authority officers 
throughout the UK in 2007-08, and to provide printed and online materials for 
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consumers, businesses and EHOs and TSOs. Gowland then repeated the survey in 2008 
to assess the impact of the FSA initiatives.  
8.2 Work with food manufacturers – establishing best practice for allergen 
controls and information for prepacked foods 
David Reading and Hazel Gowland had both worked closely with leading food 
manufacturers since the mid-1990s. This included visits to production sites around the 
UK, learning about the practicalities and constraints of food production, gaining an 
understanding of food science, food safety and food allergen controls throughout the 
supply chain and establishing working relationships with staff and particularly food 
technologists and quality assurance teams. Sites visited were producing a range of 
products including breakfast cereals, biscuits, confectionery, Christmas cakes and 
puddings, cream crackers, raw meat products, cooked meat products and pies, party 
cakes, fruit and vegetable washing and packaging, chilled desserts, ready meals and 
ambient sauces. Gowland was invited to review pilot projects to redesign production 
facilities and equipment, and verification and validation of cleaning and allergen 
management processes and staff training.  
This ‘hands on’ experience for a wide range of food types and production environments 
was useful for the FSA’s next project – voluntary best practice guidance for food 
manufacturers. (Guidance on Allergen Management and Consumer Information FSA 
2006 (W8 – 2006).  
The FSA Allergy branch brought together a working group of key stakeholders including 
the Food and Drink Federation (representing manufacturers), the British Retail 
Consortium (representing supermarkets and other retailers), EHOs and TSOs 
representing the Local Authority Coordinators of Regulatory Services (LACORS) and 
Gowland representing the Anaphylaxis Campaign. They collected examples of best 
practice for allergen risk assessment, management and communication and produced a 
definitive 58 page practical guide which included worked examples and useful contacts 
and resources. This guide was widely adopted and set standards for improved allergen 
management in food manufacturing. A simplified version of the guidance was made 
available for smaller scale food producers (A5 Leaflet for small businesses - Allergy: 
What to consider when labelling food: A guide for small businesses that make or sell pre-
packed food 2006 and the Welsh version Allergedd). 
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8.3 Work with caterers and businesses selling ready to eat foods – establishing 
best practice for allergen controls and information for non-prepacked foods 
Attention now focused on non-prepacked and catered foods. Between 2006 and 2008, 
the FSA undertook a number of projects to identify food allergy risks, and develop best 
practice for catering and open food suppliers. At the same time it was recognised that 
EHOs and TSOs would be better able to provide advice and protect food sensitive 
consumers if they had appropriate training and resources available. 
Another FSA working group was established, with similar representative stakeholders to 
the previous group, and additional representation from catering suppliers and the 
hospitality sector. Gowland provided expertise in consumer behaviour and expectations 
and also from consultancy projects developing codes of practice and training with a wide 
range of caterers and other food businesses. The FSA published the second guide; 
Voluntary food industry guidance The Provision of Allergen Information for Non-
Prepacked Foods in 2008 (W13 – 2008). 
8.4 Developing materials and training for Environmental Health and Trading 
Standards Officers throughout the UK 
The FSA commissioned Dr Ian Leitch to research and tailor the core knowledge and skills 
required by EHOs and TSOs in supporting food businesses. Key FSA staff from the Allergy 
branch and the Enforcement team reviewed the practicalities of including food allergen 
controls in the everyday activities of local authority food officers.   
In autumn 2006, the FSA put out a tender for a training project to develop and deliver a 
pilot workshop with online pre-course learning for Food Environmental Health and 
Trading Standards Officers in England. The contractor appointed was Hygiene Audit 
Systems in partnership with Allergy Action.  
Gowland worked closely with Dr Lisa Ackerley and experienced EHO and interactive 
trainer Karen Martin to develop the online learning and administer and deliver the 
courses. A pilot one day workshop was delivered successfully in London in December 
2006 and was followed by a programme of 10 further workshops in January – March 
2007 delivered by Gowland and Martin. The programme was then extended to include 
workshops for officers in Scotland, Wales and Northern Ireland. In total 1043 officers, 
Public Analysts and FSA staff participated and 49 courses were delivered, finishing in 
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spring 2008. An FSA representative said that the workshop programme was ‘a 
phenomenal success’ (W10 – 2006). 
The new FSA industry guides and associated posters and leaflets were distributed to all 
delegates (A5 Leaflet for restaurants, takeaways and other businesses preparing and 
selling non-prepacked foods Food Allergy: What you need to know and A3 laminated 
poster for caterers selling non-prepacked foods Think Allergy). 
The course content was then developed into free online learning for food handlers, 
still available in updated form on the FSA website 
(http://allergytraining.food.gov.uk/english/ ). 
8.5 Developing and delivering a cross-border training programme and 
conferences in Ireland 
During this period a separate project was underway across the border of Northern 
Ireland and the Republic of Ireland funded by the CAWT and safefood organisations. 
Allergy Action (Gowland), Hygiene Audit Systems (Ackerley) and Allergy Audit (Dr Ian 
Leitch) had successfully tendered to deliver a programme of one day programmes with 
online learning and conferences. 45 Northern Ireland and 50 Republic of Ireland EHOs, 
and Public Analysts participated and cascaded key messages and best practice to their 
colleagues. This project also provided officers with extensive supplies of additional 
resources for distribution to food businesses including dialogue posters, aide-mémoires, 
key messages and manager’s checklists (W12 – 2008). 
8.6 Update research study on current allergy-related activities undertaken by 
UK Local Authority Food Safety and Standards Enforcement Officers 2008 
The study followed a similar protocol to that used in 2004, and used the same 
questionnaire with tick boxes for the majority of replies, and additional boxes for 
comments about training and resources. In order to provide some indication of the 
impact of the FSA workshop programme, a new question (11a) was added: 
I attended an FSA funded one day workshop on allergens.  
(38% of respondents had done so.)  
This questionnaire was emailed in April 2008 to the 92 food enforcement officers who 
had submitted a completed questionnaire in 2004. Officers were requested to forward 
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the email questionnaire to colleagues working on food standards / safety issues if they 
were no longer working in this area.  
37 officers replied; 27 who had submitted questionnaires in 2004 and 10 who had since 
taken over the work of a respondent in 2004.   
Respondents to the survey included 19/37 (51%) responsible for food standards and 
26/37 (70%) responsible for food safety. Some officers enforce both.  
Respondents reported an increase in work to control and communicate the presence 
of allergens in food businesses in considering legal action relating to food allergens and 
in sampling programmes to assess allergy risks.  
 
Figure 14: Local authority EHO and TSO food allergy activity: comparison 2004 and 2008 
Comments were collected on guidance now available for food businesses, training for 
officers, national guidance and support on enforcement for allergen issues, and the 
availability of materials and resources. It was recognised that further training and 
resources both for businesses and officers were still required, as well as time during their 
inspection visits to discuss and then review allergen controls. Specialist expertise would 
also be valuable for managing and controlling allergy risks (integrated with health and 
safety) in other environments eg childcare, schools, care homes, hairdressers, beauty 
salons but in some cases fell beyond the remit of the Food Standards Agency. 
Gowland collated the replies, and submitted the report to the FSA on behalf of the 
Anaphylaxis Campaign.  
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8.7 European research collaborations - Informall and Europrevall  
David Reading had contributed to an early EU-funded network, Protall, looking at food 
allergenicity and the science behind allergy diagnosis and allergen analysis on behalf of 
the Anaphylaxis Campaign. He and Gowland were then invited to participate more 
formally in the Informall project which followed. In addition to establishing an allergen 
database, consideration began to be given to the needs of consumers and allergy 
patients, and also for the first time, assessment of the economic and social impact of 
living with food allergies.  
From 2004 to 2009, Gowland was one of the consumer / patient representatives on the 
Europrevall Integrated Project. Her main contributions were to work packages looking 
into the quality of life and cost of living with food allergy, and the dissemination of 
findings to appropriate audiences. The development of questionnaires or ‘tools’ to 
assess the impact of quality of life for people with food allergies (and then intolerances) 
led by Dr Audrey DunnGalvin at the University of Cork led to further projects to 
understand key issues and develop policies to reduce risks and improve their lives and 
the lives of people caring for them.  
The project also examined progress towards agreed allergen thresholds to control 
allergens in food production sufficiently to protect consumers at risk, and published a 
number of position papers including (P6 – 2010). Gowland also contributed to a study 
into school preparedness for managing food allergic children in their care in different 
countries. She provided expert patient / consumer insight, and experience as a 
schoolteacher in designing the questionnaire, reviewing the analysed data, and 
contributed to writing and editing the paper (P16 – 2014).  
8.8 Teenagers and young adults 
On-going research into fatal and ‘near miss’ allergic reactions had identified teenagers 
and young adults as a high risk group. Social and physical characteristics of adolescence 
were thought to be responsible – perhaps not having experienced a severe reaction 
ever, or at least not in recent memory, being away from parental supervision, eating out 
and travelling with friends, and co-factors such as poor asthma control and the impact 
of hormonal changes. The need for age-appropriate allergy care and support, possibly 
through transition clinics was discussed. (Now Dr) Hannah Monks, a medical student at 
Southampton University led a study to interview teenagers and young adults in clinic 
and learn more about allergy self-management and attitudes to risk (P7 – 2010).  
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Personalised strategies to undertake risk assessment, make food choices, carry and use 
emergency medication depended on parental, school and social support leading 
towards competent and confident self-management.  
8.9 Modelling the outcome of allergic reactions 
Together with Anaphylaxis Campaign colleagues, Gowland had been collecting details 
of allergic reactions since 1994. As discussed, the Campaign’s Reaction Record 
addressed symptoms, timing, treatment and some details of how the allergen might 
have been encountered – eaten, touched, inhaled etc. Data collected had been 
published formally and presented informally.  
Gowland developed the diagram below (Figure 15) to illustrate the routes which might 
be followed by a consumer, parent or carer following an allergic reaction. It was 
published in a book chapter (B3 – 2014) and has been used to model reactions, 
outcomes and complaints. 
Figure 15: Possible routes of treatment and investigation following an allergic reaction to a 
suspected food from B3 – 2014 
8.10 Review of progress to date - 2008 
126 
 
By 2008, Gowland was recognised as an authoritative partner in advocacy and training 
projects and experienced research collaborator. Through the Anaphylaxis Campaign and 
independently, she had become a ‘hub’, linking a wide range of individuals and 
organisations and helping to identify common ground. On the regulatory front, key 
allergens were now identified on prepacked foods and foods delivered to caterers. Early 
discussions were underway to require the provision of allergen information when eating 
out or buying non-prepacked foods as part of a major EU review of all food labelling 
(which led to Regulation 1169/2011 EC.)  The possible unintentional presence of 
allergens (precautionary allergen labelling – PAL see 5.2 above) was not regulated for 
prepacked or non-prepacked foods. (It is still voluntary in 2018). Debate was still on-
going as to whether a food safety inspection should include the control of allergens as 
well as the traditionally policed risks (chemical, physical and microbiological.)  The Food 
Standards Agency introduced the Food Hygiene Ratings Scheme, but food allergen 
controls were not necessarily included in the associated food safety risk assessment or 
scoring. This was (is) considered misleading by consumers with food allergies and 
intolerances.  
Gowland and Dr Michael Walker continued their research into food allergy-related court 
cases. This led to the poster (A3 – 2011) which was presented at UK (BSACI) and EU 
(EAACI) allergy research meetings.  
8.11 Research into living with a nut and / or peanut allergy 
Anaphylaxis Campaign member data, and reports of fatal and other severe food 
allergic reactions suggested that allergies to peanuts and tree nuts were those most 
commonly reported in the UK population. The Food Standards Agency commissioned a 
consortium led by (now Professor) Julie Barnett at Surrey, then Brunel and now Bath 
University. Gowland acted as expert project adviser with a team of experienced 
research psychologists and Professor Jane Lucas from Southampton University. The 
study included an accompanied shop using a novel ‘thinking out loud’ methodology to 
collect data about consumer decision-making in-store, as well as an in-depth interview 
and a shopping basket activity. Gowland brought experience from her own study in 
(W4 – 2002) and as a peanut / nut allergic consumer, as well as her presentation and 
training skills to prepare the researchers and to analyse the data.  
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The output from the project was significant. In addition to the project report to the Food 
Standards Agency (Final Technical Report T07058 Understanding the food choice 
reasoning of nut allergic consumers), Gowland gave an oral presentation at the EAACI 
Food Allergy and Anaphylaxis Meeting in Venice (A2 – 2011). Papers were published on 
eating out with a nut / peanut allergy (P8 – 2011), interpreting labelling and packaging 
(P9 – 2011) and using ‘May contain’ labelling (P10 – 2011).  Additional data analysis led 
to a poster (A6 – 2012) and papers (P11 – 2012) on travelling with a nut / peanut allergy 
and on other strategies used by consumers and those choosing their food (P12 – 2013). 
Gowland also gave oral presentations on eating out in a restaurant and managing food 
allergies in school at the EAACI Paediatric Allergy meeting in Barcelona (A4 – 2011 and 
A5 – 2011).   
8.12 MSc courses in Allergy 
Gowland had worked with the allergy clinicians at Southampton University School of 
Medicine / Southampton General Hospital since 1996. The part time modular MSc 
course in Allergy attracts students from around the world and from a range of 
backgrounds including general practice, paediatrics, dietetics and immunology. From 
2009, Gowland was invited to give an annual lecture on this programme - Living with 
Allergy (W15 – 2009). This has also involved supporting some student projects.  
From 2016, Gowland was also invited to deliver an annual lecture on the MSc in Allergy 
at Imperial College Medical School, London - Risk Management in Food Allergy (W23 – 
2016).  
8.13 Training partnership in Scotland 
From 2009 Gowland worked with Graeme Kerr of Allergy and Hygiene Systems Ltd on 
developing and delivering a three hour training programme on Allergy Awareness. 
Initially this course was supported and accredited by James Watt College (now West 
College, Scotland) where Kerr was a lecturer. The interactive learning programme was 
shaped for a range of audiences (schools, nurseries, manufacturing, prisons, hospitals, 
hotels and restaurants), and includes a multiple choice assessment (W14 – 2009). 
In 2011, Gowland and Kerr entered into partnership with the Royal Environmental 
Health Institute in Scotland (REHIS) to establish the Joint Award in Allergy Awareness 
(W16 – 2011). 
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They now provide materials, training and support for this accredited award to over 30 
trainers delivering the award in Scotland and two in England.  
8.14 Support for the London 2012 Olympics  
Gowland was invited to produce food allergy guidance for caterers by Sustain - the 
alliance for better food and farming for the London 2012 Olympics (W17 – 2012). 
8.15 Investigating Anaphylaxis Campaign member data and market research 
Gowland and colleagues continued to collect data about Anaphylaxis Campaign 
members avoiding different food allergens. From 2008, these data were presented in 
Campaign talks, and shared with food industry and regulatory representatives.  
It was noted that the list of food allergens on Annex IIIa (see Directive 2003/89/EC) did 
not include some foods to which members were commonly allergic. It was, and 
continues to be important to alert food suppliers to allergies which are ‘on the horizon’ 
or growing in prevalence. Gowland prepared and presented this poster at BSACI (A7 – 
2012). 
Further data on allergens avoided were made available by the study initiated by Dr 
Stella Cochrane and René Crevel of Unilever and undertaken by Mintel.  This 
population survey provided data about consumers with food allergies from different 
areas of Great Britain and subjects from different economic and social backgrounds. 
Poster (A1 - 2010) and journal paper (P13 – 2013) were key outputs from this study.  
8.16 The Food Information to Consumers Regulation  
Regulation (EU) No 1169/2011 EC was developed from 2008 onwards, published in 
November 2011 and enforceable from December 13th, 2014 throughout the European 
Union. One key intention was to ensure that information on key allergens present as 
ingredients should be available for catered and non-prepacked foods. Another was to 
regulate the size of text on packaging to make it more legible. The practice of 
repeating key allergen ingredients in a Contains box was no longer permitted; instead 
they needed to be highlighted (eg bolded) in the ingredients list on packaging.  
Individual member states were required to develop schemes to provide allergen 
information for loose foods, but allowed the flexibility to decide how best this should 
be done. Gowland worked closely with the leading catering organisations, the Food 
Standards Agency and Anaphylaxis Campaign colleagues to establish practical and 
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flexible ways to enable businesses to provide oral information, provided that they 
encourage consumers to make enquiries (by signage on counters, menus and 
websites) and the information is ‘accurate, consistent and verifiable.’  
In order to shape policy and ensure the needs of consumers with allergies, 
intolerances and coeliac disease were best met, the Food Standards Agency put out a 
research call. The core team led by Professor Julie Barnett at Bath University were 
contracted to carry out a questionnaire survey and in-depth interviews with 
representative consumers throughout the UK. The study report, The preferences of 
those with food allergies and/or intolerances when eating out (FS305013) 
https://www.food.gov.uk/sites/default/files/fs305013-final-report.pdf was followed by 
papers on consumer preferences for information, (P23 – 2016), experiences and 
behaviour when eating out with children with a food hypersensitivity, and a summary 
paper reviewing changes in eating out practices with the new law in place (P26 – 
2018). At the time of writing, a final manuscript from this study is under review, 
examining the behaviour and expectations of consumers avoiding different food 
allergens (P29 – 2018). 
8.17 Bringing the new regulation into practice 
The requirement for all food businesses of any size to provide allergen information 
represented a major change in everyday practice. By comparison with food regulators 
in other EU member states, the Allergy and Labelling teams at the UK Food Standards 
Agency were well prepared. Working closely with stakeholders at all levels (including 
Gowland and the Anaphylaxis Campaign), they developed support materials, from the 
simplest information poster to more complex and detailed sector specific guidance with 
helpful visuals and content in community languages. Nevertheless there was a lot of 
work to do. 
Gowland undertook consultancy work for many more clients in 2013-2014 than in 
previous years. She and Dr Chun-Han Chan of the FSA Allergy branch worked in a small 
team to deliver workshops and briefing sessions around the UK for the University 
Caterers Organisation (TUCO) and many others. She also wrote articles on the new 
regulation for different audiences - for example (P14 – 2013) for the Royal Society of 
Public Health (RSPH) and (W21 – 2014) for The Guardian.  
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Stocks of the Allergytraining DVD Training Pack first developed in 2006 were running 
low, and the content needed to be updated to meet the new regulatory requirements. 
Gowland revised the script and included some new film, marketing it through a new 
website www.allergytraining.com .  
The regulation came into force just before Christmas which was not particularly helpful 
for restaurants and hotels at their busiest time of year. Gowland made a comic video 
(W22 – 2014) about all the resources now available to help meet the new requirements. 
She wrote the words, designed the graphics and persuaded musical friends to record 
the soundtrack.    
Parallel work was underway to update the ‘Catering Industry Guide’ for the first time in 
two decades. Gowland was invited to add a chapter on how to meet legal requirements 
to manage and control food allergens (W24 – 2016). 
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8.18 Food fraud: allergen substitution in the food supply chain 
In response to a number of fatal reactions and many more ‘near miss’ reactions 
following inaccurate food description, and possibly deliberate mislabelling (for example 
cheaper peanut substituted for more expensive almond in curries), Gowland and 
collaborator, Dr Michael Walker were particularly aware of the potential risks to people 
with food allergies from deliberate and inadvertent ingredient substitution. Following 
the ‘horsemeat’ mislabelling episode, Walker worked closely with Professor Chris Elliott 
to examine, understand and report on UK food supply networks, and arranged for 
Gowland to give formal evidence of food allergy cases with which she had been involved 
where mislabelling and food fraud might have been involved (W18 – 2013). They also 
presented a poster at the EAACI Food Allergy and Anaphylaxis meeting in Dublin (A9 – 
2015). 
Walker’s work as Consultant Referee Analyst for the Government Chemist Programme 
and on-going partnership with Gowland looking into methods for allergen analysis and 
the forensic aspects of evidence to support regulation continued. Walker coordinates 
the Masters in Chemical Analysis (MChemA) training programme in food examination 
for Public Analysts, and invited Gowland to deliver the key food allergen content with 
him in 2015 and 2017. Both are members of the Scientific Committee of the Institute of 
Food Science and Technology (IFST) who published their article Food allergy - A forensic 
perspective (P17 – 2014).  
They also wrote an article for The Guardian (W20 – 2014). 
8.19 R v Zaman – a landmark case 
On January 30th, 2014, a chef and bar manager, Paul Wilson (38) bought a takeaway 
curry from an Indian restaurant in North Yorkshire. He had had a peanut allergy since 
the age of 7, and asked for his meal to be made without peanuts. This was documented 
on the order docket and on the lid of the meal. Hours later, he was found dead in the 
bathroom of his flat. He had suffered a severe allergic reaction. The remains of his meal 
were on the kitchen table. Analysis of post mortem samples and the curry meal indicated 
the presence of peanut protein.  
The owner of the restaurant, Mohammed Khalique Zaman, had a number of other 
restaurants. One of these had sold a curry meal to a 17 year old girl on January 3rd 2014. 
She had also declared a peanut allergy, and had a severe allergic reaction. She had 
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recovered after emergency treatment in hospital. The local Trading Standards team 
were notified and investigated the restaurant in question. Formal food samples were 
collected and analysed.  A meal sold as suitable for a person with a peanut allergy was 
found to contain peanut protein. In addition, menus indicated that dishes were made 
with almonds when in fact they were made with peanut powder. Staff at that restaurant 
were advised not to sell meals to people declaring a peanut allergy.  
Mr Wilson’s death led to a combined North Yorkshire police and local authority trading 
standards investigation supported by the West Yorkshire Public Analyst and the Food 
Standards Agency. Gowland supported the investigation and provided background 
information about other fatal cases, particularly involving peanut in curries. A supply 
chain investigation indicated that the owner of the restaurants had changed from using 
ground almond to cheaper peanut powder the previous summer. A representative from 
one of his wholesale suppliers gave evidence that Mr Zaman had been advised that the 
new peanut ingredient was not the same as ground almond and might represent a risk 
for some people. He was also advised to update and correct his menus to reflect this 
change which he did not do.  
In May 2016, Zaman was convicted of gross negligence manslaughter. It was considered 
that if he had acted to alert all his restaurants using the peanut powder ingredient 
instead of ground almond, and taken his responsibilities as a food business operator 
more seriously, Mr Wilson might not have died. He was also convicted of a number of 
food offences: Placing food on the market that was unsafe and injurious to health 
(Regulation (EC) No 178/2002 and Food Hygiene (England) Regulations 2013), Selling 
food not of the substance demanded and Falsely describing food as containing almonds 
when it contained peanuts (Food Safety Act 1990). Mr Zaman was sentenced to 6 years 
in jail. Appeals against his conviction and sentence in October 2017 were both dismissed.  
Gowland and Walker continue to examine and review cases involving food allergy and 
the evidence required for a criminal conviction or civil claim. They presented a summary 
poster (A12 – 2016) at the BSACI (UK allergy clinicians) meeting and also at the annual 
meeting of the Association of Public Analysts, and published the paper (P18 – 2015) and 
article (P20 – 2015).  
Their long-standing collaboration with leading professors in chemical and biological 
analysis led to the publication of the critical review paper (P21 – 2016) targeted primarily 
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at the analytical community, but also at regulators and people managing food allergens 
throughout the supply chain.  
The analytical community led by AOAC International (previously the Association of 
Official Analytical Chemists) published an open access special edition of their journal 
looking into many aspects of food allergy and food allergen control and analysis (P27 – 
2018).  
Walker, Gowland and fellow IFST scientific committee member, John Points 
contributed the chapter Managing Food Allergens in the U.K. Retail Supply Chain. The 
influence of UK retailers (primarily supermarkets) in supervising and controlling 
allergens in the supply chain for their own brand products, and also in managing 
relationships with food–sensitive consumers, understanding consumer information 
needs and expectations continues to shape best practice, enhance consumer choice 
and reduce risks for people with food sensitivities.   
8.20 Following the EU Food Information to Consumers Regulation 
This regulation, and its requirement that all businesses preparing and selling food 
should provide information about key allergen ingredients on request were widely 
publicised throughout the European Union. In many cases this was the first time that 
clinicians providing patient advice to people with food intolerances and coeliac disease 
were as well-informed about food regulation to help those in their care. The Food 
Standards Agency produced guidance for consumers from November 2013 Advice on 
food allergen labelling – How to buy food safely when you have a food allergy or 
intolerance.  
Leading allergy physicians and researchers, Professor Nikos Papadopoulos, President of 
the European Academy of Allergy and Clinical Immunology (EAACI) at this time and 
Professor Antonella Muraro, his successor from 2016 were both closely engaged in food 
allergy patient advocacy. It was significant at this time that EAACI prioritised food allergy 
and patient / consumer support. This was achieved a) by influencing the practical 
implementation of food information provision at EU level, b) by setting up the EAACI 
Food Allergy and Anaphylaxis Guidelines Group and c) by ensuring participation from a 
range of clinical stakeholders with close working relationships with patient 
representatives, food allergen scientists and regulators. The resulting EAACI Food 
Allergy and Anaphylaxis Guidelines and paper (P15 – 2014) continue to provide 
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authoritative guidance for clinicians and shape policy at EU level. Gowland contributed 
background information as a food allergic consumer, but also from experience advising 
a wide range of food businesses and shaping regulation and best practice. It became 
important at this time for allergy clinicians advising patients on allergen avoidance to 
understand food labelling, and also the issue of Precautionary Allergen Labelling (PAL) 
also known as ‘May contain’ labelling. One leading UK clinician with an informed interest 
in this area is Dr Paul Turner at Imperial College, London with whom Gowland wrote the 
letter to Allergy (the EAACI journal) (P24 – 2016).  
8.21 Understanding the severity of allergic reactions 
The food allergy community had long recognised that allergic reactions to foods were 
very rarely fatal, and that in many cases, even severe symptoms seemed to wane 
without treatment (Simons, 2008 and P22 – 2016).  Living with the risk of severe 
allergy is unpredictable. It was also recognised that various factors may affect the 
progression of symptoms including the amount of allergen consumed (eliciting dose) 
for the weight of the person, and the form (matrix) in which the food is served, as well 
as co-factors (such as infection, asthma, age, exertion, alcohol, stress, medication).  
Using data supplied by researchers in Australia and the UK (including Gowland’s fatal 
allergy data supplied to the UK Fatal Anaphylaxis Registry), Turner presented a poster 
at the international American Academy of Allergy, Asthma and Immunology (AAAAI) 
meeting in the USA in 2014 (A8 – 2014). 
As described in sections 4.5 and 5 above, it is increasingly recognised that on-going 
work from clinical challenges to establish (minimum eliciting dose) threshold amounts 
of proteins from different foods known to cause allergic symptoms represented only 
one possible component in managing allergens and reducing risks.  
Another component in allergy risk assessment is the likelihood of a food allergic person 
encountering a food to which he or she is allergic. The food industry and others 
recognise that food allergies differ across different populations (Nwaru et al., 2014) 
and are influenced by external factors such as age of moving to a different country 
(Tang et al., 2017).  
Yet another component is the likelihood of a reaction becoming life-threatening. 
Following Pumphrey’s work investigating and reporting fatal anaphylaxis (Pumphrey, 
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2000, and P4 – 2007), Turner, Gowland and colleagues involved in the EU-funded iFAAM 
(Integrated Approaches to Food Allergen and Allergy Risk Management) collaboration 
examined the perception of reaction severity. It was increasingly recognised that 
symptoms which may look dramatic (eg facial swelling, rash) may not be as severe as 
others which are less obvious such as respiratory or circulatory collapse. Some 
individuals who have experienced anaphylaxis may not have a lower eliciting dose of a 
food allergen compared with others whose symptoms are less severe (P22 – 2016).  
As described above, a perennial challenge for food sensitive consumers and for food 
suppliers is the use of precautionary allergen labelling (PAL) or ‘May contain’ warnings 
to indicate the possibility of an allergen being present, not as an ingredient but from 
the production environment. Gowland contributed to best practice guidance eg The 
IFST Dealing with allergens in Good Manufacturing Practice – A guide to its responsible 
management in 1998 and recognised industry standards since (including the British 
Retail Consortium (BRC) Global Standard 2015) which aim to optimise allergen 
segregation and control to minimise the need for PAL.  
Some recent work in this area comes from a consortium which includes experienced 
allergy physicians, many of whom have contributed data from clinical and research food 
challenges which have helped to establish thresholds for different food allergens, and 
understand more about allergy symptoms severity. The consortium which was 
supported by ILSI, an international industry sponsored research organisation also 
included the industry regulatory and scientific community, the regulatory perspective, 
patient and consumer representatives and experts in allergen controls and allergen 
management (P28 – 2018). 
It is now recognised that although quantitative risk assessment (QRA) for food allergens 
has made considerable progress in recent years, its use in practice is limited due to the 
feasibility of including the additional variable of reaction severity. This depends on 
multiple factors, related both to the food and the allergen, and also to the person 
experiencing symptoms, as well as any treatment they may receive. Even when food 
challenges are administered under highly controlled conditions, the relationship 
between dose and severity is complex and not clear.  Epidemiological studies collecting 
reaction data have limited benefit. One answer might be to undertake a single-dose 
challenge – giving everybody the same dose of allergenic protein in the same food item 
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to reliably identify the effect of dose on severity for use in QRA. This might reduce 
uncertainty among people at risk and those who care for them, thereby improving their 
food choice.  
8.22 On the horizon 
The first paper from the TRACE study looking into the relationship between allergen 
dose, severity and associated co-factors has recently been published online (Dua S, et 
al., 2018). 
Further publications and the full study report for the Food Standards Agency will 
follow. They will describe valuable minute by minute details of symptoms 
development at different challenge doses of peanut protein and under any influence of 
a) exercise and b) lack of sleep.   
 
Gowland continues her involvement in other horizon-scanning activities.  One such is 
monitoring foods which are more frequently mentioned as causing more reactions (for 
example peas, beans and other legumes, particularly when used in unexpected foods eg 
bakery items.) This is made easier, not just through monitoring Anaphylaxis Campaign 
member data, but also through social media and particularly Twitter – using hashtags 
such as #foodallergy, #stupidpeas, #stupidsoy, #14allergens #freefrom #hivessuck etc. 
(See Hamshaw et al., 2018).  
Another activity with which Gowland is involved is providing expert insight for 
individuals and organisations working on technological innovations. Dr Lauri-Ann van 
der Poel, consultant allergy physician also has an interest in the FoodMaestro digital 
platform in partnership with the Kings College and Guy’s & St Thomas’ NHS Trust 
(http://www.foodmaestro.me/home.html). It offers mobile apps combined with 
clinically verified data (ie following diagnosis by a health professional), enabling users 
to find products they can eat when living with allergies, intolerances and other food 
avoidance needs. Gowland worked with the dietetics and allergy team on this poster 
(A10 – 2016). 
Twenty four years after Gowland joined the Anaphylaxis Campaign and started her 
allergy work, colleagues continue to monitor and record enquiries from members, 
journalists and many others. These remain one key method of assessing the daily 
impact of severe allergy, and the challenges still faced by those at risk (A11 – 2016). 
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9 Conclusion 
 
When she joined a small team of Anaphylaxis Campaign volunteers in 1994, Gowland 
never anticipated that this would become her main occupation or continue over two 
decades. The time was definitely right for both advocacy and research, and Gowland 
had the opportunity, skills, experience and support from those around her to make a 
viable contribution in this field. One early role of the Campaign was to become a 
recognised and authoritative hub, joining people and organisations who might not 
otherwise encounter one another. Gowland too has become a hub – helping different 
stakeholders connected with allergy to identify and work with others. This is shown in 
the wide variety of publications – journals, newspapers, magazines and other media in 
which Gowland’s work has been disseminated.  
In 2003, Gowland was invited to chair a Food Allergy conference organised by a leading 
food law publication. At first this was a daunting prospect, but it soon became clear 
that she was the only person who knew nearly everybody in the room, and as such was 
able to ensure that all voices were heard, all questions answered and the event was 
considered a great success.  
In a cross-disciplinary role for which there were no formal professional or academic 
qualifications, Gowland has adapted to understand and find common ground with 
many other organisations and individuals. This would not have been possible without 
the support of key colleagues, and particularly David Reading and Moira Austin. Their 
partnership has been innovative, effective, fruitful and enduring.  
It was useful in the very early days that there were enough capable individuals at the 
heart of the Campaign for people to specialise. Gowland had primary involvement with 
issues relating to food – the food industry, regulation, guidance and standards, whilst 
having secondary involvement with issues affecting schools and child care, and also 
contributing to managing a fast-growing national voluntary organisation.  
9.1 Skills development 
Gowland has developed skills in four key areas: 
 Advocacy including media 
 Research methodology 
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 Training  
 Administrative and business skills 
9.1.1 Advocacy skills  
 Political – House of Commons, House of Lords,  European Union and Codex 
 Bereavement support 
 Pastoral support 
 Listening to and representing the interests of families and individuals 
 Taking complaints on behalf of individuals 
 Taking histories 
 Completing reaction records 
 Giving evidence – written and oral 
 Recognised point of contact for the BBC and other journalists 
 TV and radio interviews and also shaping documentaries  
 Writing news articles and press releases 
 Networking 
9.1.2 Research methodology 
 Submitting and developing applications for funding and support 
 Building collaborative teams 
 Contributing to project ethics 
 Literature review 
 Setting up and managing databases 
 Modelling – presenting ideas 
 Preparing abstracts 
 Preparing and producing posters 
 Presenting posters at meetings 
 Giving workshop conference presentations 
 Writing papers 
 Collaborative writing and editing 
 Developing graphics for publications and posters 
 Responding to reviewer comments 
 Explaining science and technology 
 Explaining consumer and patient behaviour 
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9.1.3 Training skills 
 Materials development 
 Session planning 
 Creating a learning environment  
 Developing interactive learning 
 Preparing slides 
 Devising and developing online learning for different audiences 
 Creative learning methods 
 Developing and marketing packs  
 Accredited learning – HCTC / HTF,  RSPH, REHIS  standards 
 Making learning accessible for students and exam candidates 
 Adapting content and materials for care homes, nurseries, schools, colleges, 
university caterers, factories etc  
 Logistics 
 Setting learning aims, objectives and assessments 
 Setting learning standards to reduce risks 
9.1.4 Administrative and business skills 
 Communications – responding quickly and flexibly 
 Writing press releases, giving interviews 
 Public speaking to a wide range of audiences 
 Consultancy – being a trusted and respected authority 
 Supporting business decision-making at all levels from café and factory floor to 
board level 
 Setting up and managing a small business and brand 
 Project tendering and contracts 
 Conference and events management and logistics 
 Film making – script writing, editing, production, managing and directing 
actors, scene-setting, props, sourcing music, artwork, locations, marketing, 
online sales and ethics. 
 Websites – building, designing, managing, retail 
 Collecting and designing content for slide presentations  
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9.2 The Impact of innovation 
In the early days, all communication between Campaign colleagues and others was 
undertaken by telephone, letter and occasionally fax. Most committee members were 
employed elsewhere in the day time, and undertook their Campaign roles in the 
evenings and at weekends. Contact with members was primarily through the printed 
and posted newsletter. The first office was opened and staffed during normal office 
hours in 1997, and Gowland’s earliest emails with the Campaign date from the late 
1990s.  The Campaign was involved in making educational films from 1996 and had a 
website from about 2000 when Gowland also set up her first website as Allergy Action. 
Food allergy product alerts were sent out from 1999, initially by letter from the office, 
then using an external company to print and post out letters, and eventually using 
texts and emails. From about 2000, the Food Standards Agency was also involved in 
allergy alerts and people could subscribe directly to receive them by text and email.   
In more recent years, contact by email and via social media (eg Facebook and Twitter) 
or the Campaign’s website has become more common than by phone or letter. Figure 
16 is taken from poster (A11 – 2016).   
Figure 16: Routes of contact with the Anaphylaxis Campaign 2015 and 2016 
 
In addition, advocacy may involve social media. People who have suffered an allergic 
reaction may raise this with the food business and / or regulatory authority publicly on 
Twitter or Facebook. Reputational damage may be mitigated by a swift response, 
apology if relevant and a thorough explanation of how the incident occurred. 
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Consumers may expect such replies late into the evening; for example, one leading UK 
retailer has staff monitoring and responding to Twitter until 11pm.  
Technological developments have also had an impact on research methodology. 
Subjects (eg for the TRACE Study) were recruited online and via social media. Microsoft 
packages such as Excel (for the hospital admissions and fatal anaphylaxis databases, 
and also for data collection for the milk, egg, sesame and ‘May contain’ studies, and 
for managing student data for training) and Powerpoint (used for lectures and 
presentations and much training) had been available from the late 1990s. Online 
journal access and shared editing using ‘tracked changes’ were more widely used from 
about 2006. This enabled international collaborators in different time zones to add 
timely comments and edits, and respond to reviewer comments promptly. Being able 
to email and share larger files means that working groups can fine-tune amendments 
without the need for face to face meetings.  
Early surveys were undertaken on paper, and data was collected by post. As described 
above, the very first survey on milk and egg allergy involved a short note in the 
Campaign’s newsletter and 300 lengthy letters in reply. The sesame surveys which 
followed involved posting out paper forms and stamped addressed envelopes. A few 
subjects emailed their responses.  
More recently, researchers including many masters’ students use applications such as 
Survey Monkey to collect data. Links to the studies are posted on social media. Some 
studies (eg the FSA funded study looking at consumer behaviour before and after the 
introduction of the Food Information to Consumers Regulation (EU) No 1169/2011) 
have relied on consent being obtained in the early stage for subjects to be contacted 
again to participate in the later stage. It has to be recognised that online surveys and 
other innovations have some limitations and may exclude some people whose views 
may not be represented.  
The internet has also had a major impact on research into severe and fatal reactions. 
News media and social media may pick up a news story involving allergy within days or 
sometimes even hours. Inquests and other court cases may be reported in real time via 
local and national news sites and then circulated via Twitter and Facebook. When 
supporting bereaved and other families, Gowland now has to brief them about the 
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immediate and longer term impacts of media coverage on all family members and 
friends.  
At the same time, it is now possible to watch Twitter feeds and to review and manage 
allergy misinformation promptly. Posting a link to a reputable evidence-based 
publication or adding a corrected précis of a journal paper or news story can often 
limit anxiety and prevent further circulation of inaccuracies. Helping people to find 
trusted information sources is an on-going challenge – see Hamshaw et al., 2018.   
From 2001, Gowland travelled widely within Europe to participate in research 
workshops and European Union funded projects including Informall, Europrevall and 
ILSI initiatives. These, whilst enabling face to face collaboration and the establishment 
of effective working relationships, are expensive in time and travel. More recent 
collaborations have involved partners meeting for a one day workshop at a hub 
location, or more commonly in 2018, a teleconference or online meeting with shared 
screen access.  
9.3 The changing role of patient and consumer support organisations 
The Campaign began because particular needs were identified. These included: 
 Wider recognition of the risks from severe allergies 
 Support in accessing medical care – both for emergencies, and on-going 
specialist care for allergy and related conditions 
 Impact assessment to really understand how many people are living with 
allergy, what people are allergic to and what impact it has on their lives 
 Engaging in dialogue to improve food information and reduce risks in food 
supply to protect those at risk 
 Ensuring regulatory and best practice guidance in a number of areas to protect 
those at risk 
 Support for individuals at risk in different scenarios – school, child care, 
university, workplace, travel etc 
Individual, (health care) professional and corporate food and pharmaceutical industry 
members joined the Campaign to support its aims and to access up to date news and 
information.  This is still the case, but subscription membership of voluntary 
organisations has been in decline for the last decade. Fundraising through sponsored 
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events (eg marathon running) and to some extent through ‘in memoriam’ funding 
continues. External fundraising through charitable trusts is not as accessible as it used 
to be and far more competitive. Economic constraints, attitudes to charitable activity 
and alternative routes of advocacy all have their impact.   
Technological innovations described above have changed the role of patient and 
consumer support organisations, not least the internet. Information is available free 
from a wide range of sources at anytime and anywhere. Training and education can be 
delivered using online webinars and videos eg YouTube. Identifying with, promoting 
and supporting a cause or an organisation can be undertaken for free via social media. 
Tweets, emails, Facebook messages and Mumsnet threads may lead to instant 
comments or replies. Conferences and other events are transmitted in real time and 
posters and key slides shared online.  
9.4 Protecting people with food allergies 
Through this commentary, Gowland has described work to protect consumers with 
food allergies, and her contribution to this since 1994.  
Key research studies which she has undertaken, and with which she has been 
associated have contributed significantly to understanding the impact of food allergy 
from many different perspectives.  
She has established and built on relationships with many different organisations and 
individuals, learning from them, and encouraging and helping them to develop 
strategies, materials, knowledge and skills to reduce risks to people with food allergies.  
Her work with local, national and international regulatory bodies and with those 
developing policies, protocols and guidance across many different sectors has shaped 
both regulation and voluntary best practice. 
Her legacy also includes the establishment of ethical standards and working practices 
for advocacy, research and training to represent the interests of those at risk from 
allergy and those who care for them.  
Whilst her career has often been more reactive than proactive, she continues to adapt 
to new circumstances, remaining focused on understanding and representing the 
needs of those at risk from allergy. This has involved the development of novel and 
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creative methods for advocacy, research and training, and the establishment of lasting 
and successful working partnerships.  
10 Future considerations 
At the viva examination on October 15th, 2018, Gowland was asked by her examiners 
to comment on the underlying principles of her work, and how they would influence 
future work in advocacy, research and training to support and protect those at risk 
from food allergy.  
10.1 Commitment to enabling and empowering  
The key principle of advocacy is that living with food allergy is manageable. With 
appropriate diagnosis, guidance on allergen avoidance, and support in recognising and 
managing symptoms, those at risk and those who care for them should be able to lead 
as full lives as possible.  
10.2 Commitment to building relationships  
Future work to support and protect those at risk should continue to involve identifying 
partners and potential allies, finding common ground and creating alliances with 
individuals and organisations who may be able to raise awareness of allergy risks, 
understand them more fully, and adapt policies and practice to improve lives.   
10.3 Commitment to listening to those at risk 
The final commitment is to recognise that effective advocacy and support depend 
entirely on continuing to listen closely to those living with food allergy, respecting their 
(sometimes conflicting) perspectives and including them and those who care for them 
in food and healthcare policy decision-making for the improved management of 
allergens and allergy.  
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